ticker,company,group,sector,country,quarter,quarter_end,metric,value,currency
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q4,2025-12-31,Tax Effect Of Unusual Items,-3484995.159729,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q3,2025-09-30,Tax Effect Of Unusual Items,-301158000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q2,2025-06-30,Tax Effect Of Unusual Items,-152337192.474674,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q1,2025-03-31,Tax Effect Of Unusual Items,116130000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q4,2025-12-31,Tax Rate For Calcs,0.232333,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q3,2025-09-30,Tax Rate For Calcs,0.338,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q2,2025-06-30,Tax Rate For Calcs,0.267728,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q1,2025-03-31,Tax Rate For Calcs,0.21,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q4,2025-12-31,Normalized EBITDA,3962000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q3,2025-09-30,Normalized EBITDA,4053000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q2,2025-06-30,Normalized EBITDA,4455000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q1,2025-03-31,Normalized EBITDA,3473000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q4,2025-12-31,Total Unusual Items,-15000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q3,2025-09-30,Total Unusual Items,-891000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q2,2025-06-30,Total Unusual Items,-569000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q1,2025-03-31,Total Unusual Items,553000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q4,2025-12-31,Total Unusual Items Excluding Goodwill,-15000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q3,2025-09-30,Total Unusual Items Excluding Goodwill,-891000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q2,2025-06-30,Total Unusual Items Excluding Goodwill,-569000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q1,2025-03-31,Total Unusual Items Excluding Goodwill,553000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q4,2025-12-31,Net Income From Continuing Operation Net Minority Interest,1959000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q3,2025-09-30,Net Income From Continuing Operation Net Minority Interest,1054000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q2,2025-06-30,Net Income From Continuing Operation Net Minority Interest,1676000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q1,2025-03-31,Net Income From Continuing Operation Net Minority Interest,2148000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q4,2025-12-31,Reconciled Cost Of Revenue,6943000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q3,2025-09-30,Reconciled Cost Of Revenue,6596000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q2,2025-06-30,Reconciled Cost Of Revenue,6558000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q1,2025-03-31,Reconciled Cost Of Revenue,6044000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q4,2025-12-31,EBITDA,3947000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q3,2025-09-30,EBITDA,3162000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q2,2025-06-30,EBITDA,3886000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q1,2025-03-31,EBITDA,4026000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q4,2025-12-31,EBIT,3947000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q3,2025-09-30,EBIT,3162000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q2,2025-06-30,EBIT,3886000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q1,2025-03-31,EBIT,4026000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q4,2025-12-31,Net Interest Income,-1069000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q3,2025-09-30,Net Interest Income,-1165000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q2,2025-06-30,Net Interest Income,-764000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q1,2025-03-31,Net Interest Income,-984000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q4,2025-12-31,Interest Expense,848000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q3,2025-09-30,Interest Expense,903000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q2,2025-06-30,Interest Expense,1122000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q1,2025-03-31,Interest Expense,818000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q2,2025-06-30,Interest Income,273000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q1,2025-03-31,Interest Income,30000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q4,2025-12-31,Normalized Income,1970515004.840271,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q3,2025-09-30,Normalized Income,1643842000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q2,2025-06-30,Normalized Income,2092662807.525326,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q1,2025-03-31,Normalized Income,1711130000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q4,2025-12-31,Net Income From Continuing And Discontinued Operation,1959000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q3,2025-09-30,Net Income From Continuing And Discontinued Operation,1054000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q2,2025-06-30,Net Income From Continuing And Discontinued Operation,1676000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q1,2025-03-31,Net Income From Continuing And Discontinued Operation,2148000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q4,2025-12-31,Total Expenses,11506000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q3,2025-09-30,Total Expenses,10928000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q2,2025-06-30,Total Expenses,10991000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q1,2025-03-31,Total Expenses,10040000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q3,2025-09-30,Total Operating Income As Reported,4205000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q2,2025-06-30,Total Operating Income As Reported,3968000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q1,2025-03-31,Total Operating Income As Reported,3538000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q4,2025-12-31,Diluted Average Shares,1984000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q1,2025-03-31,Diluted Average Shares,1994000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q4,2025-12-31,Basic Average Shares,1984000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q1,2025-03-31,Basic Average Shares,1994000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q4,2025-12-31,Diluted EPS,0.99,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q1,2025-03-31,Diluted EPS,1.08,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q4,2025-12-31,Basic EPS,0.99,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q1,2025-03-31,Basic EPS,1.08,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q4,2025-12-31,Diluted NI Availto Com Stockholders,1959000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q3,2025-09-30,Diluted NI Availto Com Stockholders,1054000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q2,2025-06-30,Diluted NI Availto Com Stockholders,1676000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q1,2025-03-31,Diluted NI Availto Com Stockholders,2148000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q4,2025-12-31,Net Income Common Stockholders,1959000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q3,2025-09-30,Net Income Common Stockholders,1054000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q2,2025-06-30,Net Income Common Stockholders,1676000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q1,2025-03-31,Net Income Common Stockholders,2148000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q4,2025-12-31,Net Income,1959000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q3,2025-09-30,Net Income,1054000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q2,2025-06-30,Net Income,1676000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q1,2025-03-31,Net Income,2148000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q4,2025-12-31,Minority Interests,-418000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q3,2025-09-30,Minority Interests,-478000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q2,2025-06-30,Minority Interests,-348000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q1,2025-03-31,Minority Interests,-396000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q4,2025-12-31,Net Income Including Noncontrolling Interests,2379000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q3,2025-09-30,Net Income Including Noncontrolling Interests,1533000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q2,2025-06-30,Net Income Including Noncontrolling Interests,2024000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q1,2025-03-31,Net Income Including Noncontrolling Interests,2544000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q4,2025-12-31,Net Income Continuous Operations,2379000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q3,2025-09-30,Net Income Continuous Operations,1533000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q2,2025-06-30,Net Income Continuous Operations,2024000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q1,2025-03-31,Net Income Continuous Operations,2544000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q4,2025-12-31,Tax Provision,720000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q3,2025-09-30,Tax Provision,726000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q2,2025-06-30,Tax Provision,740000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q1,2025-03-31,Tax Provision,664000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q4,2025-12-31,Pretax Income,3099000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q3,2025-09-30,Pretax Income,2259000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q2,2025-06-30,Pretax Income,2764000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q1,2025-03-31,Pretax Income,3208000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q4,2025-12-31,Other Income Expense,118000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q3,2025-09-30,Other Income Expense,-781000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q2,2025-06-30,Other Income Expense,-486000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q1,2025-03-31,Other Income Expense,605000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q4,2025-12-31,Special Income Charges,-410000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q3,2025-09-30,Special Income Charges,56000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q2,2025-06-30,Special Income Charges,-7000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q1,2025-03-31,Special Income Charges,-49000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q4,2025-12-31,Gain On Sale Of Business,-322000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q3,2025-09-30,Gain On Sale Of Business,94000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q2,2025-06-30,Gain On Sale Of Business,-10000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q1,2025-03-31,Gain On Sale Of Business,-37000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q4,2025-12-31,Other Special Charges,35000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q3,2025-09-30,Other Special Charges,18000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q4,2025-12-31,Restructuring And Mergern Acquisition,53000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q3,2025-09-30,Restructuring And Mergern Acquisition,20000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q2,2025-06-30,Restructuring And Mergern Acquisition,35000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q1,2025-03-31,Restructuring And Mergern Acquisition,12000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q4,2025-12-31,Earnings From Equity Interest,133000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q3,2025-09-30,Earnings From Equity Interest,110000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q2,2025-06-30,Earnings From Equity Interest,83000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q1,2025-03-31,Earnings From Equity Interest,52000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q4,2025-12-31,Gain On Sale Of Security,395000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q3,2025-09-30,Gain On Sale Of Security,-947000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q2,2025-06-30,Gain On Sale Of Security,-562000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q1,2025-03-31,Gain On Sale Of Security,602000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q4,2025-12-31,Net Non Operating Interest Income Expense,-1069000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q3,2025-09-30,Net Non Operating Interest Income Expense,-1165000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q2,2025-06-30,Net Non Operating Interest Income Expense,-764000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q1,2025-03-31,Net Non Operating Interest Income Expense,-984000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q4,2025-12-31,Total Other Finance Cost,221000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q3,2025-09-30,Total Other Finance Cost,262000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q2,2025-06-30,Total Other Finance Cost,-85000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q1,2025-03-31,Total Other Finance Cost,196000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q4,2025-12-31,Interest Expense Non Operating,848000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q3,2025-09-30,Interest Expense Non Operating,903000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q2,2025-06-30,Interest Expense Non Operating,1122000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q1,2025-03-31,Interest Expense Non Operating,818000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q2,2025-06-30,Interest Income Non Operating,273000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q1,2025-03-31,Interest Income Non Operating,30000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q4,2025-12-31,Operating Income,4050000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q3,2025-09-30,Operating Income,4205000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q2,2025-06-30,Operating Income,4013000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q1,2025-03-31,Operating Income,3587000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q4,2025-12-31,Operating Expense,4563000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q3,2025-09-30,Operating Expense,4332000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q2,2025-06-30,Operating Expense,4433000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q1,2025-03-31,Operating Expense,3996000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q4,2025-12-31,Other Operating Expenses,-223000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q3,2025-09-30,Other Operating Expenses,-203000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q2,2025-06-30,Other Operating Expenses,-191000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q1,2025-03-31,Other Operating Expenses,-192000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q4,2025-12-31,Selling General And Administration,4786000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q3,2025-09-30,Selling General And Administration,4535000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q2,2025-06-30,Selling General And Administration,4624000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q1,2025-03-31,Selling General And Administration,4188000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q4,2025-12-31,Gross Profit,8613000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q3,2025-09-30,Gross Profit,8537000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q2,2025-06-30,Gross Profit,8446000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q1,2025-03-31,Gross Profit,7583000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q4,2025-12-31,Cost Of Revenue,6943000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q3,2025-09-30,Cost Of Revenue,6596000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q2,2025-06-30,Cost Of Revenue,6558000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q1,2025-03-31,Cost Of Revenue,6044000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q4,2025-12-31,Total Revenue,15555000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q3,2025-09-30,Total Revenue,15133000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q2,2025-06-30,Total Revenue,15004000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q1,2025-03-31,Total Revenue,13628000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q4,2025-12-31,Operating Revenue,15555000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q3,2025-09-30,Operating Revenue,15133000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q2,2025-06-30,Operating Revenue,15004000000.0,EUR
ABI.BR,Anheuser-Busch InBev,end_market,beverages,Belgium,2025-Q1,2025-03-31,Operating Revenue,13628000000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q2,2025-06-30,Tax Effect Of Unusual Items,-168000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q1,2025-03-31,Tax Effect Of Unusual Items,-861000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q2,2025-06-30,Tax Rate For Calcs,0.21,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q1,2025-03-31,Tax Rate For Calcs,0.21,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q2,2025-06-30,Normalized EBITDA,214700000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q1,2025-03-31,Normalized EBITDA,139000000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q2,2025-06-30,Total Unusual Items,-800000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q1,2025-03-31,Total Unusual Items,-4100000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q2,2025-06-30,Total Unusual Items Excluding Goodwill,-800000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q1,2025-03-31,Total Unusual Items Excluding Goodwill,-4100000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q2,2025-06-30,Net Income From Continuing Operation Net Minority Interest,99300000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q1,2025-03-31,Net Income From Continuing Operation Net Minority Interest,107100000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q2,2025-06-30,Reconciled Cost Of Revenue,319700000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q1,2025-03-31,Reconciled Cost Of Revenue,274400000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q2,2025-06-30,EBITDA,213900000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q1,2025-03-31,EBITDA,134900000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q2,2025-06-30,EBIT,213900000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q1,2025-03-31,EBIT,134900000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q2,2025-06-30,Net Interest Income,-25700000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q1,2025-03-31,Net Interest Income,-25200000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q2,2025-06-30,Interest Expense,26700000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q1,2025-03-31,Interest Expense,28200000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q2,2025-06-30,Interest Income,3700000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q1,2025-03-31,Interest Income,4500000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q2,2025-06-30,Normalized Income,99932000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q1,2025-03-31,Normalized Income,110339000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q2,2025-06-30,Net Income From Continuing And Discontinued Operation,99300000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q1,2025-03-31,Net Income From Continuing And Discontinued Operation,107100000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q2,2025-06-30,Total Expenses,639500000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q1,2025-03-31,Total Expenses,532200000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q2,2025-06-30,Total Operating Income As Reported,211800000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q1,2025-03-31,Total Operating Income As Reported,129100000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q2,2025-06-30,Diluted Average Shares,1200596861.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q1,2025-03-31,Diluted Average Shares,1200394943.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q2,2025-06-30,Basic Average Shares,1200596861.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q1,2025-03-31,Basic Average Shares,1200394943.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q2,2025-06-30,Diluted EPS,0.155839,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q1,2025-03-31,Diluted EPS,0.089221,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q2,2025-06-30,Basic EPS,0.155839,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q1,2025-03-31,Basic EPS,0.089221,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q2,2025-06-30,Diluted NI Availto Com Stockholders,99300000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q1,2025-03-31,Diluted NI Availto Com Stockholders,107100000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q2,2025-06-30,Net Income Common Stockholders,99300000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q1,2025-03-31,Net Income Common Stockholders,107100000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q2,2025-06-30,Otherunder Preferred Stock Dividend,0.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q1,2025-03-31,Otherunder Preferred Stock Dividend,0.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q2,2025-06-30,Net Income,99300000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q1,2025-03-31,Net Income,107100000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q2,2025-06-30,Minority Interests,300000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q1,2025-03-31,Minority Interests,400000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q2,2025-06-30,Net Income Including Noncontrolling Interests,99000000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q1,2025-03-31,Net Income Including Noncontrolling Interests,106700000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q2,2025-06-30,Net Income Continuous Operations,99100000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q1,2025-03-31,Net Income Continuous Operations,106700000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q2,2025-06-30,Pretax Income,187200000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q1,2025-03-31,Pretax Income,106700000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q2,2025-06-30,Special Income Charges,-800000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q1,2025-03-31,Special Income Charges,-4100000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q2,2025-06-30,Other Special Charges,2600000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q1,2025-03-31,Other Special Charges,-200000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q1,2025-03-31,Impairment Of Capital Assets,4300000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q2,2025-06-30,Net Non Operating Interest Income Expense,-25700000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q1,2025-03-31,Net Non Operating Interest Income Expense,-25200000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q2,2025-06-30,Total Other Finance Cost,2700000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q1,2025-03-31,Total Other Finance Cost,1500000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q2,2025-06-30,Interest Expense Non Operating,26700000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q1,2025-03-31,Interest Expense Non Operating,28200000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q2,2025-06-30,Interest Income Non Operating,3700000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q1,2025-03-31,Interest Income Non Operating,4500000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q2,2025-06-30,Operating Income,222800000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q1,2025-03-31,Operating Income,133400000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q2,2025-06-30,Operating Expense,319800000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q1,2025-03-31,Operating Expense,257800000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q2,2025-06-30,Other Operating Expenses,52100000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q1,2025-03-31,Other Operating Expenses,2700000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q2,2025-06-30,Selling General And Administration,6300000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q1,2025-03-31,Selling General And Administration,255100000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q2,2025-06-30,Selling And Marketing Expense,147000000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q1,2025-03-31,Selling And Marketing Expense,92100000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q2,2025-06-30,General And Administrative Expense,-140700000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q1,2025-03-31,General And Administrative Expense,163000000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q2,2025-06-30,Gross Profit,542600000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q1,2025-03-31,Gross Profit,391200000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q2,2025-06-30,Cost Of Revenue,319700000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q1,2025-03-31,Cost Of Revenue,274400000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q2,2025-06-30,Total Revenue,862300000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q1,2025-03-31,Total Revenue,665600000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q2,2025-06-30,Operating Revenue,862300000.0,EUR
CPR.MI,Campari,end_market,beverages,Italy,2025-Q1,2025-03-31,Operating Revenue,665600000.0,EUR
ORK.OL,Orkla,end_market,food,Norway,2025-Q4,2025-12-31,Tax Effect Of Unusual Items,-55280373.831776,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q3,2025-09-30,Tax Effect Of Unusual Items,-61244366.549825,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q2,2025-06-30,Tax Effect Of Unusual Items,-6608361.364728,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q1,2025-03-31,Tax Effect Of Unusual Items,-9558074.965294,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q4,2025-12-31,Tax Rate For Calcs,0.163551,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q3,2025-09-30,Tax Rate For Calcs,0.152729,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q2,2025-06-30,Tax Rate For Calcs,0.183566,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q1,2025-03-31,Tax Rate For Calcs,0.187413,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q4,2025-12-31,Normalized EBITDA,3376000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q3,2025-09-30,Normalized EBITDA,3313000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q2,2025-06-30,Normalized EBITDA,2997000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q1,2025-03-31,Normalized EBITDA,3095000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q4,2025-12-31,Total Unusual Items,-338000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q3,2025-09-30,Total Unusual Items,-401000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q2,2025-06-30,Total Unusual Items,-36000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q1,2025-03-31,Total Unusual Items,-51000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q4,2025-12-31,Total Unusual Items Excluding Goodwill,-338000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q3,2025-09-30,Total Unusual Items Excluding Goodwill,-401000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q2,2025-06-30,Total Unusual Items Excluding Goodwill,-36000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q1,2025-03-31,Total Unusual Items Excluding Goodwill,-51000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q4,2025-12-31,Net Income From Continuing Operation Net Minority Interest,1587000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q3,2025-09-30,Net Income From Continuing Operation Net Minority Interest,1571000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q2,2025-06-30,Net Income From Continuing Operation Net Minority Interest,1553000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q1,2025-03-31,Net Income From Continuing Operation Net Minority Interest,1642000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q4,2025-12-31,Reconciled Depreciation,724000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q3,2025-09-30,Reconciled Depreciation,676000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q2,2025-06-30,Reconciled Depreciation,676000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q1,2025-03-31,Reconciled Depreciation,656000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q4,2025-12-31,EBITDA,3038000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q3,2025-09-30,EBITDA,2912000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q2,2025-06-30,EBITDA,2961000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q1,2025-03-31,EBITDA,3044000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q4,2025-12-31,EBIT,2314000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q3,2025-09-30,EBIT,2236000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q2,2025-06-30,EBIT,2285000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q1,2025-03-31,EBIT,2388000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q4,2025-12-31,Net Interest Income,-195000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q3,2025-09-30,Net Interest Income,-246000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q2,2025-06-30,Net Interest Income,-215000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q1,2025-03-31,Net Interest Income,-245000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q4,2025-12-31,Interest Expense,174000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q3,2025-09-30,Interest Expense,239000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q2,2025-06-30,Interest Expense,204000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q1,2025-03-31,Interest Expense,227000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q4,2025-12-31,Normalized Income,1869719626.168224,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q3,2025-09-30,Normalized Income,1910755633.450175,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q2,2025-06-30,Normalized Income,1582391638.635272,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q1,2025-03-31,Normalized Income,1683441925.034706,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q4,2025-12-31,Net Income From Continuing And Discontinued Operation,1888000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q3,2025-09-30,Net Income From Continuing And Discontinued Operation,1571000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q2,2025-06-30,Net Income From Continuing And Discontinued Operation,6221000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q1,2025-03-31,Net Income From Continuing And Discontinued Operation,1793000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q4,2025-12-31,Total Expenses,16798000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q3,2025-09-30,Total Expenses,15907000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q2,2025-06-30,Total Expenses,15777000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q1,2025-03-31,Total Expenses,15418000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q4,2025-12-31,Total Operating Income As Reported,1826000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q3,2025-09-30,Total Operating Income As Reported,1638000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q2,2025-06-30,Total Operating Income As Reported,1872000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q1,2025-03-31,Total Operating Income As Reported,1750000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q4,2025-12-31,Diluted Average Shares,998176000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q3,2025-09-30,Diluted Average Shares,1000105000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q2,2025-06-30,Diluted Average Shares,999452000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q1,2025-03-31,Diluted Average Shares,999484000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q4,2025-12-31,Basic Average Shares,995628000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q3,2025-09-30,Basic Average Shares,997318000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q2,2025-06-30,Basic Average Shares,996564000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q1,2025-03-31,Basic Average Shares,997055000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q4,2025-12-31,Diluted EPS,1.89,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q3,2025-09-30,Diluted EPS,1.57,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q2,2025-06-30,Diluted EPS,6.22,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q1,2025-03-31,Diluted EPS,1.79,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q4,2025-12-31,Basic EPS,1.9,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q3,2025-09-30,Basic EPS,1.58,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q2,2025-06-30,Basic EPS,6.24,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q1,2025-03-31,Basic EPS,1.8,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q4,2025-12-31,Diluted NI Availto Com Stockholders,1888000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q3,2025-09-30,Diluted NI Availto Com Stockholders,1571000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q2,2025-06-30,Diluted NI Availto Com Stockholders,6221000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q1,2025-03-31,Diluted NI Availto Com Stockholders,1793000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q4,2025-12-31,Net Income Common Stockholders,1888000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q3,2025-09-30,Net Income Common Stockholders,1571000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q2,2025-06-30,Net Income Common Stockholders,6221000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q1,2025-03-31,Net Income Common Stockholders,1793000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q4,2025-12-31,Otherunder Preferred Stock Dividend,0.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q3,2025-09-30,Otherunder Preferred Stock Dividend,0.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q2,2025-06-30,Otherunder Preferred Stock Dividend,0.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q1,2025-03-31,Otherunder Preferred Stock Dividend,0.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q4,2025-12-31,Net Income,1888000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q3,2025-09-30,Net Income,1571000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q2,2025-06-30,Net Income,6221000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q1,2025-03-31,Net Income,1793000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q4,2025-12-31,Minority Interests,-203000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q3,2025-09-30,Minority Interests,-121000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q2,2025-06-30,Minority Interests,-146000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q1,2025-03-31,Minority Interests,-114000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q4,2025-12-31,Net Income Including Noncontrolling Interests,2091000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q3,2025-09-30,Net Income Including Noncontrolling Interests,1692000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q2,2025-06-30,Net Income Including Noncontrolling Interests,6367000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q1,2025-03-31,Net Income Including Noncontrolling Interests,1907000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q4,2025-12-31,Net Income Discontinuous Operations,301000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q3,2025-09-30,Net Income Discontinuous Operations,0.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q2,2025-06-30,Net Income Discontinuous Operations,4668000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q1,2025-03-31,Net Income Discontinuous Operations,151000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q4,2025-12-31,Net Income Continuous Operations,1790000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q3,2025-09-30,Net Income Continuous Operations,1692000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q2,2025-06-30,Net Income Continuous Operations,1699000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q1,2025-03-31,Net Income Continuous Operations,1756000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q4,2025-12-31,Tax Provision,350000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q3,2025-09-30,Tax Provision,305000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q2,2025-06-30,Tax Provision,382000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q1,2025-03-31,Tax Provision,405000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q4,2025-12-31,Pretax Income,2140000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q3,2025-09-30,Pretax Income,1997000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q2,2025-06-30,Pretax Income,2081000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q1,2025-03-31,Pretax Income,2161000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q4,2025-12-31,Other Non Operating Income Expenses,187000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q2,2025-06-30,Other Non Operating Income Expenses,35000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q1,2025-03-31,Other Non Operating Income Expenses,43000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q4,2025-12-31,Special Income Charges,-338000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q3,2025-09-30,Special Income Charges,-401000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q2,2025-06-30,Special Income Charges,-36000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q1,2025-03-31,Special Income Charges,-51000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q4,2025-12-31,Write Off,110000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q3,2025-09-30,Write Off,372000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q2,2025-06-30,Write Off,0.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q1,2025-03-31,Write Off,2000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q4,2025-12-31,Restructuring And Mergern Acquisition,228000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q3,2025-09-30,Restructuring And Mergern Acquisition,29000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q2,2025-06-30,Restructuring And Mergern Acquisition,36000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q1,2025-03-31,Restructuring And Mergern Acquisition,49000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q4,2025-12-31,Net Non Operating Interest Income Expense,-195000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q3,2025-09-30,Net Non Operating Interest Income Expense,-246000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q2,2025-06-30,Net Non Operating Interest Income Expense,-215000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q1,2025-03-31,Net Non Operating Interest Income Expense,-245000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q4,2025-12-31,Total Other Finance Cost,21000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q3,2025-09-30,Total Other Finance Cost,7000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q2,2025-06-30,Total Other Finance Cost,11000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q1,2025-03-31,Total Other Finance Cost,18000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q4,2025-12-31,Interest Expense Non Operating,174000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q3,2025-09-30,Interest Expense Non Operating,239000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q2,2025-06-30,Interest Expense Non Operating,204000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q1,2025-03-31,Interest Expense Non Operating,227000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q4,2025-12-31,Operating Income,1977000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q3,2025-09-30,Operating Income,2039000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q2,2025-06-30,Operating Income,1873000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q1,2025-03-31,Operating Income,1758000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q4,2025-12-31,Operating Expense,16798000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q3,2025-09-30,Operating Expense,15907000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q2,2025-06-30,Operating Expense,15777000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q1,2025-03-31,Operating Expense,15418000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q4,2025-12-31,Other Operating Expenses,16074000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q3,2025-09-30,Other Operating Expenses,15231000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q2,2025-06-30,Other Operating Expenses,15101000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q1,2025-03-31,Other Operating Expenses,14762000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q4,2025-12-31,Depreciation And Amortization In Income Statement,724000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q3,2025-09-30,Depreciation And Amortization In Income Statement,676000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q2,2025-06-30,Depreciation And Amortization In Income Statement,676000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q1,2025-03-31,Depreciation And Amortization In Income Statement,656000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q4,2025-12-31,Depreciation Income Statement,724000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q3,2025-09-30,Depreciation Income Statement,676000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q2,2025-06-30,Depreciation Income Statement,676000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q1,2025-03-31,Depreciation Income Statement,656000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q4,2025-12-31,Total Revenue,18775000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q3,2025-09-30,Total Revenue,17946000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q2,2025-06-30,Total Revenue,17650000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q1,2025-03-31,Total Revenue,17176000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q4,2025-12-31,Operating Revenue,18775000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q3,2025-09-30,Operating Revenue,17946000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q2,2025-06-30,Operating Revenue,17650000000.0,NOK
ORK.OL,Orkla,end_market,food,Norway,2025-Q1,2025-03-31,Operating Revenue,17176000000.0,NOK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q4,2025-12-31,Tax Effect Of Unusual Items,-29425000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q2,2025-06-30,Tax Effect Of Unusual Items,-13446000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q1,2025-03-31,Tax Effect Of Unusual Items,10500000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q4,2025-12-31,Tax Rate For Calcs,0.275,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q2,2025-06-30,Tax Rate For Calcs,0.249,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q1,2025-03-31,Tax Rate For Calcs,0.25,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q4,2025-12-31,Normalized EBITDA,6829000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q2,2025-06-30,Normalized EBITDA,6245000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q1,2025-03-31,Normalized EBITDA,6145000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q4,2025-12-31,Total Unusual Items,-107000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q2,2025-06-30,Total Unusual Items,-54000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q1,2025-03-31,Total Unusual Items,42000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q4,2025-12-31,Total Unusual Items Excluding Goodwill,-107000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q2,2025-06-30,Total Unusual Items Excluding Goodwill,-54000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q1,2025-03-31,Total Unusual Items Excluding Goodwill,42000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q4,2025-12-31,Net Income From Continuing Operation Net Minority Interest,3208000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q2,2025-06-30,Net Income From Continuing Operation Net Minority Interest,3038000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q1,2025-03-31,Net Income From Continuing Operation Net Minority Interest,3069000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q4,2025-12-31,Reconciled Depreciation,1861000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q2,2025-06-30,Reconciled Depreciation,1751000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q1,2025-03-31,Reconciled Depreciation,1747000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q4,2025-12-31,Reconciled Cost Of Revenue,23024000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q2,2025-06-30,Reconciled Cost Of Revenue,22796000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q1,2025-03-31,Reconciled Cost Of Revenue,23512000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q4,2025-12-31,EBITDA,6722000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q2,2025-06-30,EBITDA,6191000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q1,2025-03-31,EBITDA,6187000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q4,2025-12-31,EBIT,4861000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q2,2025-06-30,EBIT,4440000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q1,2025-03-31,EBIT,4440000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q4,2025-12-31,Net Interest Income,-309000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q2,2025-06-30,Net Interest Income,-333000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q1,2025-03-31,Net Interest Income,-373000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q4,2025-12-31,Normalized Income,3285575000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q2,2025-06-30,Normalized Income,3078554000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q1,2025-03-31,Normalized Income,3037500000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q4,2025-12-31,Net Income From Continuing And Discontinued Operation,3208000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q2,2025-06-30,Net Income From Continuing And Discontinued Operation,3038000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q1,2025-03-31,Net Income From Continuing And Discontinued Operation,3069000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q4,2025-12-31,Total Expenses,29834000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q2,2025-06-30,Total Expenses,29745000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q1,2025-03-31,Total Expenses,30536000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q4,2025-12-31,Total Operating Income As Reported,4754000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q2,2025-06-30,Total Operating Income As Reported,4386000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q1,2025-03-31,Total Operating Income As Reported,4482000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q4,2025-12-31,Diluted Average Shares,683909626.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q2,2025-06-30,Diluted Average Shares,691473246.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q1,2025-03-31,Diluted Average Shares,693400000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q4,2025-12-31,Basic Average Shares,683909626.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q2,2025-06-30,Basic Average Shares,691473246.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q1,2025-03-31,Basic Average Shares,693400000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q4,2025-12-31,Diluted EPS,4.69,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q2,2025-06-30,Diluted EPS,4.39,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q1,2025-03-31,Diluted EPS,4.43,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q4,2025-12-31,Basic EPS,4.69,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q2,2025-06-30,Basic EPS,4.39,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q1,2025-03-31,Basic EPS,4.43,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q4,2025-12-31,Diluted NI Availto Com Stockholders,3208000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q2,2025-06-30,Diluted NI Availto Com Stockholders,3038000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q1,2025-03-31,Diluted NI Availto Com Stockholders,3069000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q4,2025-12-31,Net Income Common Stockholders,3208000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q2,2025-06-30,Net Income Common Stockholders,3038000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q1,2025-03-31,Net Income Common Stockholders,3069000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q4,2025-12-31,Otherunder Preferred Stock Dividend,0.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q2,2025-06-30,Otherunder Preferred Stock Dividend,0.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q1,2025-03-31,Otherunder Preferred Stock Dividend,0.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q4,2025-12-31,Net Income,3208000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q2,2025-06-30,Net Income,3038000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q1,2025-03-31,Net Income,3069000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q4,2025-12-31,Minority Interests,-16000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q2,2025-06-30,Minority Interests,-15000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q1,2025-03-31,Minority Interests,-14000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q4,2025-12-31,Net Income Including Noncontrolling Interests,3224000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q2,2025-06-30,Net Income Including Noncontrolling Interests,3053000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q1,2025-03-31,Net Income Including Noncontrolling Interests,3083000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q4,2025-12-31,Net Income Discontinuous Operations,0.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q2,2025-06-30,Net Income Discontinuous Operations,0.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q1,2025-03-31,Net Income Discontinuous Operations,0.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q4,2025-12-31,Net Income Continuous Operations,3224000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q2,2025-06-30,Net Income Continuous Operations,3053000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q1,2025-03-31,Net Income Continuous Operations,3083000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q4,2025-12-31,Tax Provision,1226000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q2,2025-06-30,Tax Provision,1014000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q1,2025-03-31,Tax Provision,1025000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q4,2025-12-31,Pretax Income,4450000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q2,2025-06-30,Pretax Income,4067000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q1,2025-03-31,Pretax Income,4108000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q4,2025-12-31,Special Income Charges,-107000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q2,2025-06-30,Special Income Charges,-54000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q1,2025-03-31,Special Income Charges,42000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q4,2025-12-31,Other Special Charges,107000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q2,2025-06-30,Other Special Charges,54000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q1,2025-03-31,Other Special Charges,-42000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q4,2025-12-31,Net Non Operating Interest Income Expense,-309000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q2,2025-06-30,Net Non Operating Interest Income Expense,-333000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q1,2025-03-31,Net Non Operating Interest Income Expense,-373000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q4,2025-12-31,Operating Income,4861000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q2,2025-06-30,Operating Income,4440000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q1,2025-03-31,Operating Income,4440000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q4,2025-12-31,Operating Expense,6810000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q2,2025-06-30,Operating Expense,6949000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q1,2025-03-31,Operating Expense,7024000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q4,2025-12-31,Depreciation And Amortization In Income Statement,232000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q2,2025-06-30,Depreciation And Amortization In Income Statement,241000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q1,2025-03-31,Depreciation And Amortization In Income Statement,256000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q4,2025-12-31,Amortization,232000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q2,2025-06-30,Amortization,241000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q1,2025-03-31,Amortization,256000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q4,2025-12-31,Depreciation Income Statement,0.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q2,2025-06-30,Depreciation Income Statement,0.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q1,2025-03-31,Depreciation Income Statement,0.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q4,2025-12-31,Selling General And Administration,6578000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q2,2025-06-30,Selling General And Administration,6708000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q1,2025-03-31,Selling General And Administration,6768000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q4,2025-12-31,General And Administrative Expense,6578000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q2,2025-06-30,General And Administrative Expense,6708000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q1,2025-03-31,General And Administrative Expense,6768000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q4,2025-12-31,Gross Profit,11671000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q2,2025-06-30,Gross Profit,11389000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q1,2025-03-31,Gross Profit,11464000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q4,2025-12-31,Cost Of Revenue,23024000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q2,2025-06-30,Cost Of Revenue,22796000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q1,2025-03-31,Cost Of Revenue,23512000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q4,2025-12-31,Total Revenue,34695000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q2,2025-06-30,Total Revenue,34185000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q1,2025-03-31,Total Revenue,34976000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q4,2025-12-31,Operating Revenue,34695000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q2,2025-06-30,Operating Revenue,34185000000.0,SEK
ESSITY-B.ST,Essity,end_market,hpc,Sweden,2025-Q1,2025-03-31,Operating Revenue,34976000000.0,SEK
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q4,2025-12-31,Tax Effect Of Unusual Items,0.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q3,2025-09-30,Tax Effect Of Unusual Items,0.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q2,2025-06-30,Tax Effect Of Unusual Items,0.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q1,2025-03-31,Tax Effect Of Unusual Items,0.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q4,2025-12-31,Tax Rate For Calcs,0.252952,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q3,2025-09-30,Tax Rate For Calcs,0.063,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q2,2025-06-30,Tax Rate For Calcs,0.112,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q1,2025-03-31,Tax Rate For Calcs,0.181076,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q4,2025-12-31,Normalized EBITDA,5073000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q3,2025-09-30,Normalized EBITDA,5841000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q2,2025-06-30,Normalized EBITDA,6076000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q1,2025-03-31,Normalized EBITDA,5831000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q4,2025-12-31,Net Income From Continuing Operation Net Minority Interest,2409000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q3,2025-09-30,Net Income From Continuing Operation Net Minority Interest,3928000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q2,2025-06-30,Net Income From Continuing Operation Net Minority Interest,4041000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q1,2025-03-31,Net Income From Continuing Operation Net Minority Interest,3606000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q4,2025-12-31,Reconciled Depreciation,1551000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q3,2025-09-30,Reconciled Depreciation,1364000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q2,2025-06-30,Reconciled Depreciation,1256000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q1,2025-03-31,Reconciled Depreciation,1154000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q4,2025-12-31,Reconciled Cost Of Revenue,3611000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q3,2025-09-30,Reconciled Cost Of Revenue,3539000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q2,2025-06-30,Reconciled Cost Of Revenue,3322000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q1,2025-03-31,Reconciled Cost Of Revenue,3227000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q4,2025-12-31,EBITDA,5073000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q3,2025-09-30,EBITDA,5841000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q2,2025-06-30,EBITDA,6076000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q1,2025-03-31,EBITDA,5831000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q4,2025-12-31,EBIT,3522000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q3,2025-09-30,EBIT,4477000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q2,2025-06-30,EBIT,4820000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q1,2025-03-31,EBIT,4677000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q4,2025-12-31,Net Interest Income,-96000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q3,2025-09-30,Net Interest Income,-301000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q2,2025-06-30,Net Interest Income,-330000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q1,2025-03-31,Net Interest Income,-253000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q4,2025-12-31,Interest Expense,304000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q3,2025-09-30,Interest Expense,281000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q2,2025-06-30,Interest Expense,289000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q1,2025-03-31,Interest Expense,270000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q4,2025-12-31,Normalized Income,2409000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q3,2025-09-30,Normalized Income,3928000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q2,2025-06-30,Normalized Income,4041000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q1,2025-03-31,Normalized Income,3606000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q4,2025-12-31,Net Income From Continuing And Discontinued Operation,2409000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q3,2025-09-30,Net Income From Continuing And Discontinued Operation,3928000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q2,2025-06-30,Net Income From Continuing And Discontinued Operation,4041000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q1,2025-03-31,Net Income From Continuing And Discontinued Operation,3606000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q4,2025-12-31,Total Expenses,10244000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q3,2025-09-30,Total Expenses,9857000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q2,2025-06-30,Total Expenses,9972000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q1,2025-03-31,Total Expenses,8957000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q4,2025-12-31,Total Operating Income As Reported,3616000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q3,2025-09-30,Total Operating Income As Reported,4501000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q2,2025-06-30,Total Operating Income As Reported,4864000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q1,2025-03-31,Total Operating Income As Reported,4663000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q4,2025-12-31,Diluted Average Shares,1929000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q2,2025-06-30,Diluted Average Shares,1960000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q1,2025-03-31,Diluted Average Shares,1979000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q4,2025-12-31,Basic Average Shares,1913000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q2,2025-06-30,Basic Average Shares,1948000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q1,2025-03-31,Basic Average Shares,1968000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q4,2025-12-31,Diluted EPS,1.25,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q2,2025-06-30,Diluted EPS,2.06,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q1,2025-03-31,Diluted EPS,1.82,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q4,2025-12-31,Basic EPS,1.26,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q2,2025-06-30,Basic EPS,2.07,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q1,2025-03-31,Basic EPS,1.83,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q4,2025-12-31,Diluted NI Availto Com Stockholders,2409000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q3,2025-09-30,Diluted NI Availto Com Stockholders,3928000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q2,2025-06-30,Diluted NI Availto Com Stockholders,4041000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q1,2025-03-31,Diluted NI Availto Com Stockholders,3606000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q4,2025-12-31,Net Income Common Stockholders,2409000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q3,2025-09-30,Net Income Common Stockholders,3928000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q2,2025-06-30,Net Income Common Stockholders,4041000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q1,2025-03-31,Net Income Common Stockholders,3606000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q4,2025-12-31,Net Income,2409000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q3,2025-09-30,Net Income,3928000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q2,2025-06-30,Net Income,4041000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q1,2025-03-31,Net Income,3606000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q4,2025-12-31,Minority Interests,5000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q3,2025-09-30,Minority Interests,-2000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q2,2025-06-30,Minority Interests,17000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q1,2025-03-31,Minority Interests,-3000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q4,2025-12-31,Net Income Including Noncontrolling Interests,2404000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q3,2025-09-30,Net Income Including Noncontrolling Interests,3930000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q2,2025-06-30,Net Income Including Noncontrolling Interests,4024000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q1,2025-03-31,Net Income Including Noncontrolling Interests,3609000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q4,2025-12-31,Net Income Continuous Operations,2404000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q3,2025-09-30,Net Income Continuous Operations,3930000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q2,2025-06-30,Net Income Continuous Operations,4024000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q1,2025-03-31,Net Income Continuous Operations,3609000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q4,2025-12-31,Tax Provision,814000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q3,2025-09-30,Tax Provision,266000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q2,2025-06-30,Tax Provision,507000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q1,2025-03-31,Tax Provision,798000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q4,2025-12-31,Pretax Income,3218000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q3,2025-09-30,Pretax Income,4196000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q2,2025-06-30,Pretax Income,4531000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q1,2025-03-31,Pretax Income,4407000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q4,2025-12-31,Other Income Expense,-302000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q3,2025-09-30,Other Income Expense,-4000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q2,2025-06-30,Other Income Expense,-3000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q1,2025-03-31,Other Income Expense,-3000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q4,2025-12-31,Earnings From Equity Interest,-2000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q3,2025-09-30,Earnings From Equity Interest,-4000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q2,2025-06-30,Earnings From Equity Interest,-3000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q1,2025-03-31,Earnings From Equity Interest,-3000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q4,2025-12-31,Net Non Operating Interest Income Expense,-96000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q3,2025-09-30,Net Non Operating Interest Income Expense,-301000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q2,2025-06-30,Net Non Operating Interest Income Expense,-330000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q1,2025-03-31,Net Non Operating Interest Income Expense,-253000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q4,2025-12-31,Total Other Finance Cost,165000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q3,2025-09-30,Total Other Finance Cost,20000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q2,2025-06-30,Total Other Finance Cost,41000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q1,2025-03-31,Total Other Finance Cost,-17000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q4,2025-12-31,Interest Expense Non Operating,304000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q3,2025-09-30,Interest Expense Non Operating,281000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q2,2025-06-30,Interest Expense Non Operating,289000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q1,2025-03-31,Interest Expense Non Operating,270000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q4,2025-12-31,Operating Income,3616000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q3,2025-09-30,Operating Income,4501000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q2,2025-06-30,Operating Income,4864000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q1,2025-03-31,Operating Income,4663000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q4,2025-12-31,Operating Expense,6633000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q3,2025-09-30,Operating Expense,6318000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q2,2025-06-30,Operating Expense,6650000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q1,2025-03-31,Operating Expense,5730000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q4,2025-12-31,Other Operating Expenses,30000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q3,2025-09-30,Other Operating Expenses,66000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q2,2025-06-30,Other Operating Expenses,481000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q1,2025-03-31,Other Operating Expenses,306000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q4,2025-12-31,Research And Development,3163000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q3,2025-09-30,Research And Development,2944000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q2,2025-06-30,Research And Development,2727000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q1,2025-03-31,Research And Development,2366000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q4,2025-12-31,Selling General And Administration,3440000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q3,2025-09-30,Selling General And Administration,3308000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q2,2025-06-30,Selling General And Administration,3442000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q1,2025-03-31,Selling General And Administration,3058000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q4,2025-12-31,Gross Profit,10249000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q3,2025-09-30,Gross Profit,10819000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q2,2025-06-30,Gross Profit,11514000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q1,2025-03-31,Gross Profit,10393000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q4,2025-12-31,Cost Of Revenue,3611000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q3,2025-09-30,Cost Of Revenue,3539000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q2,2025-06-30,Cost Of Revenue,3322000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q1,2025-03-31,Cost Of Revenue,3227000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q4,2025-12-31,Total Revenue,13860000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q3,2025-09-30,Total Revenue,14358000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q2,2025-06-30,Total Revenue,14836000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q1,2025-03-31,Total Revenue,13620000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q4,2025-12-31,Operating Revenue,13336000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q3,2025-09-30,Operating Revenue,13909000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q2,2025-06-30,Operating Revenue,14054000000.0,CHF
NOVN.SW,Novartis,end_market,pharma,Switzerland,2025-Q1,2025-03-31,Operating Revenue,13233000000.0,CHF
SAN.PA,Sanofi,end_market,pharma,France,2025-Q3,2025-09-30,Tax Effect Of Unusual Items,-31073000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q2,2025-06-30,Tax Effect Of Unusual Items,-38279494.382022,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q1,2025-03-31,Tax Effect Of Unusual Items,-39248000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q3,2025-09-30,Tax Rate For Calcs,0.193,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q2,2025-06-30,Tax Rate For Calcs,0.161517,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q1,2025-03-31,Tax Rate For Calcs,0.223,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q3,2025-09-30,Normalized EBITDA,4359000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q2,2025-06-30,Normalized EBITDA,2126000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q1,2025-03-31,Normalized EBITDA,2946000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q3,2025-09-30,Total Unusual Items,-161000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q2,2025-06-30,Total Unusual Items,-237000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q1,2025-03-31,Total Unusual Items,-176000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q3,2025-09-30,Total Unusual Items Excluding Goodwill,-161000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q2,2025-06-30,Total Unusual Items Excluding Goodwill,-237000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q1,2025-03-31,Total Unusual Items Excluding Goodwill,-176000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q3,2025-09-30,Net Income From Continuing Operation Net Minority Interest,2822000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q2,2025-06-30,Net Income From Continuing Operation Net Minority Interest,1233000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q1,2025-03-31,Net Income From Continuing Operation Net Minority Interest,1698000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q3,2025-09-30,Reconciled Depreciation,461000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q2,2025-06-30,Reconciled Depreciation,378000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q1,2025-03-31,Reconciled Depreciation,399000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q3,2025-09-30,Reconciled Cost Of Revenue,3412000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q2,2025-06-30,Reconciled Cost Of Revenue,2992000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q1,2025-03-31,Reconciled Cost Of Revenue,2889000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q3,2025-09-30,EBITDA,4198000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q2,2025-06-30,EBITDA,1889000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q1,2025-03-31,EBITDA,2770000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q3,2025-09-30,EBIT,3737000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q2,2025-06-30,EBIT,1511000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q1,2025-03-31,EBIT,2371000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q3,2025-09-30,Net Interest Income,-113000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q2,2025-06-30,Net Interest Income,-51000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q1,2025-03-31,Net Interest Income,-127000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q3,2025-09-30,Interest Expense,227000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q2,2025-06-30,Interest Expense,87000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q1,2025-03-31,Interest Expense,213000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q3,2025-09-30,Interest Income,114000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q2,2025-06-30,Interest Income,76000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q1,2025-03-31,Interest Income,86000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q3,2025-09-30,Normalized Income,2951927000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q2,2025-06-30,Normalized Income,1431720505.617978,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q1,2025-03-31,Normalized Income,1834752000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q3,2025-09-30,Net Income From Continuing And Discontinued Operation,2802000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q2,2025-06-30,Net Income From Continuing And Discontinued Operation,3940000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q1,2025-03-31,Net Income From Continuing And Discontinued Operation,1872000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q3,2025-09-30,Total Expenses,9385000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q2,2025-06-30,Total Expenses,9023000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q1,2025-03-31,Total Expenses,8145000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q3,2025-09-30,Total Operating Income As Reported,3623000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q2,2025-06-30,Total Operating Income As Reported,1474000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q1,2025-03-31,Total Operating Income As Reported,2285000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q4,2025-12-31,Diluted Average Shares,1212700000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q1,2025-03-31,Diluted Average Shares,1233900000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q4,2025-12-31,Basic Average Shares,1212700000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q1,2025-03-31,Basic Average Shares,1233900000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q4,2025-12-31,Diluted EPS,-0.66,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q1,2025-03-31,Diluted EPS,1.52,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q4,2025-12-31,Basic EPS,-0.66,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q1,2025-03-31,Basic EPS,1.52,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q3,2025-09-30,Diluted NI Availto Com Stockholders,2802000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q2,2025-06-30,Diluted NI Availto Com Stockholders,3940000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q1,2025-03-31,Diluted NI Availto Com Stockholders,1872000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q3,2025-09-30,Net Income Common Stockholders,2802000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q2,2025-06-30,Net Income Common Stockholders,3940000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q1,2025-03-31,Net Income Common Stockholders,1872000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q3,2025-09-30,Net Income,2802000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q2,2025-06-30,Net Income,3940000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q1,2025-03-31,Net Income,1872000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q3,2025-09-30,Minority Interests,-6000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q2,2025-06-30,Minority Interests,-4000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q1,2025-03-31,Minority Interests,-21000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q3,2025-09-30,Net Income Including Noncontrolling Interests,2808000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q2,2025-06-30,Net Income Including Noncontrolling Interests,3944000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q1,2025-03-31,Net Income Including Noncontrolling Interests,1893000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q3,2025-09-30,Net Income Discontinuous Operations,-20000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q2,2025-06-30,Net Income Discontinuous Operations,2707000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q1,2025-03-31,Net Income Discontinuous Operations,174000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q3,2025-09-30,Net Income Continuous Operations,2828000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q2,2025-06-30,Net Income Continuous Operations,1237000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q1,2025-03-31,Net Income Continuous Operations,1719000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q3,2025-09-30,Earnings From Equity Interest Net Of Tax,-2000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q2,2025-06-30,Earnings From Equity Interest Net Of Tax,43000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q1,2025-03-31,Earnings From Equity Interest Net Of Tax,42000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q3,2025-09-30,Tax Provision,680000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q2,2025-06-30,Tax Provision,230000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q1,2025-03-31,Tax Provision,481000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q3,2025-09-30,Pretax Income,3510000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q2,2025-06-30,Pretax Income,1424000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q1,2025-03-31,Pretax Income,2158000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q3,2025-09-30,Other Income Expense,-161000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q2,2025-06-30,Other Income Expense,-237000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q1,2025-03-31,Other Income Expense,-176000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q3,2025-09-30,Special Income Charges,-161000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q2,2025-06-30,Special Income Charges,-238000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q1,2025-03-31,Special Income Charges,-176000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q3,2025-09-30,Gain On Sale Of Business,85000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q2,2025-06-30,Other Special Charges,20000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q1,2025-03-31,Other Special Charges,37000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q3,2025-09-30,Impairment Of Capital Assets,18000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q2,2025-06-30,Impairment Of Capital Assets,185000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q1,2025-03-31,Impairment Of Capital Assets,25000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q3,2025-09-30,Restructuring And Mergern Acquisition,228000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q2,2025-06-30,Restructuring And Mergern Acquisition,377000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q1,2025-03-31,Restructuring And Mergern Acquisition,114000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q3,2025-09-30,Net Non Operating Interest Income Expense,-113000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q2,2025-06-30,Net Non Operating Interest Income Expense,-51000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q1,2025-03-31,Net Non Operating Interest Income Expense,-127000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q3,2025-09-30,Interest Expense Non Operating,227000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q2,2025-06-30,Interest Expense Non Operating,87000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q1,2025-03-31,Interest Expense Non Operating,213000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q3,2025-09-30,Interest Income Non Operating,114000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q2,2025-06-30,Interest Income Non Operating,76000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q1,2025-03-31,Interest Income Non Operating,86000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q3,2025-09-30,Operating Income,3785000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q2,2025-06-30,Operating Income,1712000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q1,2025-03-31,Operating Income,2461000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q3,2025-09-30,Operating Expense,5973000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q2,2025-06-30,Operating Expense,6031000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q1,2025-03-31,Operating Expense,5256000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q3,2025-09-30,Other Operating Expenses,1387000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q2,2025-06-30,Other Operating Expenses,1114000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q1,2025-03-31,Other Operating Expenses,827000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q3,2025-09-30,Depreciation Amortization Depletion Income Statement,461000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q2,2025-06-30,Depreciation Amortization Depletion Income Statement,378000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q1,2025-03-31,Depreciation Amortization Depletion Income Statement,399000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q3,2025-09-30,Depreciation And Amortization In Income Statement,461000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q2,2025-06-30,Depreciation And Amortization In Income Statement,378000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q1,2025-03-31,Depreciation And Amortization In Income Statement,399000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q3,2025-09-30,Amortization,461000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q2,2025-06-30,Amortization,378000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q1,2025-03-31,Amortization,399000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q3,2025-09-30,Amortization Of Intangibles Income Statement,461000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q2,2025-06-30,Amortization Of Intangibles Income Statement,378000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q1,2025-03-31,Amortization Of Intangibles Income Statement,399000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q3,2025-09-30,Research And Development,1834000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q2,2025-06-30,Research And Development,1909000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q1,2025-03-31,Research And Development,1808000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q3,2025-09-30,Selling General And Administration,2291000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q2,2025-06-30,Selling General And Administration,2630000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q1,2025-03-31,Selling General And Administration,2222000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q3,2025-09-30,Gross Profit,9758000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q2,2025-06-30,Gross Profit,7743000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q1,2025-03-31,Gross Profit,7717000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q3,2025-09-30,Cost Of Revenue,3412000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q2,2025-06-30,Cost Of Revenue,2992000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q1,2025-03-31,Cost Of Revenue,2889000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q3,2025-09-30,Total Revenue,13170000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q2,2025-06-30,Total Revenue,10735000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q1,2025-03-31,Total Revenue,10606000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q3,2025-09-30,Operating Revenue,12434000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q2,2025-06-30,Operating Revenue,9994000000.0,EUR
SAN.PA,Sanofi,end_market,pharma,France,2025-Q1,2025-03-31,Operating Revenue,9895000000.0,EUR
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q4,2025-12-31,Tax Effect Of Unusual Items,0.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q3,2025-09-30,Tax Effect Of Unusual Items,0.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q2,2025-06-30,Tax Effect Of Unusual Items,0.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q1,2025-03-31,Tax Effect Of Unusual Items,0.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q4,2025-12-31,Tax Rate For Calcs,0.114112,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q3,2025-09-30,Tax Rate For Calcs,0.22,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q2,2025-06-30,Tax Rate For Calcs,0.22,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q1,2025-03-31,Tax Rate For Calcs,0.14,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q4,2025-12-31,Normalized EBITDA,4624000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q3,2025-09-30,Normalized EBITDA,5227000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q2,2025-06-30,Normalized EBITDA,4955000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q1,2025-03-31,Normalized EBITDA,5035000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q4,2025-12-31,Net Income From Continuing Operation Net Minority Interest,2326000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q3,2025-09-30,Net Income From Continuing Operation Net Minority Interest,2533000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q2,2025-06-30,Net Income From Continuing Operation Net Minority Interest,2450000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q1,2025-03-31,Net Income From Continuing Operation Net Minority Interest,2916000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q4,2025-12-31,Reconciled Depreciation,1511000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q3,2025-09-30,Reconciled Depreciation,1549000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q2,2025-06-30,Reconciled Depreciation,1389000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q1,2025-03-31,Reconciled Depreciation,1284000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q4,2025-12-31,Reconciled Cost Of Revenue,3118000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q3,2025-09-30,Reconciled Cost Of Revenue,2801000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q2,2025-06-30,Reconciled Cost Of Revenue,2473000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q1,2025-03-31,Reconciled Cost Of Revenue,2241000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q4,2025-12-31,EBITDA,4624000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q3,2025-09-30,EBITDA,5227000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q2,2025-06-30,EBITDA,4955000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q1,2025-03-31,EBITDA,5035000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q4,2025-12-31,EBIT,3113000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q3,2025-09-30,EBIT,3678000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q2,2025-06-30,EBIT,3566000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q1,2025-03-31,EBIT,3751000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q4,2025-12-31,Net Interest Income,-349000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q3,2025-09-30,Net Interest Income,-349000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q2,2025-06-30,Net Interest Income,-371000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q1,2025-03-31,Net Interest Income,-265000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q4,2025-12-31,Interest Expense,484000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q3,2025-09-30,Interest Expense,434000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q2,2025-06-30,Interest Expense,439000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q1,2025-03-31,Interest Expense,349000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q4,2025-12-31,Interest Income,135000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q3,2025-09-30,Interest Income,85000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q2,2025-06-30,Interest Income,68000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q1,2025-03-31,Interest Income,84000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q4,2025-12-31,Normalized Income,2326000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q3,2025-09-30,Normalized Income,2533000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q2,2025-06-30,Normalized Income,2450000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q1,2025-03-31,Normalized Income,2916000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q4,2025-12-31,Net Income From Continuing And Discontinued Operation,2326000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q3,2025-09-30,Net Income From Continuing And Discontinued Operation,2533000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q2,2025-06-30,Net Income From Continuing And Discontinued Operation,2450000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q1,2025-03-31,Net Income From Continuing And Discontinued Operation,2916000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q4,2025-12-31,Total Expenses,12525000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q3,2025-09-30,Total Expenses,11608000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q2,2025-06-30,Total Expenses,10949000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q1,2025-03-31,Total Expenses,9914000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q4,2025-12-31,Total Operating Income As Reported,2978000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q3,2025-09-30,Total Operating Income As Reported,3583000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q2,2025-06-30,Total Operating Income As Reported,3508000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q1,2025-03-31,Total Operating Income As Reported,3674000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q4,2025-12-31,Diluted Average Shares,1563000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q2,2025-06-30,Diluted Average Shares,1559000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q1,2025-03-31,Diluted Average Shares,1561000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q4,2025-12-31,Basic Average Shares,1551000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q2,2025-06-30,Basic Average Shares,1550000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q1,2025-03-31,Basic Average Shares,1550000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q4,2025-12-31,Diluted EPS,1.49,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q2,2025-06-30,Diluted EPS,1.57,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q1,2025-03-31,Diluted EPS,1.87,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q4,2025-12-31,Basic EPS,1.5,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q2,2025-06-30,Basic EPS,1.58,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q1,2025-03-31,Basic EPS,1.88,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q4,2025-12-31,Diluted NI Availto Com Stockholders,2326000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q3,2025-09-30,Diluted NI Availto Com Stockholders,2533000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q2,2025-06-30,Diluted NI Availto Com Stockholders,2450000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q1,2025-03-31,Diluted NI Availto Com Stockholders,2916000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q4,2025-12-31,Net Income Common Stockholders,2326000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q3,2025-09-30,Net Income Common Stockholders,2533000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q2,2025-06-30,Net Income Common Stockholders,2450000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q1,2025-03-31,Net Income Common Stockholders,2916000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q4,2025-12-31,Otherunder Preferred Stock Dividend,0.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q3,2025-09-30,Otherunder Preferred Stock Dividend,0.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q2,2025-06-30,Otherunder Preferred Stock Dividend,0.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q1,2025-03-31,Otherunder Preferred Stock Dividend,0.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q4,2025-12-31,Net Income,2326000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q3,2025-09-30,Net Income,2533000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q2,2025-06-30,Net Income,2450000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q1,2025-03-31,Net Income,2916000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q4,2025-12-31,Minority Interests,-3000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q3,2025-09-30,Minority Interests,-2000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q2,2025-06-30,Minority Interests,2000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q1,2025-03-31,Minority Interests,-5000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q4,2025-12-31,Net Income Including Noncontrolling Interests,2329000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q3,2025-09-30,Net Income Including Noncontrolling Interests,2535000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q2,2025-06-30,Net Income Including Noncontrolling Interests,2448000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q1,2025-03-31,Net Income Including Noncontrolling Interests,2921000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q4,2025-12-31,Net Income Continuous Operations,2329000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q3,2025-09-30,Net Income Continuous Operations,2535000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q2,2025-06-30,Net Income Continuous Operations,2448000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q1,2025-03-31,Net Income Continuous Operations,2921000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q4,2025-12-31,Tax Provision,300000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q3,2025-09-30,Tax Provision,709000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q2,2025-06-30,Tax Provision,679000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q1,2025-03-31,Tax Provision,481000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q4,2025-12-31,Pretax Income,2629000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q3,2025-09-30,Pretax Income,3244000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q2,2025-06-30,Pretax Income,3127000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q1,2025-03-31,Pretax Income,3402000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q4,2025-12-31,Net Non Operating Interest Income Expense,-349000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q3,2025-09-30,Net Non Operating Interest Income Expense,-349000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q2,2025-06-30,Net Non Operating Interest Income Expense,-371000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q1,2025-03-31,Net Non Operating Interest Income Expense,-265000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q4,2025-12-31,Interest Expense Non Operating,484000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q3,2025-09-30,Interest Expense Non Operating,434000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q2,2025-06-30,Interest Expense Non Operating,439000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q1,2025-03-31,Interest Expense Non Operating,349000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q4,2025-12-31,Interest Income Non Operating,135000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q3,2025-09-30,Interest Income Non Operating,85000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q2,2025-06-30,Interest Income Non Operating,68000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q1,2025-03-31,Interest Income Non Operating,84000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q4,2025-12-31,Operating Income,2978000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q3,2025-09-30,Operating Income,3583000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q2,2025-06-30,Operating Income,3508000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q1,2025-03-31,Operating Income,3674000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q4,2025-12-31,Operating Expense,9407000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q3,2025-09-30,Operating Expense,8807000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q2,2025-06-30,Operating Expense,8476000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q1,2025-03-31,Operating Expense,7673000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q3,2025-09-30,Other Operating Expenses,-89000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q2,2025-06-30,Other Operating Expenses,-79000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q4,2025-12-31,Research And Development,3862000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q3,2025-09-30,Research And Development,3663000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q2,2025-06-30,Research And Development,3548000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q1,2025-03-31,Research And Development,3159000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q4,2025-12-31,Selling General And Administration,5645000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q3,2025-09-30,Selling General And Administration,5233000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q2,2025-06-30,Selling General And Administration,5007000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q1,2025-03-31,Selling General And Administration,4627000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q4,2025-12-31,Selling And Marketing Expense,153000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q3,2025-09-30,Selling And Marketing Expense,148000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q2,2025-06-30,Selling And Marketing Expense,143000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q1,2025-03-31,Selling And Marketing Expense,135000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q4,2025-12-31,General And Administrative Expense,5492000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q3,2025-09-30,General And Administrative Expense,5085000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q2,2025-06-30,General And Administrative Expense,4864000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q1,2025-03-31,General And Administrative Expense,4492000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q4,2025-12-31,Gross Profit,12385000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q3,2025-09-30,Gross Profit,12390000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q2,2025-06-30,Gross Profit,11984000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q1,2025-03-31,Gross Profit,11347000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q4,2025-12-31,Cost Of Revenue,3118000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q3,2025-09-30,Cost Of Revenue,2801000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q2,2025-06-30,Cost Of Revenue,2473000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q1,2025-03-31,Cost Of Revenue,2241000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q4,2025-12-31,Total Revenue,15503000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q3,2025-09-30,Total Revenue,15191000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q2,2025-06-30,Total Revenue,14457000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q1,2025-03-31,Total Revenue,13588000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q4,2025-12-31,Operating Revenue,15503000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q3,2025-09-30,Operating Revenue,15191000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q2,2025-06-30,Operating Revenue,14457000000.0,GBp
AZN.L,AstraZeneca,end_market,pharma,UK,2025-Q1,2025-03-31,Operating Revenue,13588000000.0,GBp
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q4,2025-12-31,Tax Effect Of Unusual Items,0.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q3,2025-09-30,Tax Effect Of Unusual Items,0.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q2,2025-06-30,Tax Effect Of Unusual Items,0.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q1,2025-03-31,Tax Effect Of Unusual Items,0.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q4,2025-12-31,Tax Rate For Calcs,0.213368,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q3,2025-09-30,Tax Rate For Calcs,0.216,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q2,2025-06-30,Tax Rate For Calcs,0.216,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q1,2025-03-31,Tax Rate For Calcs,0.216,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q4,2025-12-31,Normalized EBITDA,37298000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q3,2025-09-30,Normalized EBITDA,31439000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q2,2025-06-30,Normalized EBITDA,43596000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q1,2025-03-31,Normalized EBITDA,46046000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q4,2025-12-31,Net Income From Continuing Operation Net Minority Interest,26891000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q3,2025-09-30,Net Income From Continuing Operation Net Minority Interest,20006000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q2,2025-06-30,Net Income From Continuing Operation Net Minority Interest,26503000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q1,2025-03-31,Net Income From Continuing Operation Net Minority Interest,29034000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q4,2025-12-31,Reconciled Depreciation,5562000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q3,2025-09-30,Reconciled Depreciation,7757000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q2,2025-06-30,Reconciled Depreciation,4833000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q1,2025-03-31,Reconciled Depreciation,3830000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q4,2025-12-31,Reconciled Cost Of Revenue,15148000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q3,2025-09-30,Reconciled Cost Of Revenue,17904000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q2,2025-06-30,Reconciled Cost Of Revenue,12846000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q1,2025-03-31,Reconciled Cost Of Revenue,12890000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q4,2025-12-31,EBITDA,37298000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q3,2025-09-30,EBITDA,31439000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q2,2025-06-30,EBITDA,43596000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q1,2025-03-31,EBITDA,46046000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q4,2025-12-31,EBIT,31736000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q3,2025-09-30,EBIT,23682000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q2,2025-06-30,EBIT,38763000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q1,2025-03-31,EBIT,42216000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q4,2025-12-31,Net Interest Income,2449000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q3,2025-09-30,Net Interest Income,1835000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q2,2025-06-30,Net Interest Income,356000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q1,2025-03-31,Net Interest Income,-1758000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q4,2025-12-31,Interest Expense,-4406000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q2,2025-06-30,Interest Expense,4958000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q1,2025-03-31,Interest Expense,5183000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q4,2025-12-31,Interest Income,2449000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q3,2025-09-30,Interest Income,1835000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q2,2025-06-30,Interest Income,5314000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q1,2025-03-31,Interest Income,3425000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q4,2025-12-31,Normalized Income,26891000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q3,2025-09-30,Normalized Income,20006000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q2,2025-06-30,Normalized Income,26503000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q1,2025-03-31,Normalized Income,29034000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q4,2025-12-31,Net Income From Continuing And Discontinued Operation,26891000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q3,2025-09-30,Net Income From Continuing And Discontinued Operation,20006000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q2,2025-06-30,Net Income From Continuing And Discontinued Operation,26503000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q1,2025-03-31,Net Income From Continuing And Discontinued Operation,29034000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q4,2025-12-31,Total Expenses,47408000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q3,2025-09-30,Total Expenses,51294000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q2,2025-06-30,Total Expenses,43408000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q1,2025-03-31,Total Expenses,39296000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q4,2025-12-31,Total Operating Income As Reported,31736000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q3,2025-09-30,Total Operating Income As Reported,23682000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q2,2025-06-30,Total Operating Income As Reported,33449000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q1,2025-03-31,Total Operating Income As Reported,38791000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q4,2025-12-31,Diluted Average Shares,4449400000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q2,2025-06-30,Diluted Average Shares,4446812081.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q1,2025-03-31,Diluted Average Shares,4446400000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q4,2025-12-31,Basic Average Shares,4443600000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q2,2025-06-30,Basic Average Shares,4446812081.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q1,2025-03-31,Basic Average Shares,4439500000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q4,2025-12-31,Diluted EPS,6.04,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q2,2025-06-30,Diluted EPS,5.96,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q1,2025-03-31,Diluted EPS,6.53,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q4,2025-12-31,Basic EPS,6.06,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q2,2025-06-30,Basic EPS,5.96,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q1,2025-03-31,Basic EPS,6.54,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q4,2025-12-31,Diluted NI Availto Com Stockholders,26891000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q3,2025-09-30,Diluted NI Availto Com Stockholders,20006000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q2,2025-06-30,Diluted NI Availto Com Stockholders,26503000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q1,2025-03-31,Diluted NI Availto Com Stockholders,29034000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q4,2025-12-31,Net Income Common Stockholders,26891000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q3,2025-09-30,Net Income Common Stockholders,20006000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q2,2025-06-30,Net Income Common Stockholders,26503000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q1,2025-03-31,Net Income Common Stockholders,29034000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q4,2025-12-31,Net Income,26891000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q3,2025-09-30,Net Income,20006000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q2,2025-06-30,Net Income,26503000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q1,2025-03-31,Net Income,29034000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q4,2025-12-31,Net Income Including Noncontrolling Interests,26891000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q3,2025-09-30,Net Income Including Noncontrolling Interests,20006000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q2,2025-06-30,Net Income Including Noncontrolling Interests,26503000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q1,2025-03-31,Net Income Including Noncontrolling Interests,29034000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q4,2025-12-31,Net Income Continuous Operations,26891000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q3,2025-09-30,Net Income Continuous Operations,20006000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q2,2025-06-30,Net Income Continuous Operations,26503000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q1,2025-03-31,Net Income Continuous Operations,29034000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q4,2025-12-31,Tax Provision,7294000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q3,2025-09-30,Tax Provision,5511000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q2,2025-06-30,Tax Provision,7302000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q1,2025-03-31,Tax Provision,7999000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q4,2025-12-31,Pretax Income,34185000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q3,2025-09-30,Pretax Income,25517000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q2,2025-06-30,Pretax Income,33805000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q1,2025-03-31,Pretax Income,37033000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q4,2025-12-31,Net Non Operating Interest Income Expense,2449000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q3,2025-09-30,Net Non Operating Interest Income Expense,1835000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q2,2025-06-30,Net Non Operating Interest Income Expense,356000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q1,2025-03-31,Net Non Operating Interest Income Expense,-1758000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q4,2025-12-31,Interest Expense Non Operating,-4406000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q2,2025-06-30,Interest Expense Non Operating,4958000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q1,2025-03-31,Interest Expense Non Operating,5183000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q4,2025-12-31,Interest Income Non Operating,2449000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q3,2025-09-30,Interest Income Non Operating,1835000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q2,2025-06-30,Interest Income Non Operating,5314000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q1,2025-03-31,Interest Income Non Operating,3425000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q4,2025-12-31,Operating Income,31736000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q3,2025-09-30,Operating Income,23682000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q2,2025-06-30,Operating Income,33449000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q1,2025-03-31,Operating Income,38791000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q4,2025-12-31,Operating Expense,32260000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q3,2025-09-30,Operating Expense,33390000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q2,2025-06-30,Operating Expense,30562000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q1,2025-03-31,Operating Expense,26406000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q4,2025-12-31,Other Operating Expenses,174000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q3,2025-09-30,Other Operating Expenses,117000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q2,2025-06-30,Other Operating Expenses,23000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q1,2025-03-31,Other Operating Expenses,-14000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q4,2025-12-31,Research And Development,14648000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q3,2025-09-30,Research And Development,15393000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q2,2025-06-30,Research And Development,11690000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q1,2025-03-31,Research And Development,10308000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q4,2025-12-31,Selling General And Administration,17438000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q3,2025-09-30,Selling General And Administration,17880000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q2,2025-06-30,Selling General And Administration,18849000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q1,2025-03-31,Selling General And Administration,16112000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q4,2025-12-31,Selling And Marketing Expense,15889000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q3,2025-09-30,Selling And Marketing Expense,15996000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q2,2025-06-30,Selling And Marketing Expense,17533000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q1,2025-03-31,Selling And Marketing Expense,14892000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q4,2025-12-31,General And Administrative Expense,1549000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q3,2025-09-30,General And Administrative Expense,1884000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q2,2025-06-30,General And Administrative Expense,1316000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q1,2025-03-31,General And Administrative Expense,1220000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q4,2025-12-31,Other Gand A,1549000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q3,2025-09-30,Other Gand A,1884000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q2,2025-06-30,Other Gand A,1316000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q1,2025-03-31,Other Gand A,1220000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q4,2025-12-31,Gross Profit,63996000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q3,2025-09-30,Gross Profit,57072000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q2,2025-06-30,Gross Profit,64011000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q1,2025-03-31,Gross Profit,65197000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q4,2025-12-31,Cost Of Revenue,15148000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q3,2025-09-30,Cost Of Revenue,17904000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q2,2025-06-30,Cost Of Revenue,12846000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q1,2025-03-31,Cost Of Revenue,12890000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q4,2025-12-31,Total Revenue,79144000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q3,2025-09-30,Total Revenue,74976000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q2,2025-06-30,Total Revenue,76857000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q1,2025-03-31,Total Revenue,78087000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q4,2025-12-31,Operating Revenue,79144000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q3,2025-09-30,Operating Revenue,74976000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q2,2025-06-30,Operating Revenue,76857000000.0,DKK
NOVO-B.CO,Novo Nordisk,end_market,pharma,Denmark,2025-Q1,2025-03-31,Operating Revenue,78087000000.0,DKK
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q3,2025-09-30,Tax Effect Of Unusual Items,0.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q2,2025-06-30,Tax Effect Of Unusual Items,0.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q1,2025-03-31,Tax Effect Of Unusual Items,0.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q3,2025-09-30,Tax Rate For Calcs,0.173988,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q2,2025-06-30,Tax Rate For Calcs,0.15,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q1,2025-03-31,Tax Rate For Calcs,0.287432,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q3,2025-09-30,Normalized EBITDA,606000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q2,2025-06-30,Normalized EBITDA,236000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q1,2025-03-31,Normalized EBITDA,3477000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q3,2025-09-30,Net Income From Continuing Operation Net Minority Interest,-963000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q2,2025-06-30,Net Income From Continuing Operation Net Minority Interest,-199000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q1,2025-03-31,Net Income From Continuing Operation Net Minority Interest,1299000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q3,2025-09-30,Reconciled Depreciation,1005000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q2,2025-06-30,Reconciled Depreciation,272000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q1,2025-03-31,Reconciled Depreciation,1174000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q3,2025-09-30,Reconciled Cost Of Revenue,4307000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q2,2025-06-30,Reconciled Cost Of Revenue,4364000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q1,2025-03-31,Reconciled Cost Of Revenue,5625000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q3,2025-09-30,EBITDA,606000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q2,2025-06-30,EBITDA,236000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q1,2025-03-31,EBITDA,3477000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q3,2025-09-30,EBIT,-399000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q2,2025-06-30,EBIT,-36000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q1,2025-03-31,EBIT,2303000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q3,2025-09-30,Net Interest Income,-632000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q2,2025-06-30,Net Interest Income,-401000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q1,2025-03-31,Net Interest Income,-510000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q3,2025-09-30,Interest Expense,762000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q2,2025-06-30,Interest Expense,390000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q1,2025-03-31,Interest Expense,473000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q3,2025-09-30,Interest Income,130000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q1,2025-03-31,Interest Income,92000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q3,2025-09-30,Normalized Income,-963000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q2,2025-06-30,Normalized Income,-199000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q1,2025-03-31,Normalized Income,1299000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q3,2025-09-30,Net Income From Continuing And Discontinued Operation,-963000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q2,2025-06-30,Net Income From Continuing And Discontinued Operation,-199000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q1,2025-03-31,Net Income From Continuing And Discontinued Operation,1299000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q3,2025-09-30,Total Expenses,10203000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q2,2025-06-30,Total Expenses,10726000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q1,2025-03-31,Total Expenses,11414000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q3,2025-09-30,Diluted Average Shares,982420000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q2,2025-06-30,Diluted Average Shares,982420000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q1,2025-03-31,Diluted Average Shares,982420000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q3,2025-09-30,Basic Average Shares,982420000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q2,2025-06-30,Basic Average Shares,982420000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q1,2025-03-31,Basic Average Shares,982420000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q3,2025-09-30,Diluted EPS,-0.98,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q2,2025-06-30,Diluted EPS,-0.2,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q1,2025-03-31,Diluted EPS,1.32,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q3,2025-09-30,Basic EPS,-0.98,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q2,2025-06-30,Basic EPS,-0.2,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q1,2025-03-31,Basic EPS,1.32,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q3,2025-09-30,Diluted NI Availto Com Stockholders,-963000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q2,2025-06-30,Diluted NI Availto Com Stockholders,-199000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q1,2025-03-31,Diluted NI Availto Com Stockholders,1299000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q3,2025-09-30,Net Income Common Stockholders,-963000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q2,2025-06-30,Net Income Common Stockholders,-199000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q1,2025-03-31,Net Income Common Stockholders,1299000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q3,2025-09-30,Otherunder Preferred Stock Dividend,0.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q2,2025-06-30,Otherunder Preferred Stock Dividend,0.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q1,2025-03-31,Otherunder Preferred Stock Dividend,0.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q3,2025-09-30,Net Income,-963000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q2,2025-06-30,Net Income,-199000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q1,2025-03-31,Net Income,1299000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q3,2025-09-30,Minority Interests,-4000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q2,2025-06-30,Minority Interests,-9000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q1,2025-03-31,Minority Interests,-5000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q3,2025-09-30,Net Income Including Noncontrolling Interests,-959000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q2,2025-06-30,Net Income Including Noncontrolling Interests,-190000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q1,2025-03-31,Net Income Including Noncontrolling Interests,1304000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q3,2025-09-30,Net Income Continuous Operations,-959000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q2,2025-06-30,Net Income Continuous Operations,-190000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q1,2025-03-31,Net Income Continuous Operations,1304000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q3,2025-09-30,Tax Provision,-202000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q2,2025-06-30,Tax Provision,-236000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q1,2025-03-31,Tax Provision,526000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q3,2025-09-30,Pretax Income,-1161000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q2,2025-06-30,Pretax Income,-426000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q1,2025-03-31,Pretax Income,1830000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q3,2025-09-30,Net Non Operating Interest Income Expense,-632000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q2,2025-06-30,Net Non Operating Interest Income Expense,-401000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q1,2025-03-31,Net Non Operating Interest Income Expense,-510000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q2,2025-06-30,Total Other Finance Cost,11000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q1,2025-03-31,Total Other Finance Cost,37000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q3,2025-09-30,Interest Expense Non Operating,762000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q2,2025-06-30,Interest Expense Non Operating,390000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q1,2025-03-31,Interest Expense Non Operating,473000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q3,2025-09-30,Interest Income Non Operating,130000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q1,2025-03-31,Interest Income Non Operating,92000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q3,2025-09-30,Operating Income,-543000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q2,2025-06-30,Operating Income,13000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q1,2025-03-31,Operating Income,2324000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q3,2025-09-30,Operating Expense,5896000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q2,2025-06-30,Operating Expense,6362000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q1,2025-03-31,Operating Expense,5789000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q3,2025-09-30,Other Operating Expenses,1309000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q2,2025-06-30,Other Operating Expenses,2111000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q1,2025-03-31,Other Operating Expenses,829000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q3,2025-09-30,Research And Development,1498000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q2,2025-06-30,Research And Development,1408000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q1,2025-03-31,Research And Development,1458000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q3,2025-09-30,Selling General And Administration,3405000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q2,2025-06-30,Selling General And Administration,3545000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q1,2025-03-31,Selling General And Administration,3707000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q3,2025-09-30,Selling And Marketing Expense,2923000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q2,2025-06-30,Selling And Marketing Expense,3032000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q1,2025-03-31,Selling And Marketing Expense,3159000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q3,2025-09-30,General And Administrative Expense,482000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q2,2025-06-30,General And Administrative Expense,513000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q1,2025-03-31,General And Administrative Expense,548000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q3,2025-09-30,Gross Profit,5353000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q2,2025-06-30,Gross Profit,6375000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q1,2025-03-31,Gross Profit,8113000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q3,2025-09-30,Cost Of Revenue,4307000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q2,2025-06-30,Cost Of Revenue,4364000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q1,2025-03-31,Cost Of Revenue,5625000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q3,2025-09-30,Total Revenue,9660000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q2,2025-06-30,Total Revenue,10739000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q1,2025-03-31,Total Revenue,13738000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q3,2025-09-30,Operating Revenue,9660000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q2,2025-06-30,Operating Revenue,10739000000.0,EUR
BAYN.DE,Bayer,end_market,pharma,Germany,2025-Q1,2025-03-31,Operating Revenue,13738000000.0,EUR
GSK.L,GSK,end_market,pharma,UK,2025-Q3,2025-09-30,Tax Effect Of Unusual Items,0.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q2,2025-06-30,Tax Effect Of Unusual Items,0.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q1,2025-03-31,Tax Effect Of Unusual Items,0.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q3,2025-09-30,Tax Rate For Calcs,0.127036,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q2,2025-06-30,Tax Rate For Calcs,0.128,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q1,2025-03-31,Tax Rate For Calcs,0.159,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q3,2025-09-30,Normalized EBITDA,3361000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q2,2025-06-30,Normalized EBITDA,3230000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q1,2025-03-31,Normalized EBITDA,3093000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q3,2025-09-30,Net Income From Continuing Operation Net Minority Interest,2013000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q2,2025-06-30,Net Income From Continuing Operation Net Minority Interest,1443000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q1,2025-03-31,Net Income From Continuing Operation Net Minority Interest,1624000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q3,2025-09-30,Reconciled Depreciation,738000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q2,2025-06-30,Reconciled Depreciation,1159000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q1,2025-03-31,Reconciled Depreciation,823000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q3,2025-09-30,Reconciled Cost Of Revenue,2258000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q2,2025-06-30,Reconciled Cost Of Revenue,2165000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q1,2025-03-31,Reconciled Cost Of Revenue,1937000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q3,2025-09-30,EBITDA,3361000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q2,2025-06-30,EBITDA,3230000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q1,2025-03-31,EBITDA,3093000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q3,2025-09-30,EBIT,2623000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q2,2025-06-30,EBIT,2071000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q1,2025-03-31,EBIT,2270000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q3,2025-09-30,Net Interest Income,-141000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q2,2025-06-30,Net Interest Income,-134000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q1,2025-03-31,Net Interest Income,-108000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q3,2025-09-30,Interest Expense,167000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q2,2025-06-30,Interest Expense,184000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q1,2025-03-31,Interest Expense,162000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q3,2025-09-30,Interest Income,26000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q2,2025-06-30,Interest Income,50000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q1,2025-03-31,Interest Income,54000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q3,2025-09-30,Normalized Income,2013000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q2,2025-06-30,Normalized Income,1443000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q1,2025-03-31,Normalized Income,1624000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q3,2025-09-30,Net Income From Continuing And Discontinued Operation,2013000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q2,2025-06-30,Net Income From Continuing And Discontinued Operation,1443000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q1,2025-03-31,Net Income From Continuing And Discontinued Operation,1624000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q3,2025-09-30,Total Expenses,5954000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q2,2025-06-30,Total Expenses,5963000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q1,2025-03-31,Total Expenses,5300000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q3,2025-09-30,Total Operating Income As Reported,2593000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q2,2025-06-30,Total Operating Income As Reported,2023000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q1,2025-03-31,Total Operating Income As Reported,2216000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q4,2025-12-31,Diluted Average Shares,4086000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q2,2025-06-30,Diluted Average Shares,4110000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q1,2025-03-31,Diluted Average Shares,4137000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q4,2025-12-31,Basic Average Shares,4019000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q2,2025-06-30,Basic Average Shares,4063000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q1,2025-03-31,Basic Average Shares,4088000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q4,2025-12-31,Diluted EPS,0.156,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q2,2025-06-30,Diluted EPS,0.351,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q1,2025-03-31,Diluted EPS,0.393,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q4,2025-12-31,Basic EPS,0.158,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q2,2025-06-30,Basic EPS,0.355,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q1,2025-03-31,Basic EPS,0.397,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q3,2025-09-30,Diluted NI Availto Com Stockholders,2013000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q2,2025-06-30,Diluted NI Availto Com Stockholders,1443000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q1,2025-03-31,Diluted NI Availto Com Stockholders,1624000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q3,2025-09-30,Net Income Common Stockholders,2013000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q2,2025-06-30,Net Income Common Stockholders,1443000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q1,2025-03-31,Net Income Common Stockholders,1624000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q3,2025-09-30,Otherunder Preferred Stock Dividend,0.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q2,2025-06-30,Otherunder Preferred Stock Dividend,0.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q1,2025-03-31,Otherunder Preferred Stock Dividend,0.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q3,2025-09-30,Net Income,2013000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q2,2025-06-30,Net Income,1443000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q1,2025-03-31,Net Income,1624000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q3,2025-09-30,Minority Interests,-131000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q2,2025-06-30,Minority Interests,-203000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q1,2025-03-31,Minority Interests,-148000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q3,2025-09-30,Net Income Including Noncontrolling Interests,2144000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q2,2025-06-30,Net Income Including Noncontrolling Interests,1646000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q1,2025-03-31,Net Income Including Noncontrolling Interests,1772000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q3,2025-09-30,Net Income Continuous Operations,2144000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q2,2025-06-30,Net Income Continuous Operations,1646000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q1,2025-03-31,Net Income Continuous Operations,1772000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q3,2025-09-30,Tax Provision,312000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q2,2025-06-30,Tax Provision,241000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q1,2025-03-31,Tax Provision,336000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q3,2025-09-30,Pretax Income,2456000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q2,2025-06-30,Pretax Income,1887000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q1,2025-03-31,Pretax Income,2108000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q3,2025-09-30,Net Non Operating Interest Income Expense,-141000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q2,2025-06-30,Net Non Operating Interest Income Expense,-134000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q1,2025-03-31,Net Non Operating Interest Income Expense,-108000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q3,2025-09-30,Interest Expense Non Operating,167000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q2,2025-06-30,Interest Expense Non Operating,184000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q1,2025-03-31,Interest Expense Non Operating,162000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q3,2025-09-30,Interest Income Non Operating,26000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q2,2025-06-30,Interest Income Non Operating,50000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q1,2025-03-31,Interest Income Non Operating,54000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q3,2025-09-30,Operating Income,2593000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q2,2025-06-30,Operating Income,2023000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q1,2025-03-31,Operating Income,2216000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q3,2025-09-30,Operating Expense,3696000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q2,2025-06-30,Operating Expense,3798000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q1,2025-03-31,Operating Expense,3363000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q1,2025-03-31,Other Operating Expenses,11000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q3,2025-09-30,Research And Development,1689000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q2,2025-06-30,Research And Development,2024000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q1,2025-03-31,Research And Development,1462000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q3,2025-09-30,Selling General And Administration,2239000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q2,2025-06-30,Selling General And Administration,2140000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q1,2025-03-31,Selling General And Administration,2070000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q3,2025-09-30,General And Administrative Expense,2239000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q2,2025-06-30,General And Administrative Expense,2140000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q1,2025-03-31,General And Administrative Expense,2070000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q3,2025-09-30,Gross Profit,6289000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q2,2025-06-30,Gross Profit,5821000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q1,2025-03-31,Gross Profit,5579000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q3,2025-09-30,Cost Of Revenue,2258000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q2,2025-06-30,Cost Of Revenue,2165000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q1,2025-03-31,Cost Of Revenue,1937000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q3,2025-09-30,Total Revenue,8547000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q2,2025-06-30,Total Revenue,7986000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q1,2025-03-31,Total Revenue,7516000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q3,2025-09-30,Operating Revenue,8547000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q2,2025-06-30,Operating Revenue,7986000000.0,GBp
GSK.L,GSK,end_market,pharma,UK,2025-Q1,2025-03-31,Operating Revenue,7516000000.0,GBp
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q4,2025-12-31,Tax Effect Of Unusual Items,0.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q3,2025-09-30,Tax Effect Of Unusual Items,0.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q2,2025-06-30,Tax Effect Of Unusual Items,0.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q1,2025-03-31,Tax Effect Of Unusual Items,0.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q4,2025-12-31,Tax Rate For Calcs,0.216917,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q3,2025-09-30,Tax Rate For Calcs,0.233957,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q2,2025-06-30,Tax Rate For Calcs,0.212735,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q1,2025-03-31,Tax Rate For Calcs,0.233748,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q4,2025-12-31,Normalized EBITDA,1896000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q3,2025-09-30,Normalized EBITDA,1839000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q2,2025-06-30,Normalized EBITDA,1828000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q1,2025-03-31,Normalized EBITDA,1870000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q4,2025-12-31,Net Income From Continuing Operation Net Minority Interest,577000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q3,2025-09-30,Net Income From Continuing Operation Net Minority Interest,584000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q2,2025-06-30,Net Income From Continuing Operation Net Minority Interest,548000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q1,2025-03-31,Net Income From Continuing Operation Net Minority Interest,554000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q4,2025-12-31,Reconciled Depreciation,960000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q3,2025-09-30,Reconciled Depreciation,885000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q2,2025-06-30,Reconciled Depreciation,933000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q1,2025-03-31,Reconciled Depreciation,937000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q4,2025-12-31,Reconciled Cost Of Revenue,17206000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q3,2025-09-30,Reconciled Cost Of Revenue,16543000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q2,2025-06-30,Reconciled Cost Of Revenue,16985000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q1,2025-03-31,Reconciled Cost Of Revenue,17104000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q4,2025-12-31,EBITDA,1896000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q3,2025-09-30,EBITDA,1839000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q2,2025-06-30,EBITDA,1828000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q1,2025-03-31,EBITDA,1870000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q4,2025-12-31,EBIT,936000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q3,2025-09-30,EBIT,954000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q2,2025-06-30,EBIT,895000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q1,2025-03-31,EBIT,933000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q4,2025-12-31,Net Interest Income,-166000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q3,2025-09-30,Net Interest Income,-155000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q2,2025-06-30,Net Interest Income,-169000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q1,2025-03-31,Net Interest Income,-156000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q4,2025-12-31,Interest Expense,203000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q3,2025-09-30,Interest Expense,206000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q2,2025-06-30,Interest Expense,204000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q1,2025-03-31,Interest Expense,210000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q4,2025-12-31,Interest Income,49000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q3,2025-09-30,Interest Income,23000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q2,2025-06-30,Interest Income,42000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q1,2025-03-31,Interest Income,46000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q4,2025-12-31,Normalized Income,577000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q3,2025-09-30,Normalized Income,584000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q2,2025-06-30,Normalized Income,548000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q1,2025-03-31,Normalized Income,554000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q4,2025-12-31,Net Income From Continuing And Discontinued Operation,577000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q3,2025-09-30,Net Income From Continuing And Discontinued Operation,584000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q2,2025-06-30,Net Income From Continuing And Discontinued Operation,548000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q1,2025-03-31,Net Income From Continuing And Discontinued Operation,554000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q4,2025-12-31,Total Expenses,22715000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q3,2025-09-30,Total Expenses,21701000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q2,2025-06-30,Total Expenses,22346000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q1,2025-03-31,Total Expenses,22508000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q4,2025-12-31,Total Operating Income As Reported,899000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q3,2025-09-30,Total Operating Income As Reported,902000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q2,2025-06-30,Total Operating Income As Reported,861000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q1,2025-03-31,Total Operating Income As Reported,880000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q4,2025-12-31,Diluted Average Shares,893000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q2,2025-06-30,Diluted Average Shares,909000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q1,2025-03-31,Diluted Average Shares,916000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q4,2025-12-31,Basic Average Shares,889000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q2,2025-06-30,Basic Average Shares,906000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q1,2025-03-31,Basic Average Shares,912000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q4,2025-12-31,Diluted EPS,0.65,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q2,2025-06-30,Diluted EPS,0.6,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q1,2025-03-31,Diluted EPS,0.6,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q4,2025-12-31,Basic EPS,0.65,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q2,2025-06-30,Basic EPS,0.61,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q1,2025-03-31,Basic EPS,0.61,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q4,2025-12-31,Diluted NI Availto Com Stockholders,577000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q3,2025-09-30,Diluted NI Availto Com Stockholders,584000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q2,2025-06-30,Diluted NI Availto Com Stockholders,548000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q1,2025-03-31,Diluted NI Availto Com Stockholders,554000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q4,2025-12-31,Net Income Common Stockholders,577000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q3,2025-09-30,Net Income Common Stockholders,584000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q2,2025-06-30,Net Income Common Stockholders,548000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q1,2025-03-31,Net Income Common Stockholders,554000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q4,2025-12-31,Otherunder Preferred Stock Dividend,0.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q3,2025-09-30,Otherunder Preferred Stock Dividend,0.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q2,2025-06-30,Otherunder Preferred Stock Dividend,0.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q1,2025-03-31,Otherunder Preferred Stock Dividend,0.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q4,2025-12-31,Net Income,577000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q3,2025-09-30,Net Income,584000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q2,2025-06-30,Net Income,548000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q1,2025-03-31,Net Income,554000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q4,2025-12-31,Minority Interests,0.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q3,2025-09-30,Minority Interests,0.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q2,2025-06-30,Minority Interests,0.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q1,2025-03-31,Minority Interests,0.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q4,2025-12-31,Net Income Including Noncontrolling Interests,577000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q3,2025-09-30,Net Income Including Noncontrolling Interests,584000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q2,2025-06-30,Net Income Including Noncontrolling Interests,548000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q1,2025-03-31,Net Income Including Noncontrolling Interests,554000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q4,2025-12-31,Net Income Discontinuous Operations,0.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q2,2025-06-30,Net Income Discontinuous Operations,0.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q1,2025-03-31,Net Income Discontinuous Operations,0.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q4,2025-12-31,Net Income Continuous Operations,577000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q3,2025-09-30,Net Income Continuous Operations,584000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q2,2025-06-30,Net Income Continuous Operations,548000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q1,2025-03-31,Net Income Continuous Operations,554000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q4,2025-12-31,Tax Provision,159000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q3,2025-09-30,Tax Provision,175000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q2,2025-06-30,Tax Provision,147000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q1,2025-03-31,Tax Provision,169000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q4,2025-12-31,Pretax Income,733000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q3,2025-09-30,Pretax Income,748000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q2,2025-06-30,Pretax Income,691000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q1,2025-03-31,Pretax Income,723000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q4,2025-12-31,Other Non Operating Income Expenses,124000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q3,2025-09-30,Other Non Operating Income Expenses,109000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q2,2025-06-30,Other Non Operating Income Expenses,114000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q1,2025-03-31,Other Non Operating Income Expenses,112000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q4,2025-12-31,Net Non Operating Interest Income Expense,-166000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q3,2025-09-30,Net Non Operating Interest Income Expense,-155000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q2,2025-06-30,Net Non Operating Interest Income Expense,-169000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q1,2025-03-31,Net Non Operating Interest Income Expense,-156000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q4,2025-12-31,Total Other Finance Cost,12000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q3,2025-09-30,Total Other Finance Cost,-28000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q2,2025-06-30,Total Other Finance Cost,7000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q1,2025-03-31,Total Other Finance Cost,-8000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q4,2025-12-31,Interest Expense Non Operating,203000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q3,2025-09-30,Interest Expense Non Operating,206000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q2,2025-06-30,Interest Expense Non Operating,204000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q1,2025-03-31,Interest Expense Non Operating,210000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q4,2025-12-31,Interest Income Non Operating,49000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q3,2025-09-30,Interest Income Non Operating,23000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q2,2025-06-30,Interest Income Non Operating,42000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q1,2025-03-31,Interest Income Non Operating,46000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q4,2025-12-31,Operating Income,775000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q3,2025-09-30,Operating Income,793000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q2,2025-06-30,Operating Income,746000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q1,2025-03-31,Operating Income,768000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q4,2025-12-31,Operating Expense,5509000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q3,2025-09-30,Operating Expense,5158000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q2,2025-06-30,Operating Expense,5361000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q1,2025-03-31,Operating Expense,5404000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q4,2025-12-31,Selling General And Administration,5509000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q3,2025-09-30,Selling General And Administration,5158000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q2,2025-06-30,Selling General And Administration,5361000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q1,2025-03-31,Selling General And Administration,5404000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q4,2025-12-31,Selling And Marketing Expense,4497000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q3,2025-09-30,Selling And Marketing Expense,4291000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q2,2025-06-30,Selling And Marketing Expense,4431000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q1,2025-03-31,Selling And Marketing Expense,4502000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q4,2025-12-31,General And Administrative Expense,1012000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q3,2025-09-30,General And Administrative Expense,867000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q2,2025-06-30,General And Administrative Expense,930000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q1,2025-03-31,General And Administrative Expense,902000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q4,2025-12-31,Gross Profit,6284000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q3,2025-09-30,Gross Profit,5951000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q2,2025-06-30,Gross Profit,6107000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q1,2025-03-31,Gross Profit,6172000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q4,2025-12-31,Cost Of Revenue,17206000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q3,2025-09-30,Cost Of Revenue,16543000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q2,2025-06-30,Cost Of Revenue,16985000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q1,2025-03-31,Cost Of Revenue,17104000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q4,2025-12-31,Total Revenue,23490000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q3,2025-09-30,Total Revenue,22494000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q2,2025-06-30,Total Revenue,23092000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q1,2025-03-31,Total Revenue,23276000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q4,2025-12-31,Operating Revenue,23490000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q3,2025-09-30,Operating Revenue,22494000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q2,2025-06-30,Operating Revenue,23092000000.0,EUR
AD.AS,Ahold Delhaize,end_market,retail,Netherlands,2025-Q1,2025-03-31,Operating Revenue,23276000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q3,2025-09-30,Tax Effect Of Unusual Items,0.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q2,2025-06-30,Tax Effect Of Unusual Items,0.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q1,2025-03-31,Tax Effect Of Unusual Items,-1781065.088757,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q3,2025-09-30,Tax Rate For Calcs,0.22028,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q2,2025-06-30,Tax Rate For Calcs,0.281407,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q1,2025-03-31,Tax Rate For Calcs,0.254438,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q3,2025-09-30,Normalized EBITDA,657000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q2,2025-06-30,Normalized EBITDA,569000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q1,2025-03-31,Normalized EBITDA,542000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q1,2025-03-31,Total Unusual Items,-7000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q1,2025-03-31,Total Unusual Items Excluding Goodwill,-7000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q3,2025-09-30,Net Income From Continuing Operation Net Minority Interest,214000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q2,2025-06-30,Net Income From Continuing Operation Net Minority Interest,142000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q1,2025-03-31,Net Income From Continuing Operation Net Minority Interest,127000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q3,2025-09-30,Reconciled Depreciation,286000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q2,2025-06-30,Reconciled Depreciation,283000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q1,2025-03-31,Reconciled Depreciation,279000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q3,2025-09-30,Reconciled Cost Of Revenue,7244000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q2,2025-06-30,Reconciled Cost Of Revenue,7195000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q1,2025-03-31,Reconciled Cost Of Revenue,6636000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q3,2025-09-30,EBITDA,657000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q2,2025-06-30,EBITDA,569000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q1,2025-03-31,EBITDA,535000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q3,2025-09-30,EBIT,371000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q2,2025-06-30,EBIT,286000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q1,2025-03-31,EBIT,256000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q3,2025-09-30,Net Interest Income,-85000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q2,2025-06-30,Net Interest Income,-87000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q1,2025-03-31,Net Interest Income,-78000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q3,2025-09-30,Interest Expense,85000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q2,2025-06-30,Interest Expense,87000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q1,2025-03-31,Interest Expense,87000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q1,2025-03-31,Interest Income,12000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q3,2025-09-30,Normalized Income,214000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q2,2025-06-30,Normalized Income,142000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q1,2025-03-31,Normalized Income,132218934.911243,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q3,2025-09-30,Net Income From Continuing And Discontinued Operation,214000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q2,2025-06-30,Net Income From Continuing And Discontinued Operation,142000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q1,2025-03-31,Net Income From Continuing And Discontinued Operation,127000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q3,2025-09-30,Total Expenses,8767000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q2,2025-06-30,Total Expenses,8734000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q1,2025-03-31,Total Expenses,8128000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q3,2025-09-30,Total Operating Income As Reported,372000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q2,2025-06-30,Total Operating Income As Reported,286000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q1,2025-03-31,Total Operating Income As Reported,241000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q3,2025-09-30,Diluted Average Shares,627198124.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q2,2025-06-30,Diluted Average Shares,629153744.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q1,2025-03-31,Diluted Average Shares,635000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q3,2025-09-30,Basic Average Shares,627198124.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q2,2025-06-30,Basic Average Shares,629153744.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q1,2025-03-31,Basic Average Shares,635000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q3,2025-09-30,Diluted EPS,0.3412,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q2,2025-06-30,Diluted EPS,0.2257,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q1,2025-03-31,Diluted EPS,0.2,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q3,2025-09-30,Basic EPS,0.3412,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q2,2025-06-30,Basic EPS,0.2257,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q1,2025-03-31,Basic EPS,0.2,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q3,2025-09-30,Diluted NI Availto Com Stockholders,214000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q2,2025-06-30,Diluted NI Availto Com Stockholders,142000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q1,2025-03-31,Diluted NI Availto Com Stockholders,127000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q3,2025-09-30,Net Income Common Stockholders,214000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q2,2025-06-30,Net Income Common Stockholders,142000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q1,2025-03-31,Net Income Common Stockholders,127000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q3,2025-09-30,Otherunder Preferred Stock Dividend,0.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q2,2025-06-30,Otherunder Preferred Stock Dividend,0.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q1,2025-03-31,Otherunder Preferred Stock Dividend,0.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q3,2025-09-30,Net Income,214000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q2,2025-06-30,Net Income,142000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q1,2025-03-31,Net Income,127000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q3,2025-09-30,Minority Interests,-8000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q2,2025-06-30,Minority Interests,-1000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q1,2025-03-31,Minority Interests,2000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q3,2025-09-30,Net Income Including Noncontrolling Interests,223000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q2,2025-06-30,Net Income Including Noncontrolling Interests,143000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q1,2025-03-31,Net Income Including Noncontrolling Interests,126000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q3,2025-09-30,Net Income Continuous Operations,223000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q2,2025-06-30,Net Income Continuous Operations,143000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q1,2025-03-31,Net Income Continuous Operations,126000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q3,2025-09-30,Tax Provision,63000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q2,2025-06-30,Tax Provision,56000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q1,2025-03-31,Tax Provision,43000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q3,2025-09-30,Pretax Income,286000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q2,2025-06-30,Pretax Income,199000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q1,2025-03-31,Pretax Income,169000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q1,2025-03-31,Special Income Charges,-7000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q1,2025-03-31,Impairment Of Capital Assets,2000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q1,2025-03-31,Restructuring And Mergern Acquisition,5000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q3,2025-09-30,Net Non Operating Interest Income Expense,-85000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q2,2025-06-30,Net Non Operating Interest Income Expense,-87000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q1,2025-03-31,Net Non Operating Interest Income Expense,-78000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q1,2025-03-31,Total Other Finance Cost,3000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q3,2025-09-30,Interest Expense Non Operating,85000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q2,2025-06-30,Interest Expense Non Operating,87000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q1,2025-03-31,Interest Expense Non Operating,87000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q1,2025-03-31,Interest Income Non Operating,12000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q3,2025-09-30,Operating Income,371000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q2,2025-06-30,Operating Income,286000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q1,2025-03-31,Operating Income,249000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q3,2025-09-30,Operating Expense,1523000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q2,2025-06-30,Operating Expense,1539000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q1,2025-03-31,Operating Expense,1492000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q3,2025-09-30,Other Operating Expenses,6000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q2,2025-06-30,Other Operating Expenses,52000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q3,2025-09-30,Selling General And Administration,1517000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q2,2025-06-30,Selling General And Administration,1487000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q1,2025-03-31,Selling General And Administration,1492000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q3,2025-09-30,Selling And Marketing Expense,1377000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q2,2025-06-30,Selling And Marketing Expense,1353000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q1,2025-03-31,Selling And Marketing Expense,1342000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q3,2025-09-30,General And Administrative Expense,140000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q2,2025-06-30,General And Administrative Expense,134000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q1,2025-03-31,General And Administrative Expense,150000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q3,2025-09-30,Gross Profit,1894000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q2,2025-06-30,Gross Profit,1825000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q1,2025-03-31,Gross Profit,1741000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q3,2025-09-30,Cost Of Revenue,7244000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q2,2025-06-30,Cost Of Revenue,7195000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q1,2025-03-31,Cost Of Revenue,6636000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q3,2025-09-30,Total Revenue,9138000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q2,2025-06-30,Total Revenue,9020000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q1,2025-03-31,Total Revenue,8377000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q3,2025-09-30,Operating Revenue,9138000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q2,2025-06-30,Operating Revenue,9020000000.0,EUR
JMT.LS,Jernimo Martins,end_market,retail,Portugal,2025-Q1,2025-03-31,Operating Revenue,8377000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q2,2025-06-30,Tax Effect Of Unusual Items,0.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q1,2025-03-31,Tax Effect Of Unusual Items,-600000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q2,2025-06-30,Tax Rate For Calcs,0.299919,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q1,2025-03-31,Tax Rate For Calcs,0.3,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q2,2025-06-30,Normalized EBITDA,2736000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q1,2025-03-31,Normalized EBITDA,2713000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q1,2025-03-31,Total Unusual Items,-2000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q1,2025-03-31,Total Unusual Items Excluding Goodwill,-2000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q2,2025-06-30,Net Income From Continuing Operation Net Minority Interest,815000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q1,2025-03-31,Net Income From Continuing Operation Net Minority Interest,786000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q2,2025-06-30,Reconciled Depreciation,1190000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q1,2025-03-31,Reconciled Depreciation,1220000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q2,2025-06-30,Reconciled Cost Of Revenue,17836000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q1,2025-03-31,Reconciled Cost Of Revenue,18680000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q2,2025-06-30,EBITDA,2736000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q1,2025-03-31,EBITDA,2711000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q2,2025-06-30,EBIT,1546000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q1,2025-03-31,EBIT,1491000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q2,2025-06-30,Net Interest Income,-217000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q1,2025-03-31,Net Interest Income,-209000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q2,2025-06-30,Interest Expense,319000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q1,2025-03-31,Interest Expense,305000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q2,2025-06-30,Interest Income,102000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q1,2025-03-31,Interest Income,96000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q2,2025-06-30,Normalized Income,815000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q1,2025-03-31,Normalized Income,787400000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q2,2025-06-30,Net Income From Continuing And Discontinued Operation,815000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q1,2025-03-31,Net Income From Continuing And Discontinued Operation,786000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q2,2025-06-30,Total Expenses,18465000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q1,2025-03-31,Total Expenses,19435000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q2,2025-06-30,Total Operating Income As Reported,1429000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q1,2025-03-31,Total Operating Income As Reported,1370000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q2,2025-06-30,Diluted Average Shares,1131944444.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q1,2025-03-31,Diluted Average Shares,1173251791.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q2,2025-06-30,Basic Average Shares,1131944444.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q1,2025-03-31,Basic Average Shares,1151156211.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q2,2025-06-30,Diluted EPS,0.72,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q1,2025-03-31,Diluted EPS,0.67,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q2,2025-06-30,Basic EPS,0.72,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q1,2025-03-31,Basic EPS,0.68,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q2,2025-06-30,Diluted NI Availto Com Stockholders,815000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q1,2025-03-31,Diluted NI Availto Com Stockholders,788000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q1,2025-03-31,Average Dilution Earnings,1000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q2,2025-06-30,Net Income Common Stockholders,815000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q1,2025-03-31,Net Income Common Stockholders,786000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q2,2025-06-30,Otherunder Preferred Stock Dividend,0.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q1,2025-03-31,Otherunder Preferred Stock Dividend,0.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q2,2025-06-30,Net Income,815000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q1,2025-03-31,Net Income,786000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q2,2025-06-30,Minority Interests,-44000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q1,2025-03-31,Minority Interests,-43000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q2,2025-06-30,Net Income Including Noncontrolling Interests,859000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q1,2025-03-31,Net Income Including Noncontrolling Interests,830000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q2,2025-06-30,Net Income Continuous Operations,859000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q1,2025-03-31,Net Income Continuous Operations,830000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q2,2025-06-30,Tax Provision,368000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q1,2025-03-31,Tax Provision,356000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q2,2025-06-30,Pretax Income,1227000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q1,2025-03-31,Pretax Income,1186000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q1,2025-03-31,Special Income Charges,-2000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q1,2025-03-31,Write Off,2000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q2,2025-06-30,Net Non Operating Interest Income Expense,-217000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q1,2025-03-31,Net Non Operating Interest Income Expense,-209000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q2,2025-06-30,Interest Expense Non Operating,319000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q1,2025-03-31,Interest Expense Non Operating,305000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q2,2025-06-30,Interest Income Non Operating,102000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q1,2025-03-31,Interest Income Non Operating,96000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q2,2025-06-30,Operating Income,1361000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q1,2025-03-31,Operating Income,1374000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q2,2025-06-30,Operating Expense,629000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q1,2025-03-31,Operating Expense,755000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q2,2025-06-30,Other Operating Expenses,1310000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q1,2025-03-31,Other Operating Expenses,1347000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q2,2025-06-30,Gross Profit,1990000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q1,2025-03-31,Gross Profit,2129000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q2,2025-06-30,Cost Of Revenue,17836000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q1,2025-03-31,Cost Of Revenue,18680000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q2,2025-06-30,Total Revenue,19826000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q1,2025-03-31,Total Revenue,20809000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q2,2025-06-30,Operating Revenue,19826000000.0,EUR
DHL.DE,DHL Group,end_market,logistics,Germany,2025-Q1,2025-03-31,Operating Revenue,20809000000.0,EUR
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q4,2025-12-31,Tax Effect Of Unusual Items,-552860000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q2,2025-06-30,Tax Effect Of Unusual Items,-231211000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q1,2025-03-31,Tax Effect Of Unusual Items,0.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q4,2025-12-31,Tax Rate For Calcs,0.22,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q2,2025-06-30,Tax Rate For Calcs,0.283,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q1,2025-03-31,Tax Rate For Calcs,0.245,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q4,2025-12-31,Normalized EBITDA,7810000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q2,2025-06-30,Normalized EBITDA,7271000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q1,2025-03-31,Normalized EBITDA,6037000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q4,2025-12-31,Total Unusual Items,-2513000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q2,2025-06-30,Total Unusual Items,-817000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q1,2025-03-31,Total Unusual Items,0.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q4,2025-12-31,Total Unusual Items Excluding Goodwill,-2513000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q2,2025-06-30,Total Unusual Items Excluding Goodwill,-817000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q1,2025-03-31,Total Unusual Items Excluding Goodwill,0.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q4,2025-12-31,Net Income From Continuing Operation Net Minority Interest,1118000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q2,2025-06-30,Net Income From Continuing Operation Net Minority Interest,2330000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q1,2025-03-31,Net Income From Continuing Operation Net Minority Interest,2797000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q4,2025-12-31,Reconciled Depreciation,2511000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q2,2025-06-30,Reconciled Depreciation,2210000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q1,2025-03-31,Reconciled Depreciation,1513000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q4,2025-12-31,Reconciled Cost Of Revenue,52566000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q2,2025-06-30,Reconciled Cost Of Revenue,44742000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q1,2025-03-31,Reconciled Cost Of Revenue,30689000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q4,2025-12-31,EBITDA,5297000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q2,2025-06-30,EBITDA,6454000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q1,2025-03-31,EBITDA,6037000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q4,2025-12-31,EBIT,2786000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q2,2025-06-30,EBIT,4244000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q1,2025-03-31,EBIT,4524000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q4,2025-12-31,Net Interest Income,-946000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q2,2025-06-30,Net Interest Income,-621000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q1,2025-03-31,Net Interest Income,-136000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q4,2025-12-31,Interest Expense,890000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q2,2025-06-30,Interest Expense,957000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q1,2025-03-31,Interest Expense,800000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q4,2025-12-31,Interest Income,76000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q2,2025-06-30,Interest Income,336000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q1,2025-03-31,Interest Income,664000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q4,2025-12-31,Normalized Income,3078140000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q2,2025-06-30,Normalized Income,2915789000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q1,2025-03-31,Normalized Income,2797000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q4,2025-12-31,Net Income From Continuing And Discontinued Operation,917000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q2,2025-06-30,Net Income From Continuing And Discontinued Operation,2330000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q1,2025-03-31,Net Income From Continuing And Discontinued Operation,2797000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q4,2025-12-31,Total Expenses,66136000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q2,2025-06-30,Total Expenses,57258000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q1,2025-03-31,Total Expenses,37820000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q4,2025-12-31,Total Operating Income As Reported,5592000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q2,2025-06-30,Total Operating Income As Reported,4725000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q1,2025-03-31,Total Operating Income As Reported,3860000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q2,2025-06-30,Diluted Average Shares,235353535.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q1,2025-03-31,Diluted Average Shares,235042017.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q2,2025-06-30,Basic Average Shares,235353535.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q1,2025-03-31,Basic Average Shares,235042017.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q2,2025-06-30,Diluted EPS,9.9,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q1,2025-03-31,Diluted EPS,11.9,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q2,2025-06-30,Basic EPS,9.9,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q1,2025-03-31,Basic EPS,11.9,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q4,2025-12-31,Diluted NI Availto Com Stockholders,917000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q2,2025-06-30,Diluted NI Availto Com Stockholders,2330000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q1,2025-03-31,Diluted NI Availto Com Stockholders,2797000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q4,2025-12-31,Net Income Common Stockholders,917000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q2,2025-06-30,Net Income Common Stockholders,2330000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q1,2025-03-31,Net Income Common Stockholders,2797000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q4,2025-12-31,Otherunder Preferred Stock Dividend,0.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q2,2025-06-30,Otherunder Preferred Stock Dividend,0.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q1,2025-03-31,Otherunder Preferred Stock Dividend,0.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q4,2025-12-31,Net Income,917000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q2,2025-06-30,Net Income,2330000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q1,2025-03-31,Net Income,2797000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q4,2025-12-31,Minority Interests,-17000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q2,2025-06-30,Minority Interests,-26000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q1,2025-03-31,Minority Interests,-15000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q4,2025-12-31,Net Income Including Noncontrolling Interests,934000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q2,2025-06-30,Net Income Including Noncontrolling Interests,2356000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q1,2025-03-31,Net Income Including Noncontrolling Interests,2812000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q4,2025-12-31,Net Income Discontinuous Operations,-201000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q4,2025-12-31,Net Income Continuous Operations,1135000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q2,2025-06-30,Net Income Continuous Operations,2356000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q1,2025-03-31,Net Income Continuous Operations,2812000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q4,2025-12-31,Tax Provision,761000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q2,2025-06-30,Tax Provision,931000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q1,2025-03-31,Tax Provision,912000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q4,2025-12-31,Pretax Income,1896000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q2,2025-06-30,Pretax Income,3287000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q1,2025-03-31,Pretax Income,3724000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q4,2025-12-31,Special Income Charges,-2513000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q2,2025-06-30,Special Income Charges,-817000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q1,2025-03-31,Special Income Charges,0.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q4,2025-12-31,Restructuring And Mergern Acquisition,2556000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q2,2025-06-30,Restructuring And Mergern Acquisition,817000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q4,2025-12-31,Net Non Operating Interest Income Expense,-946000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q2,2025-06-30,Net Non Operating Interest Income Expense,-621000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q1,2025-03-31,Net Non Operating Interest Income Expense,-136000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q4,2025-12-31,Interest Expense Non Operating,890000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q2,2025-06-30,Interest Expense Non Operating,957000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q1,2025-03-31,Interest Expense Non Operating,800000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q4,2025-12-31,Interest Income Non Operating,76000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q2,2025-06-30,Interest Income Non Operating,336000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q1,2025-03-31,Interest Income Non Operating,664000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q4,2025-12-31,Operating Income,5549000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q2,2025-06-30,Operating Income,4725000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q1,2025-03-31,Operating Income,3860000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q4,2025-12-31,Operating Expense,13570000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q2,2025-06-30,Operating Expense,12516000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q1,2025-03-31,Operating Expense,7131000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q4,2025-12-31,Other Operating Expenses,2974000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q2,2025-06-30,Other Operating Expenses,2380000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q1,2025-03-31,Other Operating Expenses,1216000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q4,2025-12-31,Depreciation And Amortization In Income Statement,2511000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q2,2025-06-30,Depreciation And Amortization In Income Statement,2210000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q1,2025-03-31,Depreciation And Amortization In Income Statement,1513000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q4,2025-12-31,Depreciation Income Statement,1912000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q2,2025-06-30,Depreciation Income Statement,2210000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q1,2025-03-31,Depreciation Income Statement,1513000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q4,2025-12-31,Gross Profit,19119000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q2,2025-06-30,Gross Profit,17241000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q1,2025-03-31,Gross Profit,10991000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q4,2025-12-31,Cost Of Revenue,52566000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q2,2025-06-30,Cost Of Revenue,44742000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q1,2025-03-31,Cost Of Revenue,30689000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q4,2025-12-31,Total Revenue,71685000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q2,2025-06-30,Total Revenue,61983000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q1,2025-03-31,Total Revenue,41680000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q4,2025-12-31,Operating Revenue,71685000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q2,2025-06-30,Operating Revenue,61983000000.0,DKK
DSV.CO,DSV,end_market,logistics,Denmark,2025-Q1,2025-03-31,Operating Revenue,41680000000.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q4,2025-12-31,Tax Effect Of Unusual Items,0.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q3,2025-09-30,Tax Effect Of Unusual Items,0.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q2,2025-06-30,Tax Effect Of Unusual Items,0.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q1,2025-03-31,Tax Effect Of Unusual Items,0.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q4,2025-12-31,Tax Rate For Calcs,0.22,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q3,2025-09-30,Tax Rate For Calcs,0.127389,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q2,2025-06-30,Tax Rate For Calcs,0.129428,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q1,2025-03-31,Tax Rate For Calcs,0.155944,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q4,2025-12-31,Net Income From Continuing Operation Net Minority Interest,-70000000.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q3,2025-09-30,Net Income From Continuing Operation Net Minority Interest,1047000000.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q2,2025-06-30,Net Income From Continuing Operation Net Minority Interest,586000000.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q1,2025-03-31,Net Income From Continuing Operation Net Minority Interest,1162000000.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q4,2025-12-31,Normalized Income,-70000000.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q3,2025-09-30,Normalized Income,1047000000.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q2,2025-06-30,Normalized Income,586000000.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q1,2025-03-31,Normalized Income,1162000000.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q4,2025-12-31,Net Income From Continuing And Discontinued Operation,-70000000.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q3,2025-09-30,Net Income From Continuing And Discontinued Operation,1047000000.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q2,2025-06-30,Net Income From Continuing And Discontinued Operation,586000000.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q1,2025-03-31,Net Income From Continuing And Discontinued Operation,1162000000.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q2,2025-06-30,Diluted Average Shares,15421053.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q1,2025-03-31,Diluted Average Shares,15702703.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q2,2025-06-30,Basic Average Shares,15421053.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q1,2025-03-31,Basic Average Shares,15702703.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q2,2025-06-30,Diluted EPS,38.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q1,2025-03-31,Diluted EPS,74.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q2,2025-06-30,Basic EPS,38.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q1,2025-03-31,Basic EPS,74.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q4,2025-12-31,Diluted NI Availto Com Stockholders,-70000000.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q3,2025-09-30,Diluted NI Availto Com Stockholders,1047000000.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q2,2025-06-30,Diluted NI Availto Com Stockholders,586000000.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q1,2025-03-31,Diluted NI Availto Com Stockholders,1162000000.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q4,2025-12-31,Net Income Common Stockholders,-70000000.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q3,2025-09-30,Net Income Common Stockholders,1047000000.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q2,2025-06-30,Net Income Common Stockholders,586000000.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q1,2025-03-31,Net Income Common Stockholders,1162000000.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q4,2025-12-31,Otherunder Preferred Stock Dividend,0.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q3,2025-09-30,Otherunder Preferred Stock Dividend,0.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q2,2025-06-30,Otherunder Preferred Stock Dividend,0.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q1,2025-03-31,Otherunder Preferred Stock Dividend,0.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q4,2025-12-31,Net Income,-70000000.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q3,2025-09-30,Net Income,1047000000.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q2,2025-06-30,Net Income,586000000.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q1,2025-03-31,Net Income,1162000000.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q4,2025-12-31,Minority Interests,-43000000.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q3,2025-09-30,Minority Interests,-49000000.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q2,2025-06-30,Minority Interests,-53000000.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q1,2025-03-31,Minority Interests,-45000000.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q4,2025-12-31,Net Income Including Noncontrolling Interests,-27000000.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q3,2025-09-30,Net Income Including Noncontrolling Interests,1096000000.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q2,2025-06-30,Net Income Including Noncontrolling Interests,639000000.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q1,2025-03-31,Net Income Including Noncontrolling Interests,1207000000.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q4,2025-12-31,Net Income Continuous Operations,-27000000.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q3,2025-09-30,Net Income Continuous Operations,1096000000.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q2,2025-06-30,Net Income Continuous Operations,639000000.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q1,2025-03-31,Net Income Continuous Operations,1207000000.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q4,2025-12-31,Tax Provision,78000000.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q3,2025-09-30,Tax Provision,160000000.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q2,2025-06-30,Tax Provision,95000000.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q1,2025-03-31,Tax Provision,223000000.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q4,2025-12-31,Pretax Income,51000000.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q3,2025-09-30,Pretax Income,1256000000.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q2,2025-06-30,Pretax Income,734000000.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q1,2025-03-31,Pretax Income,1430000000.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q4,2025-12-31,Total Revenue,13331000000.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q3,2025-09-30,Total Revenue,14206000000.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q2,2025-06-30,Total Revenue,13130000000.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q1,2025-03-31,Total Revenue,13321000000.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q4,2025-12-31,Operating Revenue,13331000000.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q3,2025-09-30,Operating Revenue,14206000000.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q2,2025-06-30,Operating Revenue,13130000000.0,DKK
MAERSK-B.CO,Maersk,end_market,logistics,Denmark,2025-Q1,2025-03-31,Operating Revenue,13321000000.0,DKK
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q2,2025-06-30,Tax Effect Of Unusual Items,0.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q1,2025-03-31,Tax Effect Of Unusual Items,0.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q2,2025-06-30,Tax Rate For Calcs,0.245509,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q1,2025-03-31,Tax Rate For Calcs,0.251852,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q2,2025-06-30,Normalized EBITDA,571000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q1,2025-03-31,Normalized EBITDA,640000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q2,2025-06-30,Net Income From Continuing Operation Net Minority Interest,240000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q1,2025-03-31,Net Income From Continuing Operation Net Minority Interest,291000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q2,2025-06-30,Reconciled Depreciation,224000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q1,2025-03-31,Reconciled Depreciation,225000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q2,2025-06-30,Reconciled Cost Of Revenue,3962000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q1,2025-03-31,Reconciled Cost Of Revenue,4093000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q2,2025-06-30,EBITDA,571000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q1,2025-03-31,EBITDA,640000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q2,2025-06-30,EBIT,347000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q1,2025-03-31,EBIT,415000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q2,2025-06-30,Net Interest Income,-9000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q1,2025-03-31,Net Interest Income,2000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q2,2025-06-30,Interest Expense,13000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q1,2025-03-31,Interest Expense,10000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q2,2025-06-30,Interest Income,4000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q1,2025-03-31,Interest Income,12000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q2,2025-06-30,Normalized Income,240000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q1,2025-03-31,Normalized Income,291000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q2,2025-06-30,Net Income From Continuing And Discontinued Operation,240000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q1,2025-03-31,Net Income From Continuing And Discontinued Operation,291000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q2,2025-06-30,Total Expenses,5807000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q1,2025-03-31,Total Expenses,5928000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q2,2025-06-30,Diluted Average Shares,118811881.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q1,2025-03-31,Diluted Average Shares,118775510.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q2,2025-06-30,Basic Average Shares,118811881.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q1,2025-03-31,Basic Average Shares,118775510.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q2,2025-06-30,Diluted EPS,2.02,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q1,2025-03-31,Diluted EPS,2.45,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q2,2025-06-30,Basic EPS,2.02,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q1,2025-03-31,Basic EPS,2.45,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q2,2025-06-30,Diluted NI Availto Com Stockholders,240000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q1,2025-03-31,Diluted NI Availto Com Stockholders,291000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q2,2025-06-30,Net Income Common Stockholders,240000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q1,2025-03-31,Net Income Common Stockholders,291000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q2,2025-06-30,Otherunder Preferred Stock Dividend,0.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q1,2025-03-31,Otherunder Preferred Stock Dividend,0.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q2,2025-06-30,Net Income,240000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q1,2025-03-31,Net Income,291000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q2,2025-06-30,Minority Interests,-12000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q1,2025-03-31,Minority Interests,-12000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q2,2025-06-30,Net Income Including Noncontrolling Interests,252000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q1,2025-03-31,Net Income Including Noncontrolling Interests,303000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q2,2025-06-30,Net Income Continuous Operations,252000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q1,2025-03-31,Net Income Continuous Operations,303000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q2,2025-06-30,Tax Provision,82000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q1,2025-03-31,Tax Provision,102000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q2,2025-06-30,Pretax Income,334000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q1,2025-03-31,Pretax Income,405000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q2,2025-06-30,Net Non Operating Interest Income Expense,-9000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q1,2025-03-31,Net Non Operating Interest Income Expense,2000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q2,2025-06-30,Interest Expense Non Operating,13000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q1,2025-03-31,Interest Expense Non Operating,10000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q2,2025-06-30,Interest Income Non Operating,4000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q1,2025-03-31,Interest Income Non Operating,12000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q2,2025-06-30,Operating Income,342000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q1,2025-03-31,Operating Income,402000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q2,2025-06-30,Operating Expense,1845000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q1,2025-03-31,Operating Expense,1835000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q2,2025-06-30,Other Operating Expenses,-8000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q1,2025-03-31,Other Operating Expenses,-5000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q2,2025-06-30,Depreciation And Amortization In Income Statement,224000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q1,2025-03-31,Depreciation And Amortization In Income Statement,225000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q2,2025-06-30,Amortization,14000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q1,2025-03-31,Amortization,15000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q2,2025-06-30,Depreciation Income Statement,210000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q1,2025-03-31,Depreciation Income Statement,210000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q2,2025-06-30,Selling General And Administration,381000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q1,2025-03-31,Selling General And Administration,367000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q2,2025-06-30,General And Administrative Expense,381000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q1,2025-03-31,General And Administrative Expense,367000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q2,2025-06-30,Gross Profit,2187000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q1,2025-03-31,Gross Profit,2237000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q2,2025-06-30,Cost Of Revenue,3962000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q1,2025-03-31,Cost Of Revenue,4093000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q2,2025-06-30,Total Revenue,6149000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q1,2025-03-31,Total Revenue,6330000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q2,2025-06-30,Operating Revenue,6149000000.0,CHF
KNIN.SW,Kuehne + Nagel,end_market,logistics,Switzerland,2025-Q1,2025-03-31,Operating Revenue,6330000000.0,CHF
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q4,2025-12-31,Tax Effect Of Unusual Items,0.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q2,2025-06-30,Tax Effect Of Unusual Items,0.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q1,2025-03-31,Tax Effect Of Unusual Items,0.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q4,2025-12-31,Tax Rate For Calcs,0.364532,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q2,2025-06-30,Tax Rate For Calcs,0.152941,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q1,2025-03-31,Tax Rate For Calcs,0.17341,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q4,2025-12-31,Normalized EBITDA,573000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q2,2025-06-30,Normalized EBITDA,248000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q1,2025-03-31,Normalized EBITDA,352000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q4,2025-12-31,Net Income From Continuing Operation Net Minority Interest,256000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q2,2025-06-30,Net Income From Continuing Operation Net Minority Interest,70000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q1,2025-03-31,Net Income From Continuing Operation Net Minority Interest,137000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q4,2025-12-31,Reconciled Depreciation,140000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q2,2025-06-30,Reconciled Depreciation,141000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q1,2025-03-31,Reconciled Depreciation,152000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q4,2025-12-31,Reconciled Cost Of Revenue,1880000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q2,2025-06-30,Reconciled Cost Of Revenue,2173000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q1,2025-03-31,Reconciled Cost Of Revenue,2321000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q4,2025-12-31,EBITDA,573000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q2,2025-06-30,EBITDA,248000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q1,2025-03-31,EBITDA,352000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q4,2025-12-31,EBIT,433000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q2,2025-06-30,EBIT,107000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q1,2025-03-31,EBIT,200000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q4,2025-12-31,Net Interest Income,-27000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q2,2025-06-30,Net Interest Income,-22000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q1,2025-03-31,Net Interest Income,-27000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q4,2025-12-31,Interest Expense,27000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q2,2025-06-30,Interest Expense,22000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q1,2025-03-31,Interest Expense,27000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q4,2025-12-31,Normalized Income,256000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q2,2025-06-30,Normalized Income,70000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q1,2025-03-31,Normalized Income,137000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q4,2025-12-31,Net Income From Continuing And Discontinued Operation,256000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q2,2025-06-30,Net Income From Continuing And Discontinued Operation,70000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q1,2025-03-31,Net Income From Continuing And Discontinued Operation,137000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q4,2025-12-31,Total Expenses,1921000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q2,2025-06-30,Total Expenses,2293000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q1,2025-03-31,Total Expenses,2450000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q4,2025-12-31,Total Operating Income As Reported,390000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q2,2025-06-30,Total Operating Income As Reported,107000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q1,2025-03-31,Total Operating Income As Reported,198000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q4,2025-12-31,Diluted Average Shares,527324000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q2,2025-06-30,Diluted Average Shares,527391000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q1,2025-03-31,Diluted Average Shares,532245000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q4,2025-12-31,Basic Average Shares,527324000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q2,2025-06-30,Basic Average Shares,527391000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q1,2025-03-31,Basic Average Shares,532245000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q4,2025-12-31,Diluted EPS,0.49,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q2,2025-06-30,Diluted EPS,0.13,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q1,2025-03-31,Diluted EPS,0.26,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q4,2025-12-31,Basic EPS,0.49,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q2,2025-06-30,Basic EPS,0.13,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q1,2025-03-31,Basic EPS,0.26,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q4,2025-12-31,Diluted NI Availto Com Stockholders,256000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q2,2025-06-30,Diluted NI Availto Com Stockholders,70000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q1,2025-03-31,Diluted NI Availto Com Stockholders,137000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q4,2025-12-31,Net Income Common Stockholders,256000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q2,2025-06-30,Net Income Common Stockholders,70000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q1,2025-03-31,Net Income Common Stockholders,137000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q4,2025-12-31,Otherunder Preferred Stock Dividend,0.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q2,2025-06-30,Otherunder Preferred Stock Dividend,0.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q1,2025-03-31,Otherunder Preferred Stock Dividend,0.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q4,2025-12-31,Net Income,256000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q2,2025-06-30,Net Income,70000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q1,2025-03-31,Net Income,137000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q4,2025-12-31,Minority Interests,-1000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q2,2025-06-30,Minority Interests,-1000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q1,2025-03-31,Minority Interests,-6000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q4,2025-12-31,Net Income Including Noncontrolling Interests,258000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q2,2025-06-30,Net Income Including Noncontrolling Interests,71000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q1,2025-03-31,Net Income Including Noncontrolling Interests,143000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q4,2025-12-31,Net Income Continuous Operations,258000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q2,2025-06-30,Net Income Continuous Operations,72000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q1,2025-03-31,Net Income Continuous Operations,143000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q4,2025-12-31,Tax Provision,148000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q2,2025-06-30,Tax Provision,13000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q1,2025-03-31,Tax Provision,30000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q4,2025-12-31,Pretax Income,406000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q2,2025-06-30,Pretax Income,85000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q1,2025-03-31,Pretax Income,173000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q4,2025-12-31,Net Non Operating Interest Income Expense,-27000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q2,2025-06-30,Net Non Operating Interest Income Expense,-22000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q1,2025-03-31,Net Non Operating Interest Income Expense,-27000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q4,2025-12-31,Interest Expense Non Operating,27000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q2,2025-06-30,Interest Expense Non Operating,22000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q1,2025-03-31,Interest Expense Non Operating,27000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q4,2025-12-31,Operating Income,391000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q2,2025-06-30,Operating Income,107000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q1,2025-03-31,Operating Income,196000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q4,2025-12-31,Operating Expense,41000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q2,2025-06-30,Operating Expense,120000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q1,2025-03-31,Operating Expense,129000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q4,2025-12-31,Depreciation And Amortization In Income Statement,140000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q2,2025-06-30,Depreciation And Amortization In Income Statement,141000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q1,2025-03-31,Depreciation And Amortization In Income Statement,152000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q4,2025-12-31,Depreciation Income Statement,140000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q2,2025-06-30,Depreciation Income Statement,141000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q1,2025-03-31,Depreciation Income Statement,152000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q4,2025-12-31,Gross Profit,432000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q2,2025-06-30,Gross Profit,227000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q1,2025-03-31,Gross Profit,325000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q4,2025-12-31,Cost Of Revenue,1880000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q2,2025-06-30,Cost Of Revenue,2173000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q1,2025-03-31,Cost Of Revenue,2321000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q4,2025-12-31,Total Revenue,2312000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q2,2025-06-30,Total Revenue,2400000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q1,2025-03-31,Total Revenue,2646000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q4,2025-12-31,Operating Revenue,2312000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q2,2025-06-30,Operating Revenue,2400000000.0,EUR
UPM.HE,UPM-Kymmene / Raflatac,competitor,label_materials,Finland,2025-Q1,2025-03-31,Operating Revenue,2646000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q4,2025-12-31,Tax Effect Of Unusual Items,0.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q2,2025-06-30,Tax Effect Of Unusual Items,0.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q1,2025-03-31,Tax Effect Of Unusual Items,0.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q4,2025-12-31,Tax Rate For Calcs,0.153488,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q2,2025-06-30,Tax Rate For Calcs,0.25,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q1,2025-03-31,Tax Rate For Calcs,0.189394,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q4,2025-12-31,Normalized EBITDA,565000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q2,2025-06-30,Normalized EBITDA,186000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q1,2025-03-31,Normalized EBITDA,274000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q4,2025-12-31,Net Income From Continuing Operation Net Minority Interest,361000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q2,2025-06-30,Net Income From Continuing Operation Net Minority Interest,24000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q1,2025-03-31,Net Income From Continuing Operation Net Minority Interest,113000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q4,2025-12-31,Reconciled Depreciation,138000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q2,2025-06-30,Reconciled Depreciation,130000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q1,2025-03-31,Reconciled Depreciation,117000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q4,2025-12-31,Reconciled Cost Of Revenue,1335000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q2,2025-06-30,Reconciled Cost Of Revenue,1611000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q1,2025-03-31,Reconciled Cost Of Revenue,1499000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q4,2025-12-31,EBITDA,565000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q2,2025-06-30,EBITDA,186000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q1,2025-03-31,EBITDA,274000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q4,2025-12-31,EBIT,427000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q2,2025-06-30,EBIT,56000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q1,2025-03-31,EBIT,157000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q4,2025-12-31,Net Interest Income,-47000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q2,2025-06-30,Net Interest Income,-44000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q1,2025-03-31,Net Interest Income,-39000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q4,2025-12-31,Normalized Income,361000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q2,2025-06-30,Normalized Income,24000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q1,2025-03-31,Normalized Income,113000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q4,2025-12-31,Net Income From Continuing And Discontinued Operation,361000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q2,2025-06-30,Net Income From Continuing And Discontinued Operation,24000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q1,2025-03-31,Net Income From Continuing And Discontinued Operation,113000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q4,2025-12-31,Total Expenses,1827000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q2,2025-06-30,Total Expenses,2370000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q1,2025-03-31,Total Expenses,2205000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q4,2025-12-31,Total Operating Income As Reported,476000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q2,2025-06-30,Total Operating Income As Reported,64000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q1,2025-03-31,Total Operating Income As Reported,171000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q4,2025-12-31,Diluted Average Shares,789700000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q2,2025-06-30,Diluted Average Shares,789700000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q1,2025-03-31,Diluted Average Shares,789600000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q4,2025-12-31,Basic Average Shares,788600000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q2,2025-06-30,Basic Average Shares,788600000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q1,2025-03-31,Basic Average Shares,788600000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q4,2025-12-31,Diluted EPS,0.46,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q2,2025-06-30,Diluted EPS,0.03,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q1,2025-03-31,Diluted EPS,0.14,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q4,2025-12-31,Basic EPS,0.46,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q2,2025-06-30,Basic EPS,0.03,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q1,2025-03-31,Basic EPS,0.14,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q4,2025-12-31,Diluted NI Availto Com Stockholders,361000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q2,2025-06-30,Diluted NI Availto Com Stockholders,24000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q1,2025-03-31,Diluted NI Availto Com Stockholders,113000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q4,2025-12-31,Net Income Common Stockholders,361000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q2,2025-06-30,Net Income Common Stockholders,24000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q1,2025-03-31,Net Income Common Stockholders,113000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q4,2025-12-31,Otherunder Preferred Stock Dividend,0.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q2,2025-06-30,Otherunder Preferred Stock Dividend,0.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q1,2025-03-31,Otherunder Preferred Stock Dividend,0.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q4,2025-12-31,Net Income,361000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q2,2025-06-30,Net Income,24000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q1,2025-03-31,Net Income,113000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q4,2025-12-31,Minority Interests,-3000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q2,2025-06-30,Minority Interests,9000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q1,2025-03-31,Minority Interests,6000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q4,2025-12-31,Net Income Including Noncontrolling Interests,363000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q2,2025-06-30,Net Income Including Noncontrolling Interests,15000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q1,2025-03-31,Net Income Including Noncontrolling Interests,107000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q4,2025-12-31,Net Income Continuous Operations,364000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q2,2025-06-30,Net Income Continuous Operations,15000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q1,2025-03-31,Net Income Continuous Operations,107000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q4,2025-12-31,Tax Provision,66000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q2,2025-06-30,Tax Provision,5000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q1,2025-03-31,Tax Provision,25000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q4,2025-12-31,Pretax Income,430000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q2,2025-06-30,Pretax Income,20000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q1,2025-03-31,Pretax Income,132000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q4,2025-12-31,Net Non Operating Interest Income Expense,-47000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q2,2025-06-30,Net Non Operating Interest Income Expense,-44000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q1,2025-03-31,Net Non Operating Interest Income Expense,-39000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q4,2025-12-31,Operating Income,427000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q2,2025-06-30,Operating Income,56000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q1,2025-03-31,Operating Income,157000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q4,2025-12-31,Operating Expense,492000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q2,2025-06-30,Operating Expense,759000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q1,2025-03-31,Operating Expense,706000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q4,2025-12-31,Other Operating Expenses,133000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q2,2025-06-30,Other Operating Expenses,103000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q1,2025-03-31,Other Operating Expenses,112000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q4,2025-12-31,Depreciation And Amortization In Income Statement,138000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q2,2025-06-30,Depreciation And Amortization In Income Statement,130000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q1,2025-03-31,Depreciation And Amortization In Income Statement,117000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q4,2025-12-31,Depreciation Income Statement,138000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q2,2025-06-30,Depreciation Income Statement,130000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q1,2025-03-31,Depreciation Income Statement,117000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q2,2025-06-30,Selling General And Administration,223000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q1,2025-03-31,Selling General And Administration,222000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q2,2025-06-30,Selling And Marketing Expense,223000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q1,2025-03-31,Selling And Marketing Expense,222000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q4,2025-12-31,Gross Profit,919000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q2,2025-06-30,Gross Profit,815000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q1,2025-03-31,Gross Profit,863000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q4,2025-12-31,Cost Of Revenue,1335000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q2,2025-06-30,Cost Of Revenue,1611000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q1,2025-03-31,Cost Of Revenue,1499000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q4,2025-12-31,Total Revenue,2254000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q2,2025-06-30,Total Revenue,2426000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q1,2025-03-31,Total Revenue,2362000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q4,2025-12-31,Operating Revenue,2254000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q2,2025-06-30,Operating Revenue,2426000000.0,EUR
STERV.HE,Stora Enso,competitor,label_materials,Finland,2025-Q1,2025-03-31,Operating Revenue,2362000000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q4,2025-12-31,Tax Effect Of Unusual Items,0.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q2,2025-06-30,Tax Effect Of Unusual Items,0.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q1,2025-03-31,Tax Effect Of Unusual Items,0.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q4,2025-12-31,Tax Rate For Calcs,0.2106,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q2,2025-06-30,Tax Rate For Calcs,0.26129,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q1,2025-03-31,Tax Rate For Calcs,0.260759,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q4,2025-12-31,Normalized EBITDA,146300000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q2,2025-06-30,Normalized EBITDA,180600000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q1,2025-03-31,Normalized EBITDA,153900000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q4,2025-12-31,Net Income From Continuing Operation Net Minority Interest,55400000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q2,2025-06-30,Net Income From Continuing Operation Net Minority Interest,21100000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q1,2025-03-31,Net Income From Continuing Operation Net Minority Interest,56900000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q4,2025-12-31,Reconciled Depreciation,53200000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q2,2025-06-30,Reconciled Depreciation,129900000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q1,2025-03-31,Reconciled Depreciation,56100000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q4,2025-12-31,Reconciled Cost Of Revenue,789900000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q2,2025-06-30,Reconciled Cost Of Revenue,887500000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q1,2025-03-31,Reconciled Cost Of Revenue,803600000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q4,2025-12-31,EBITDA,146300000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q2,2025-06-30,EBITDA,180600000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q1,2025-03-31,EBITDA,153900000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q4,2025-12-31,EBIT,93100000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q2,2025-06-30,EBIT,50700000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q1,2025-03-31,EBIT,97800000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q4,2025-12-31,Net Interest Income,-17300000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q2,2025-06-30,Net Interest Income,-15200000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q1,2025-03-31,Net Interest Income,-14100000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q4,2025-12-31,Interest Expense,21400000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q2,2025-06-30,Interest Expense,19700000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q1,2025-03-31,Interest Expense,18800000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q4,2025-12-31,Interest Income,4100000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q2,2025-06-30,Interest Income,4500000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q1,2025-03-31,Interest Income,4700000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q4,2025-12-31,Normalized Income,55400000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q2,2025-06-30,Normalized Income,21100000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q1,2025-03-31,Normalized Income,56900000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q4,2025-12-31,Net Income From Continuing And Discontinued Operation,55400000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q2,2025-06-30,Net Income From Continuing And Discontinued Operation,21100000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q1,2025-03-31,Net Income From Continuing And Discontinued Operation,56900000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q4,2025-12-31,Total Expenses,891500000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q2,2025-06-30,Total Expenses,961300000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q1,2025-03-31,Total Expenses,907800000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q4,2025-12-31,Diluted Average Shares,104528302.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q2,2025-06-30,Diluted Average Shares,104878843.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q1,2025-03-31,Diluted Average Shares,104788381.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q4,2025-12-31,Basic Average Shares,104528302.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q2,2025-06-30,Basic Average Shares,104878843.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q1,2025-03-31,Basic Average Shares,104788381.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q4,2025-12-31,Diluted EPS,0.53,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q2,2025-06-30,Diluted EPS,0.2,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q1,2025-03-31,Diluted EPS,0.54,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q4,2025-12-31,Basic EPS,0.53,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q2,2025-06-30,Basic EPS,0.2,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q1,2025-03-31,Basic EPS,0.54,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q4,2025-12-31,Diluted NI Availto Com Stockholders,55400000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q2,2025-06-30,Diluted NI Availto Com Stockholders,21100000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q1,2025-03-31,Diluted NI Availto Com Stockholders,56900000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q4,2025-12-31,Net Income Common Stockholders,55400000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q2,2025-06-30,Net Income Common Stockholders,21100000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q1,2025-03-31,Net Income Common Stockholders,56900000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q4,2025-12-31,Otherunder Preferred Stock Dividend,0.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q2,2025-06-30,Otherunder Preferred Stock Dividend,0.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q1,2025-03-31,Otherunder Preferred Stock Dividend,0.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q4,2025-12-31,Net Income,55400000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q2,2025-06-30,Net Income,21100000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q1,2025-03-31,Net Income,56900000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q4,2025-12-31,Minority Interests,-1200000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q2,2025-06-30,Minority Interests,-1700000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q1,2025-03-31,Minority Interests,-2000000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q4,2025-12-31,Net Income Including Noncontrolling Interests,56600000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q2,2025-06-30,Net Income Including Noncontrolling Interests,22800000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q1,2025-03-31,Net Income Including Noncontrolling Interests,59000000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q4,2025-12-31,Net Income Continuous Operations,56600000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q2,2025-06-30,Net Income Continuous Operations,22800000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q1,2025-03-31,Net Income Continuous Operations,59000000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q4,2025-12-31,Tax Provision,15100000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q2,2025-06-30,Tax Provision,8100000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q1,2025-03-31,Tax Provision,20600000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q4,2025-12-31,Pretax Income,71700000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q2,2025-06-30,Pretax Income,31000000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q1,2025-03-31,Pretax Income,79000000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q4,2025-12-31,Net Non Operating Interest Income Expense,-17300000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q2,2025-06-30,Net Non Operating Interest Income Expense,-15200000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q1,2025-03-31,Net Non Operating Interest Income Expense,-14100000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q4,2025-12-31,Interest Expense Non Operating,21400000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q2,2025-06-30,Interest Expense Non Operating,19700000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q1,2025-03-31,Interest Expense Non Operating,18800000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q4,2025-12-31,Interest Income Non Operating,4100000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q2,2025-06-30,Interest Income Non Operating,4500000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q1,2025-03-31,Interest Income Non Operating,4700000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q4,2025-12-31,Operating Income,89000000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q2,2025-06-30,Operating Income,46200000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q1,2025-03-31,Operating Income,93800000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q4,2025-12-31,Operating Expense,101600000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q2,2025-06-30,Operating Expense,73800000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q1,2025-03-31,Operating Expense,104200000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q4,2025-12-31,Other Operating Expenses,6500000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q2,2025-06-30,Other Operating Expenses,500000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q1,2025-03-31,Other Operating Expenses,800000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q4,2025-12-31,Research And Development,5000000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q2,2025-06-30,Research And Development,21200000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q1,2025-03-31,Research And Development,9500000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q4,2025-12-31,Selling General And Administration,105300000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q2,2025-06-30,Selling General And Administration,108500000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q1,2025-03-31,Selling General And Administration,98900000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q4,2025-12-31,Selling And Marketing Expense,25800000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q2,2025-06-30,Selling And Marketing Expense,25000000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q1,2025-03-31,Selling And Marketing Expense,25400000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q4,2025-12-31,General And Administrative Expense,79500000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q2,2025-06-30,General And Administrative Expense,83500000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q1,2025-03-31,General And Administrative Expense,73500000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q4,2025-12-31,Gross Profit,190600000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q2,2025-06-30,Gross Profit,120000000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q1,2025-03-31,Gross Profit,198000000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q4,2025-12-31,Cost Of Revenue,789900000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q2,2025-06-30,Cost Of Revenue,887500000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q1,2025-03-31,Cost Of Revenue,803600000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q4,2025-12-31,Total Revenue,980500000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q2,2025-06-30,Total Revenue,1007500000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q1,2025-03-31,Total Revenue,1001600000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q4,2025-12-31,Operating Revenue,980500000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q2,2025-06-30,Operating Revenue,1007500000.0,EUR
HUH1V.HE,Huhtamaki,competitor,label_materials,Finland,2025-Q1,2025-03-31,Operating Revenue,1001600000.0,EUR
AVY,Avery Dennison,competitor,label_materials,US,2025-Q3,2025-09-30,Tax Effect Of Unusual Items,-4876400.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q2,2025-06-30,Tax Effect Of Unusual Items,-130136.986301,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q1,2025-03-31,Tax Effect Of Unusual Items,-5313300.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q3,2025-09-30,Tax Rate For Calcs,0.292,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q2,2025-06-30,Tax Rate For Calcs,0.260274,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q1,2025-03-31,Tax Rate For Calcs,0.267,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q3,2025-09-30,Normalized EBITDA,368800000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q2,2025-06-30,Normalized EBITDA,370800000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q1,2025-03-31,Normalized EBITDA,355700000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q3,2025-09-30,Total Unusual Items,-16700000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q2,2025-06-30,Total Unusual Items,-500000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q1,2025-03-31,Total Unusual Items,-19900000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q3,2025-09-30,Total Unusual Items Excluding Goodwill,-16700000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q2,2025-06-30,Total Unusual Items Excluding Goodwill,-500000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q1,2025-03-31,Total Unusual Items Excluding Goodwill,-19900000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q3,2025-09-30,Net Income From Continuing Operation Net Minority Interest,166300000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q2,2025-06-30,Net Income From Continuing Operation Net Minority Interest,189000000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q1,2025-03-31,Net Income From Continuing Operation Net Minority Interest,166300000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q3,2025-09-30,Reconciled Depreciation,84000000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q2,2025-06-30,Reconciled Depreciation,80800000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q1,2025-03-31,Reconciled Depreciation,77900000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q3,2025-09-30,Reconciled Cost Of Revenue,1580500000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q2,2025-06-30,Reconciled Cost Of Revenue,1581400000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q1,2025-03-31,Reconciled Cost Of Revenue,1526800000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q3,2025-09-30,EBITDA,352100000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q2,2025-06-30,EBITDA,370300000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q1,2025-03-31,EBITDA,335800000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q3,2025-09-30,EBIT,268100000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q2,2025-06-30,EBIT,289500000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q1,2025-03-31,EBIT,257900000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q3,2025-09-30,Net Interest Income,-33300000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q2,2025-06-30,Net Interest Income,-34000000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q1,2025-03-31,Net Interest Income,-30900000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q3,2025-09-30,Interest Expense,33300000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q2,2025-06-30,Interest Expense,34000000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q1,2025-03-31,Interest Expense,30900000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q3,2025-09-30,Normalized Income,178123600.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q2,2025-06-30,Normalized Income,189369863.013699,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q1,2025-03-31,Normalized Income,180886700.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q3,2025-09-30,Net Income From Continuing And Discontinued Operation,166300000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q2,2025-06-30,Net Income From Continuing And Discontinued Operation,189000000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q1,2025-03-31,Net Income From Continuing And Discontinued Operation,166300000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q3,2025-09-30,Total Expenses,1934400000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q2,2025-06-30,Total Expenses,1933800000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q1,2025-03-31,Total Expenses,1873800000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q4,2025-12-31,Diluted Average Shares,77400000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q3,2025-09-30,Diluted Average Shares,78000000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q2,2025-06-30,Diluted Average Shares,78300000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q1,2025-03-31,Diluted Average Shares,79400000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q4,2025-12-31,Basic Average Shares,77295394.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q3,2025-09-30,Basic Average Shares,77545388.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q2,2025-06-30,Basic Average Shares,78044822.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q1,2025-03-31,Basic Average Shares,78552144.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q4,2025-12-31,Diluted EPS,2.15,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q3,2025-09-30,Diluted EPS,2.13,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q2,2025-06-30,Diluted EPS,2.41,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q1,2025-03-31,Diluted EPS,2.09,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q4,2025-12-31,Basic EPS,2.15278,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q3,2025-09-30,Basic EPS,2.14455,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q2,2025-06-30,Basic EPS,2.421685,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q1,2025-03-31,Basic EPS,2.117619,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q3,2025-09-30,Diluted NI Availto Com Stockholders,166300000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q2,2025-06-30,Diluted NI Availto Com Stockholders,189000000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q1,2025-03-31,Diluted NI Availto Com Stockholders,166300000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q3,2025-09-30,Net Income Common Stockholders,166300000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q2,2025-06-30,Net Income Common Stockholders,189000000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q1,2025-03-31,Net Income Common Stockholders,166300000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q3,2025-09-30,Net Income,166300000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q2,2025-06-30,Net Income,189000000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q1,2025-03-31,Net Income,166300000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q3,2025-09-30,Net Income Including Noncontrolling Interests,166300000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q2,2025-06-30,Net Income Including Noncontrolling Interests,189000000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q1,2025-03-31,Net Income Including Noncontrolling Interests,166300000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q3,2025-09-30,Net Income Continuous Operations,166300000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q2,2025-06-30,Net Income Continuous Operations,189000000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q1,2025-03-31,Net Income Continuous Operations,166300000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q3,2025-09-30,Tax Provision,68500000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q2,2025-06-30,Tax Provision,66500000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q1,2025-03-31,Tax Provision,60700000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q3,2025-09-30,Pretax Income,234800000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q2,2025-06-30,Pretax Income,255500000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q1,2025-03-31,Pretax Income,227000000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q3,2025-09-30,Other Income Expense,-13000000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q2,2025-06-30,Other Income Expense,2800000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q1,2025-03-31,Other Income Expense,-16600000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q3,2025-09-30,Other Non Operating Income Expenses,3700000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q2,2025-06-30,Other Non Operating Income Expenses,3300000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q1,2025-03-31,Other Non Operating Income Expenses,3300000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q3,2025-09-30,Special Income Charges,-16100000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q2,2025-06-30,Special Income Charges,1300000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q1,2025-03-31,Special Income Charges,-19200000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q3,2025-09-30,Gain On Sale Of Ppe,400000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q2,2025-06-30,Gain On Sale Of Ppe,11100000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q2,2025-06-30,Gain On Sale Of Business,-1800000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q1,2025-03-31,Gain On Sale Of Business,-14300000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q3,2025-09-30,Other Special Charges,4700000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q3,2025-09-30,Write Off,2300000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q2,2025-06-30,Write Off,100000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q1,2025-03-31,Write Off,200000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q3,2025-09-30,Restructuring And Mergern Acquisition,9500000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q2,2025-06-30,Restructuring And Mergern Acquisition,7900000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q1,2025-03-31,Restructuring And Mergern Acquisition,4700000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q3,2025-09-30,Gain On Sale Of Security,-600000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q2,2025-06-30,Gain On Sale Of Security,-1800000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q1,2025-03-31,Gain On Sale Of Security,-700000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q3,2025-09-30,Net Non Operating Interest Income Expense,-33300000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q2,2025-06-30,Net Non Operating Interest Income Expense,-34000000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q1,2025-03-31,Net Non Operating Interest Income Expense,-30900000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q3,2025-09-30,Interest Expense Non Operating,33300000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q2,2025-06-30,Interest Expense Non Operating,34000000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q1,2025-03-31,Interest Expense Non Operating,30900000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q3,2025-09-30,Operating Income,281100000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q2,2025-06-30,Operating Income,286700000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q1,2025-03-31,Operating Income,274500000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q3,2025-09-30,Operating Expense,353900000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q2,2025-06-30,Operating Expense,352400000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q1,2025-03-31,Operating Expense,347000000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q3,2025-09-30,Selling General And Administration,353900000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q2,2025-06-30,Selling General And Administration,352400000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q1,2025-03-31,Selling General And Administration,347000000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q3,2025-09-30,Gross Profit,635000000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q2,2025-06-30,Gross Profit,639100000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q1,2025-03-31,Gross Profit,621500000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q3,2025-09-30,Cost Of Revenue,1580500000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q2,2025-06-30,Cost Of Revenue,1581400000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q1,2025-03-31,Cost Of Revenue,1526800000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q3,2025-09-30,Total Revenue,2215500000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q2,2025-06-30,Total Revenue,2220500000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q1,2025-03-31,Total Revenue,2148300000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q3,2025-09-30,Operating Revenue,2215500000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q2,2025-06-30,Operating Revenue,2220500000.0,USD
AVY,Avery Dennison,competitor,label_materials,US,2025-Q1,2025-03-31,Operating Revenue,2148300000.0,USD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q3,2025-09-30,Tax Effect Of Unusual Items,-405665.72238,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q2,2025-06-30,Tax Effect Of Unusual Items,-175676.625659,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q1,2025-03-31,Tax Effect Of Unusual Items,-197530.864198,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q3,2025-09-30,Tax Rate For Calcs,0.253541,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q2,2025-06-30,Tax Rate For Calcs,0.250967,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q1,2025-03-31,Tax Rate For Calcs,0.246914,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q3,2025-09-30,Normalized EBITDA,423100000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q2,2025-06-30,Normalized EBITDA,422200000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q1,2025-03-31,Normalized EBITDA,411200000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q3,2025-09-30,Total Unusual Items,-1600000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q2,2025-06-30,Total Unusual Items,-700000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q1,2025-03-31,Total Unusual Items,-800000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q3,2025-09-30,Total Unusual Items Excluding Goodwill,-1600000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q2,2025-06-30,Total Unusual Items Excluding Goodwill,-700000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q1,2025-03-31,Total Unusual Items Excluding Goodwill,-800000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q3,2025-09-30,Net Income From Continuing Operation Net Minority Interest,210800000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q2,2025-06-30,Net Income From Continuing Operation Net Minority Interest,213100000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q1,2025-03-31,Net Income From Continuing Operation Net Minority Interest,207400000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q3,2025-09-30,Reconciled Depreciation,115700000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q2,2025-06-30,Reconciled Depreciation,114500000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q1,2025-03-31,Reconciled Depreciation,113800000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q3,2025-09-30,Reconciled Cost Of Revenue,1370900000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q2,2025-06-30,Reconciled Cost Of Revenue,1346300000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q1,2025-03-31,Reconciled Cost Of Revenue,1315000000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q3,2025-09-30,EBITDA,421500000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q2,2025-06-30,EBITDA,421500000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q1,2025-03-31,EBITDA,410400000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q3,2025-09-30,EBIT,305800000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q2,2025-06-30,EBIT,307000000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q1,2025-03-31,EBIT,296600000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q3,2025-09-30,Net Interest Income,-18200000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q2,2025-06-30,Net Interest Income,-17300000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q1,2025-03-31,Net Interest Income,-18500000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q3,2025-09-30,Interest Expense,23400000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q2,2025-06-30,Interest Expense,22500000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q1,2025-03-31,Interest Expense,21200000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q3,2025-09-30,Interest Income,5200000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q2,2025-06-30,Interest Income,5200000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q1,2025-03-31,Interest Income,2700000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q3,2025-09-30,Normalized Income,211994334.27762,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q2,2025-06-30,Normalized Income,213624323.374341,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q1,2025-03-31,Normalized Income,208002469.135802,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q3,2025-09-30,Net Income From Continuing And Discontinued Operation,210800000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q2,2025-06-30,Net Income From Continuing And Discontinued Operation,213100000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q1,2025-03-31,Net Income From Continuing And Discontinued Operation,207400000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q3,2025-09-30,Total Expenses,1665500000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q2,2025-06-30,Total Expenses,1634300000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q1,2025-03-31,Total Expenses,1592900000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q3,2025-09-30,Diluted Average Shares,175666667.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q2,2025-06-30,Diluted Average Shares,176115702.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q1,2025-03-31,Diluted Average Shares,177264957.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q3,2025-09-30,Basic Average Shares,174214876.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q2,2025-06-30,Basic Average Shares,176115702.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q1,2025-03-31,Basic Average Shares,175762712.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q3,2025-09-30,Diluted EPS,1.2,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q2,2025-06-30,Diluted EPS,1.21,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q1,2025-03-31,Diluted EPS,1.17,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q3,2025-09-30,Basic EPS,1.21,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q2,2025-06-30,Basic EPS,1.21,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q1,2025-03-31,Basic EPS,1.18,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q3,2025-09-30,Diluted NI Availto Com Stockholders,210800000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q2,2025-06-30,Diluted NI Availto Com Stockholders,213100000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q1,2025-03-31,Diluted NI Availto Com Stockholders,207400000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q3,2025-09-30,Net Income Common Stockholders,210800000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q2,2025-06-30,Net Income Common Stockholders,213100000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q1,2025-03-31,Net Income Common Stockholders,207400000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q3,2025-09-30,Net Income,210800000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q2,2025-06-30,Net Income,213100000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q1,2025-03-31,Net Income,207400000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q3,2025-09-30,Net Income Including Noncontrolling Interests,210800000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q2,2025-06-30,Net Income Including Noncontrolling Interests,213100000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q1,2025-03-31,Net Income Including Noncontrolling Interests,207400000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q3,2025-09-30,Net Income Continuous Operations,210800000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q2,2025-06-30,Net Income Continuous Operations,213100000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q1,2025-03-31,Net Income Continuous Operations,207400000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q3,2025-09-30,Tax Provision,71600000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q2,2025-06-30,Tax Provision,71400000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q1,2025-03-31,Tax Provision,68000000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q3,2025-09-30,Pretax Income,282400000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q2,2025-06-30,Pretax Income,284500000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q1,2025-03-31,Pretax Income,275400000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q3,2025-09-30,Other Income Expense,200000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q2,2025-06-30,Other Income Expense,1500000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q1,2025-03-31,Other Income Expense,-300000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q3,2025-09-30,Special Income Charges,-1600000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q2,2025-06-30,Special Income Charges,-700000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q1,2025-03-31,Special Income Charges,-800000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q3,2025-09-30,Restructuring And Mergern Acquisition,1600000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q2,2025-06-30,Restructuring And Mergern Acquisition,700000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q1,2025-03-31,Restructuring And Mergern Acquisition,800000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q3,2025-09-30,Earnings From Equity Interest,1800000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q2,2025-06-30,Earnings From Equity Interest,2200000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q1,2025-03-31,Earnings From Equity Interest,500000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q3,2025-09-30,Net Non Operating Interest Income Expense,-18200000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q2,2025-06-30,Net Non Operating Interest Income Expense,-17300000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q1,2025-03-31,Net Non Operating Interest Income Expense,-18500000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q3,2025-09-30,Interest Expense Non Operating,23400000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q2,2025-06-30,Interest Expense Non Operating,22500000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q1,2025-03-31,Interest Expense Non Operating,21200000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q3,2025-09-30,Interest Income Non Operating,5200000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q2,2025-06-30,Interest Income Non Operating,5200000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q1,2025-03-31,Interest Income Non Operating,2700000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q3,2025-09-30,Operating Income,300400000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q2,2025-06-30,Operating Income,300300000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q1,2025-03-31,Operating Income,294200000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q3,2025-09-30,Operating Expense,294600000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q2,2025-06-30,Operating Expense,288000000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q1,2025-03-31,Operating Expense,277900000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q3,2025-09-30,Selling General And Administration,294600000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q2,2025-06-30,Selling General And Administration,288000000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q1,2025-03-31,Selling General And Administration,277900000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q3,2025-09-30,Gross Profit,595000000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q2,2025-06-30,Gross Profit,588300000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q1,2025-03-31,Gross Profit,572100000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q3,2025-09-30,Cost Of Revenue,1370900000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q2,2025-06-30,Cost Of Revenue,1346300000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q1,2025-03-31,Cost Of Revenue,1315000000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q3,2025-09-30,Total Revenue,1965900000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q2,2025-06-30,Total Revenue,1934600000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q1,2025-03-31,Total Revenue,1887100000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q3,2025-09-30,Operating Revenue,1965900000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q2,2025-06-30,Operating Revenue,1934600000.0,CAD
CCL-B.TO,CCL Industries,competitor,label_materials,Canada,2025-Q1,2025-03-31,Operating Revenue,1887100000.0,CAD
AMCR,Amcor,competitor,packaging,US,2025-Q4,2025-12-31,Tax Effect Of Unusual Items,-2006000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q3,2025-09-30,Tax Effect Of Unusual Items,-11925000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q2,2025-06-30,Tax Effect Of Unusual Items,-30127659.574468,USD
AMCR,Amcor,competitor,packaging,US,2025-Q1,2025-03-31,Tax Effect Of Unusual Items,-5408000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q4,2025-12-31,Tax Rate For Calcs,0.017,USD
AMCR,Amcor,competitor,packaging,US,2025-Q3,2025-09-30,Tax Rate For Calcs,0.159,USD
AMCR,Amcor,competitor,packaging,US,2025-Q2,2025-06-30,Tax Rate For Calcs,0.12766,USD
AMCR,Amcor,competitor,packaging,US,2025-Q1,2025-03-31,Tax Rate For Calcs,0.169,USD
AMCR,Amcor,competitor,packaging,US,2025-Q4,2025-12-31,Normalized EBITDA,838000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q3,2025-09-30,Normalized EBITDA,916000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q2,2025-06-30,Normalized EBITDA,656000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q1,2025-03-31,Normalized EBITDA,486000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q4,2025-12-31,Total Unusual Items,-118000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q3,2025-09-30,Total Unusual Items,-75000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q2,2025-06-30,Total Unusual Items,-236000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q1,2025-03-31,Total Unusual Items,-32000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q4,2025-12-31,Total Unusual Items Excluding Goodwill,-118000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q3,2025-09-30,Total Unusual Items Excluding Goodwill,-75000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q2,2025-06-30,Total Unusual Items Excluding Goodwill,-236000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q1,2025-03-31,Total Unusual Items Excluding Goodwill,-32000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q4,2025-12-31,Net Income From Continuing Operation Net Minority Interest,177000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q3,2025-09-30,Net Income From Continuing Operation Net Minority Interest,262000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q2,2025-06-30,Net Income From Continuing Operation Net Minority Interest,-39000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q1,2025-03-31,Net Income From Continuing Operation Net Minority Interest,196000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q4,2025-12-31,Reconciled Depreciation,373000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q3,2025-09-30,Reconciled Depreciation,364000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q2,2025-06-30,Reconciled Depreciation,323000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q1,2025-03-31,Reconciled Depreciation,132000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q4,2025-12-31,Reconciled Cost Of Revenue,4181000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q3,2025-09-30,Reconciled Cost Of Revenue,4390000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q2,2025-06-30,Reconciled Cost Of Revenue,4187000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q1,2025-03-31,Reconciled Cost Of Revenue,2679000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q4,2025-12-31,EBITDA,720000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q3,2025-09-30,EBITDA,841000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q2,2025-06-30,EBITDA,420000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q1,2025-03-31,EBITDA,454000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q4,2025-12-31,EBIT,347000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q3,2025-09-30,EBIT,477000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q2,2025-06-30,EBIT,97000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q1,2025-03-31,EBIT,322000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q4,2025-12-31,Net Interest Income,-154000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q3,2025-09-30,Net Interest Income,-153000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q2,2025-06-30,Net Interest Income,-125000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q1,2025-03-31,Net Interest Income,-75000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q4,2025-12-31,Interest Expense,169000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q3,2025-09-30,Interest Expense,168000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q2,2025-06-30,Interest Expense,144000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q1,2025-03-31,Interest Expense,85000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q4,2025-12-31,Interest Income,15000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q3,2025-09-30,Interest Income,15000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q2,2025-06-30,Interest Income,19000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q1,2025-03-31,Interest Income,10000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q4,2025-12-31,Normalized Income,292994000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q3,2025-09-30,Normalized Income,325075000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q2,2025-06-30,Normalized Income,166872340.425532,USD
AMCR,Amcor,competitor,packaging,US,2025-Q1,2025-03-31,Normalized Income,222592000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q4,2025-12-31,Net Income From Continuing And Discontinued Operation,177000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q3,2025-09-30,Net Income From Continuing And Discontinued Operation,262000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q2,2025-06-30,Net Income From Continuing And Discontinued Operation,-39000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q1,2025-03-31,Net Income From Continuing And Discontinued Operation,196000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q4,2025-12-31,Total Expenses,5000000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q3,2025-09-30,Total Expenses,5209000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q2,2025-06-30,Total Expenses,4759000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q1,2025-03-31,Total Expenses,2988000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q4,2025-12-31,Total Operating Income As Reported,331000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q3,2025-09-30,Total Operating Income As Reported,461000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q2,2025-06-30,Total Operating Income As Reported,87000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q1,2025-03-31,Total Operating Income As Reported,313000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q4,2025-12-31,Diluted Average Shares,92760000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q3,2025-09-30,Diluted Average Shares,463000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q2,2025-06-30,Diluted Average Shares,408000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q1,2025-03-31,Diluted Average Shares,289200000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q4,2025-12-31,Basic Average Shares,92620000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q3,2025-09-30,Basic Average Shares,462800000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q2,2025-06-30,Basic Average Shares,407000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q1,2025-03-31,Basic Average Shares,288600000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q4,2025-12-31,Diluted EPS,1.9,USD
AMCR,Amcor,competitor,packaging,US,2025-Q3,2025-09-30,Diluted EPS,0.565,USD
AMCR,Amcor,competitor,packaging,US,2025-Q2,2025-06-30,Diluted EPS,-0.095,USD
AMCR,Amcor,competitor,packaging,US,2025-Q1,2025-03-31,Diluted EPS,0.68,USD
AMCR,Amcor,competitor,packaging,US,2025-Q4,2025-12-31,Basic EPS,1.9,USD
AMCR,Amcor,competitor,packaging,US,2025-Q3,2025-09-30,Basic EPS,0.565,USD
AMCR,Amcor,competitor,packaging,US,2025-Q2,2025-06-30,Basic EPS,-0.095,USD
AMCR,Amcor,competitor,packaging,US,2025-Q1,2025-03-31,Basic EPS,0.68,USD
AMCR,Amcor,competitor,packaging,US,2025-Q4,2025-12-31,Diluted NI Availto Com Stockholders,177000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q3,2025-09-30,Diluted NI Availto Com Stockholders,262000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q2,2025-06-30,Diluted NI Availto Com Stockholders,-39000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q1,2025-03-31,Diluted NI Availto Com Stockholders,196000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q4,2025-12-31,Net Income Common Stockholders,177000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q3,2025-09-30,Net Income Common Stockholders,262000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q2,2025-06-30,Net Income Common Stockholders,-39000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q1,2025-03-31,Net Income Common Stockholders,196000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q4,2025-12-31,Otherunder Preferred Stock Dividend,0.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q3,2025-09-30,Otherunder Preferred Stock Dividend,0.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q2,2025-06-30,Otherunder Preferred Stock Dividend,0.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q1,2025-03-31,Otherunder Preferred Stock Dividend,0.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q4,2025-12-31,Net Income,177000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q3,2025-09-30,Net Income,262000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q2,2025-06-30,Net Income,-39000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q1,2025-03-31,Net Income,196000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q4,2025-12-31,Minority Interests,0.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q3,2025-09-30,Minority Interests,0.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q2,2025-06-30,Minority Interests,0.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q1,2025-03-31,Minority Interests,-1000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q4,2025-12-31,Net Income Including Noncontrolling Interests,177000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q3,2025-09-30,Net Income Including Noncontrolling Interests,262000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q2,2025-06-30,Net Income Including Noncontrolling Interests,-39000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q1,2025-03-31,Net Income Including Noncontrolling Interests,197000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q4,2025-12-31,Net Income Continuous Operations,177000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q3,2025-09-30,Net Income Continuous Operations,262000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q2,2025-06-30,Net Income Continuous Operations,-39000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q1,2025-03-31,Net Income Continuous Operations,197000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q4,2025-12-31,Earnings From Equity Interest Net Of Tax,2000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q3,2025-09-30,Earnings From Equity Interest Net Of Tax,2000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q2,2025-06-30,Earnings From Equity Interest Net Of Tax,2000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q1,2025-03-31,Earnings From Equity Interest Net Of Tax,0.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q4,2025-12-31,Tax Provision,3000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q3,2025-09-30,Tax Provision,49000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q2,2025-06-30,Tax Provision,-6000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q1,2025-03-31,Tax Provision,40000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q4,2025-12-31,Pretax Income,178000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q3,2025-09-30,Pretax Income,309000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q2,2025-06-30,Pretax Income,-47000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q1,2025-03-31,Pretax Income,237000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q4,2025-12-31,Other Income Expense,-117000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q3,2025-09-30,Other Income Expense,-74000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q2,2025-06-30,Other Income Expense,-245000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q1,2025-03-31,Other Income Expense,-33000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q4,2025-12-31,Other Non Operating Income Expenses,1000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q3,2025-09-30,Other Non Operating Income Expenses,1000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q2,2025-06-30,Other Non Operating Income Expenses,-9000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q1,2025-03-31,Other Non Operating Income Expenses,-1000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q4,2025-12-31,Special Income Charges,-118000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q3,2025-09-30,Special Income Charges,-75000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q2,2025-06-30,Special Income Charges,-236000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q1,2025-03-31,Special Income Charges,-32000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q4,2025-12-31,Restructuring And Mergern Acquisition,118000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q3,2025-09-30,Restructuring And Mergern Acquisition,75000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q2,2025-06-30,Restructuring And Mergern Acquisition,236000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q1,2025-03-31,Restructuring And Mergern Acquisition,32000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q4,2025-12-31,Net Non Operating Interest Income Expense,-154000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q3,2025-09-30,Net Non Operating Interest Income Expense,-153000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q2,2025-06-30,Net Non Operating Interest Income Expense,-125000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q1,2025-03-31,Net Non Operating Interest Income Expense,-75000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q4,2025-12-31,Interest Expense Non Operating,169000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q3,2025-09-30,Interest Expense Non Operating,168000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q2,2025-06-30,Interest Expense Non Operating,144000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q1,2025-03-31,Interest Expense Non Operating,85000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q4,2025-12-31,Interest Income Non Operating,15000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q3,2025-09-30,Interest Income Non Operating,15000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q2,2025-06-30,Interest Income Non Operating,19000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q1,2025-03-31,Interest Income Non Operating,10000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q4,2025-12-31,Operating Income,449000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q3,2025-09-30,Operating Income,536000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q2,2025-06-30,Operating Income,323000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q1,2025-03-31,Operating Income,345000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q4,2025-12-31,Operating Expense,590000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q3,2025-09-30,Operating Expense,588000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q2,2025-06-30,Operating Expense,572000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q1,2025-03-31,Operating Expense,309000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q4,2025-12-31,Other Operating Expenses,-32000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q3,2025-09-30,Other Operating Expenses,-26000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q2,2025-06-30,Other Operating Expenses,-4000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q1,2025-03-31,Other Operating Expenses,-21000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q4,2025-12-31,Depreciation Amortization Depletion Income Statement,144000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q3,2025-09-30,Depreciation Amortization Depletion Income Statement,133000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q4,2025-12-31,Depreciation And Amortization In Income Statement,144000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q3,2025-09-30,Depreciation And Amortization In Income Statement,133000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q4,2025-12-31,Amortization,144000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q3,2025-09-30,Amortization,133000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q4,2025-12-31,Amortization Of Intangibles Income Statement,144000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q3,2025-09-30,Amortization Of Intangibles Income Statement,133000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q4,2025-12-31,Research And Development,38000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q3,2025-09-30,Research And Development,46000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q2,2025-06-30,Research And Development,38000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q1,2025-03-31,Research And Development,27000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q4,2025-12-31,Selling General And Administration,440000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q3,2025-09-30,Selling General And Administration,435000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q2,2025-06-30,Selling General And Administration,292000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q1,2025-03-31,Selling General And Administration,303000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q4,2025-12-31,Gross Profit,1039000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q3,2025-09-30,Gross Profit,1124000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q2,2025-06-30,Gross Profit,895000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q1,2025-03-31,Gross Profit,654000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q4,2025-12-31,Cost Of Revenue,4410000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q3,2025-09-30,Cost Of Revenue,4621000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q2,2025-06-30,Cost Of Revenue,4187000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q1,2025-03-31,Cost Of Revenue,2679000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q4,2025-12-31,Total Revenue,5449000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q3,2025-09-30,Total Revenue,5745000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q2,2025-06-30,Total Revenue,5082000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q1,2025-03-31,Total Revenue,3333000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q4,2025-12-31,Operating Revenue,5449000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q3,2025-09-30,Operating Revenue,5745000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q2,2025-06-30,Operating Revenue,5082000000.0,USD
AMCR,Amcor,competitor,packaging,US,2025-Q1,2025-03-31,Operating Revenue,3333000000.0,USD
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q3,2025-09-30,Tax Effect Of Unusual Items,0.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q2,2025-06-30,Tax Effect Of Unusual Items,0.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q1,2025-03-31,Tax Effect Of Unusual Items,37965900.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q3,2025-09-30,Tax Rate For Calcs,0.3,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q2,2025-06-30,Tax Rate For Calcs,0.152833,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q1,2025-03-31,Tax Rate For Calcs,0.3,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q3,2025-09-30,Normalized EBITDA,1253000000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q2,2025-06-30,Normalized EBITDA,291800000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q1,2025-03-31,Normalized EBITDA,661635000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q1,2025-03-31,Total Unusual Items,126553000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q1,2025-03-31,Total Unusual Items Excluding Goodwill,126553000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q3,2025-09-30,Net Income From Continuing Operation Net Minority Interest,247000000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q2,2025-06-30,Net Income From Continuing Operation Net Minority Interest,-193100000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q1,2025-03-31,Net Income From Continuing Operation Net Minority Interest,101083000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q3,2025-09-30,Reconciled Depreciation,888000000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q2,2025-06-30,Reconciled Depreciation,856700000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q1,2025-03-31,Reconciled Depreciation,760838000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q3,2025-09-30,Reconciled Cost Of Revenue,11306600000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q2,2025-06-30,Reconciled Cost Of Revenue,10594800000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q1,2025-03-31,Reconciled Cost Of Revenue,18010760000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q3,2025-09-30,EBITDA,1253000000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q2,2025-06-30,EBITDA,291800000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q1,2025-03-31,EBITDA,788188000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q3,2025-09-30,EBIT,365000000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q2,2025-06-30,EBIT,-564900000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q1,2025-03-31,EBIT,27350000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q3,2025-09-30,Net Interest Income,-130400000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q2,2025-06-30,Net Interest Income,-141100000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q1,2025-03-31,Net Interest Income,286160000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q3,2025-09-30,Interest Expense,130400000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q2,2025-06-30,Interest Expense,141100000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q1,2025-03-31,Interest Expense,83471000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q3,2025-09-30,Normalized Income,247000000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q2,2025-06-30,Normalized Income,-193100000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q1,2025-03-31,Normalized Income,12495900.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q3,2025-09-30,Net Income From Continuing And Discontinued Operation,247000000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q2,2025-06-30,Net Income From Continuing And Discontinued Operation,-193100000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q1,2025-03-31,Net Income From Continuing And Discontinued Operation,101083000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q3,2025-09-30,Total Expenses,17676400000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q2,2025-06-30,Total Expenses,14439900000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q1,2025-03-31,Total Expenses,22079568000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q3,2025-09-30,Diluted Average Shares,31385006.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q2,2025-06-30,Diluted Average Shares,31398374.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q3,2025-09-30,Basic Average Shares,31385006.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q2,2025-06-30,Basic Average Shares,31398374.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q3,2025-09-30,Diluted EPS,7.87,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q2,2025-06-30,Diluted EPS,-6.15,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q3,2025-09-30,Basic EPS,7.87,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q2,2025-06-30,Basic EPS,-6.15,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q3,2025-09-30,Diluted NI Availto Com Stockholders,247000000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q2,2025-06-30,Diluted NI Availto Com Stockholders,-193100000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q1,2025-03-31,Diluted NI Availto Com Stockholders,101083000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q3,2025-09-30,Net Income Common Stockholders,247000000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q2,2025-06-30,Net Income Common Stockholders,-193100000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q1,2025-03-31,Net Income Common Stockholders,101083000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q3,2025-09-30,Otherunder Preferred Stock Dividend,0.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q2,2025-06-30,Otherunder Preferred Stock Dividend,0.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q1,2025-03-31,Otherunder Preferred Stock Dividend,0.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q3,2025-09-30,Net Income,247000000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q2,2025-06-30,Net Income,-193100000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q1,2025-03-31,Net Income,101083000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q3,2025-09-30,Minority Interests,-88000000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q2,2025-06-30,Minority Interests,405000000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q1,2025-03-31,Minority Interests,187629000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q3,2025-09-30,Net Income Including Noncontrolling Interests,335000000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q2,2025-06-30,Net Income Including Noncontrolling Interests,-598100000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q1,2025-03-31,Net Income Including Noncontrolling Interests,-86546000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q3,2025-09-30,Net Income Continuous Operations,335000000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q2,2025-06-30,Net Income Continuous Operations,-598100000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q1,2025-03-31,Net Income Continuous Operations,-86546000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q3,2025-09-30,Tax Provision,-100400000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q2,2025-06-30,Tax Provision,-107900000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q1,2025-03-31,Tax Provision,30425000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q3,2025-09-30,Pretax Income,234600000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q2,2025-06-30,Pretax Income,-706000000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q1,2025-03-31,Pretax Income,-56121000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q3,2025-09-30,Other Non Operating Income Expenses,227700000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q2,2025-06-30,Other Non Operating Income Expenses,-1947500000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q1,2025-03-31,Other Non Operating Income Expenses,5596679000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q1,2025-03-31,Special Income Charges,328000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q3,2025-09-30,Net Non Operating Interest Income Expense,-130400000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q2,2025-06-30,Net Non Operating Interest Income Expense,-141100000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q1,2025-03-31,Net Non Operating Interest Income Expense,286160000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q3,2025-09-30,Interest Expense Non Operating,130400000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q2,2025-06-30,Interest Expense Non Operating,141100000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q1,2025-03-31,Interest Expense Non Operating,83471000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q3,2025-09-30,Operating Income,264000000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q2,2025-06-30,Operating Income,2946800000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q1,2025-03-31,Operating Income,-4842763000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q3,2025-09-30,Operating Expense,6369800000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q2,2025-06-30,Operating Expense,3845100000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q1,2025-03-31,Operating Expense,4068808000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q3,2025-09-30,Other Operating Expenses,3628600000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q2,2025-06-30,Other Operating Expenses,1173900000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q1,2025-03-31,Other Operating Expenses,-2059080000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q3,2025-09-30,Depreciation And Amortization In Income Statement,888000000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q2,2025-06-30,Depreciation And Amortization In Income Statement,856700000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q1,2025-03-31,Depreciation And Amortization In Income Statement,760838000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q3,2025-09-30,Depreciation Income Statement,888000000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q2,2025-06-30,Depreciation Income Statement,856700000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q1,2025-03-31,Depreciation Income Statement,760546000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q3,2025-09-30,Gross Profit,6633800000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q2,2025-06-30,Gross Profit,6791900000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q1,2025-03-31,Gross Profit,-773955000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q3,2025-09-30,Cost Of Revenue,11306600000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q2,2025-06-30,Cost Of Revenue,10594800000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q1,2025-03-31,Cost Of Revenue,18010760000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q3,2025-09-30,Total Revenue,17940400000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q2,2025-06-30,Total Revenue,17386700000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q1,2025-03-31,Total Revenue,17236805000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q3,2025-09-30,Operating Revenue,17940400000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q2,2025-06-30,Operating Revenue,17386700000.0,INR
POLYPLEX.NS,Polyplex Corporation,competitor,films,India,2025-Q1,2025-03-31,Operating Revenue,17236805000.0,INR
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q2,2025-06-30,Tax Effect Of Unusual Items,-369354.883521,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q1,2025-03-31,Tax Effect Of Unusual Items,1427634.361757,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q2,2025-06-30,Tax Rate For Calcs,0.086687,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q1,2025-03-31,Tax Rate For Calcs,0.129006,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q2,2025-06-30,Normalized EBITDA,63221676.36,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q1,2025-03-31,Normalized EBITDA,66526225.27,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q2,2025-06-30,Total Unusual Items,-4260788.99,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q1,2025-03-31,Total Unusual Items,11066390.36,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q2,2025-06-30,Total Unusual Items Excluding Goodwill,-4260788.99,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q1,2025-03-31,Total Unusual Items Excluding Goodwill,11066390.36,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q2,2025-06-30,Net Income From Continuing Operation Net Minority Interest,55547444.56,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q1,2025-03-31,Net Income From Continuing Operation Net Minority Interest,66619659.15,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q2,2025-06-30,Reconciled Cost Of Revenue,509115956.03,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q1,2025-03-31,Reconciled Cost Of Revenue,492644412.99,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q2,2025-06-30,EBITDA,58960887.37,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q1,2025-03-31,EBITDA,77592615.63,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q2,2025-06-30,EBIT,58960887.37,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q1,2025-03-31,EBIT,77592615.63,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q2,2025-06-30,Net Interest Income,3163069.48,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q1,2025-03-31,Net Interest Income,-995806.45,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q2,2025-06-30,Interest Expense,248255.67,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q1,2025-03-31,Interest Expense,977220.47,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q2,2025-06-30,Interest Income,1310230.75,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q1,2025-03-31,Interest Income,1786788.6,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q2,2025-06-30,Normalized Income,59438878.666479,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q1,2025-03-31,Normalized Income,56980903.151757,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q2,2025-06-30,Net Income From Continuing And Discontinued Operation,55547444.56,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q1,2025-03-31,Net Income From Continuing And Discontinued Operation,66619659.15,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q2,2025-06-30,Total Expenses,609374707.46,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q1,2025-03-31,Total Expenses,613619423.2,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q2,2025-06-30,Total Operating Income As Reported,44405742.1,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q1,2025-03-31,Total Operating Income As Reported,76527400.96,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q1,2025-03-31,Diluted Average Shares,1332393183.0,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q1,2025-03-31,Basic Average Shares,1332393183.0,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q1,2025-03-31,Diluted EPS,0.05,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q1,2025-03-31,Basic EPS,0.05,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q2,2025-06-30,Net Income Common Stockholders,55547444.56,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q1,2025-03-31,Net Income Common Stockholders,66619659.15,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q2,2025-06-30,Otherunder Preferred Stock Dividend,0.0,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q1,2025-03-31,Otherunder Preferred Stock Dividend,0.0,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q2,2025-06-30,Net Income,55547444.56,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q1,2025-03-31,Net Income,66619659.15,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q2,2025-06-30,Minority Interests,1924432.95,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q1,2025-03-31,Minority Interests,-111865.37,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q2,2025-06-30,Net Income Including Noncontrolling Interests,53623011.61,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q1,2025-03-31,Net Income Including Noncontrolling Interests,66731524.52,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q2,2025-06-30,Net Income Continuous Operations,53623011.61,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q1,2025-03-31,Net Income Continuous Operations,66731524.52,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q2,2025-06-30,Tax Provision,5089620.09,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q1,2025-03-31,Tax Provision,9883870.64,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q2,2025-06-30,Pretax Income,58712631.7,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q1,2025-03-31,Pretax Income,76615395.16,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q2,2025-06-30,Other Non Operating Income Expenses,14306889.6,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q1,2025-03-31,Other Non Operating Income Expenses,87994.2,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q2,2025-06-30,Special Income Charges,-4260788.99,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q1,2025-03-31,Special Income Charges,11066390.36,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q2,2025-06-30,Other Special Charges,-2529812.12,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q1,2025-03-31,Other Special Charges,721361.4,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q2,2025-06-30,Write Off,8165297.13,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q1,2025-03-31,Write Off,-11675191.65,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q2,2025-06-30,Impairment Of Capital Assets,-1374696.02,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q1,2025-03-31,Impairment Of Capital Assets,-112560.11,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q2,2025-06-30,Net Non Operating Interest Income Expense,3163069.48,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q1,2025-03-31,Net Non Operating Interest Income Expense,-995806.45,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q2,2025-06-30,Total Other Finance Cost,-2101094.4,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q1,2025-03-31,Total Other Finance Cost,1805374.58,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q2,2025-06-30,Interest Expense Non Operating,248255.67,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q1,2025-03-31,Interest Expense Non Operating,977220.47,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q2,2025-06-30,Interest Income Non Operating,1310230.75,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q1,2025-03-31,Interest Income Non Operating,1786788.6,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q2,2025-06-30,Operating Income,-6166808.25,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q1,2025-03-31,Operating Income,21673351.5,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q2,2025-06-30,Operating Expense,100258751.43,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q1,2025-03-31,Operating Expense,120975010.21,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q2,2025-06-30,Other Operating Expenses,9266048.4,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q1,2025-03-31,Other Operating Expenses,8379890.7,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q2,2025-06-30,Research And Development,29172033.29,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q1,2025-03-31,Research And Development,36129809.09,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q2,2025-06-30,Selling General And Administration,-21615581.8,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q1,2025-03-31,Selling General And Administration,78360415.8,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q2,2025-06-30,Selling And Marketing Expense,1888975.87,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q1,2025-03-31,Selling And Marketing Expense,18642804.71,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q2,2025-06-30,General And Administrative Expense,-23504557.67,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q1,2025-03-31,General And Administrative Expense,59717611.09,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q2,2025-06-30,Gross Profit,94091943.18,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q1,2025-03-31,Gross Profit,142648361.71,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q2,2025-06-30,Cost Of Revenue,509115956.03,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q1,2025-03-31,Cost Of Revenue,492644412.99,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q2,2025-06-30,Total Revenue,603207899.21,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q1,2025-03-31,Total Revenue,635292774.7,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q2,2025-06-30,Operating Revenue,603207899.21,CNY
002191.SZ,Jinjia Group,competitor,label_materials,China,2025-Q1,2025-03-31,Operating Revenue,635292774.7,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q2,2025-06-30,Tax Effect Of Unusual Items,0.0,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q1,2025-03-31,Tax Effect Of Unusual Items,0.0,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q2,2025-06-30,Tax Rate For Calcs,0.117901,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q1,2025-03-31,Tax Rate For Calcs,0.25,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q2,2025-06-30,Normalized EBITDA,-27361415.37,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q1,2025-03-31,Normalized EBITDA,-5915762.69,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q2,2025-06-30,Net Income From Continuing Operation Net Minority Interest,-33786883.61,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q1,2025-03-31,Net Income From Continuing Operation Net Minority Interest,-9813367.88,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q2,2025-06-30,Reconciled Cost Of Revenue,190046484.0,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q1,2025-03-31,Reconciled Cost Of Revenue,172775755.84,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q2,2025-06-30,EBITDA,-27361415.37,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q1,2025-03-31,EBITDA,-5915762.69,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q2,2025-06-30,EBIT,-27361415.37,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q1,2025-03-31,EBIT,-5915762.69,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q2,2025-06-30,Net Interest Income,-634989.04,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q1,2025-03-31,Net Interest Income,-1894859.95,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q2,2025-06-30,Normalized Income,-33786883.61,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q1,2025-03-31,Normalized Income,-9813367.88,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q2,2025-06-30,Net Income From Continuing And Discontinued Operation,-33786883.61,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q1,2025-03-31,Net Income From Continuing And Discontinued Operation,-9813367.88,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q2,2025-06-30,Total Expenses,198158830.46,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q1,2025-03-31,Total Expenses,193059606.71,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q2,2025-06-30,Total Operating Income As Reported,-30838298.24,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q1,2025-03-31,Total Operating Income As Reported,-6655849.75,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q1,2025-03-31,Diluted Average Shares,211494997.0,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q1,2025-03-31,Basic Average Shares,211494997.0,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q1,2025-03-31,Diluted EPS,-0.0464,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q1,2025-03-31,Basic EPS,-0.0464,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q2,2025-06-30,Net Income Common Stockholders,-33786883.61,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q1,2025-03-31,Net Income Common Stockholders,-9813367.88,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q2,2025-06-30,Otherunder Preferred Stock Dividend,0.0,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q1,2025-03-31,Otherunder Preferred Stock Dividend,0.0,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q2,2025-06-30,Net Income,-33786883.61,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q1,2025-03-31,Net Income,-9813367.88,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q2,2025-06-30,Minority Interests,-6749549.58,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q1,2025-03-31,Minority Interests,-1121374.12,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q2,2025-06-30,Net Income Including Noncontrolling Interests,-27037334.03,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q1,2025-03-31,Net Income Including Noncontrolling Interests,-8691993.76,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q2,2025-06-30,Net Income Continuous Operations,-27037334.03,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q1,2025-03-31,Net Income Continuous Operations,-8691993.76,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q2,2025-06-30,Tax Provision,-3613782.4,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q1,2025-03-31,Tax Provision,2085817.87,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q2,2025-06-30,Pretax Income,-30651116.43,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q1,2025-03-31,Pretax Income,-6606175.89,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q2,2025-06-30,Other Non Operating Income Expenses,187181.81,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q1,2025-03-31,Other Non Operating Income Expenses,49673.86,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q2,2025-06-30,Net Non Operating Interest Income Expense,-634989.04,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q1,2025-03-31,Net Non Operating Interest Income Expense,-1894859.95,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q2,2025-06-30,Total Other Finance Cost,-1874561.47,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q1,2025-03-31,Total Other Finance Cost,1894859.95,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q2,2025-06-30,Operating Income,10876666.61,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q1,2025-03-31,Operating Income,-5915762.69,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q2,2025-06-30,Operating Expense,8112346.46,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q1,2025-03-31,Operating Expense,20283850.87,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q2,2025-06-30,Other Operating Expenses,1870653.47,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q1,2025-03-31,Other Operating Expenses,728680.04,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q2,2025-06-30,Research And Development,746053.3,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q1,2025-03-31,Research And Development,457471.32,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q2,2025-06-30,Selling General And Administration,-4397102.16,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q1,2025-03-31,Selling General And Administration,21332338.73,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q2,2025-06-30,Selling And Marketing Expense,-821442.59,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q1,2025-03-31,Selling And Marketing Expense,7772167.03,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q2,2025-06-30,General And Administrative Expense,-3575659.57,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q1,2025-03-31,General And Administrative Expense,13560171.7,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q2,2025-06-30,Gross Profit,18989013.07,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q1,2025-03-31,Gross Profit,14368088.18,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q2,2025-06-30,Cost Of Revenue,190046484.0,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q1,2025-03-31,Cost Of Revenue,172775755.84,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q2,2025-06-30,Total Revenue,209035497.07,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q1,2025-03-31,Total Revenue,187143844.02,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q2,2025-06-30,Operating Revenue,209035497.07,CNY
300106.SZ,Guanhao High-Tech,competitor,release_films,China,2025-Q1,2025-03-31,Operating Revenue,187143844.02,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q2,2025-06-30,Tax Effect Of Unusual Items,-2096401.045,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q1,2025-03-31,Tax Effect Of Unusual Items,403431.03,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q2,2025-06-30,Tax Rate For Calcs,0.25,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q1,2025-03-31,Tax Rate For Calcs,0.25,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q2,2025-06-30,Normalized EBITDA,44138615.16,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q1,2025-03-31,Normalized EBITDA,26565626.3,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q2,2025-06-30,Total Unusual Items,-8385604.18,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q1,2025-03-31,Total Unusual Items,1613724.12,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q2,2025-06-30,Total Unusual Items Excluding Goodwill,-8385604.18,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q1,2025-03-31,Total Unusual Items Excluding Goodwill,1613724.12,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q2,2025-06-30,Net Income From Continuing Operation Net Minority Interest,17706172.07,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q1,2025-03-31,Net Income From Continuing Operation Net Minority Interest,13071950.97,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q2,2025-06-30,Reconciled Cost Of Revenue,1595563305.13,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q1,2025-03-31,Reconciled Cost Of Revenue,1418397774.84,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q2,2025-06-30,EBITDA,35753010.98,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q1,2025-03-31,EBITDA,28179350.42,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q2,2025-06-30,EBIT,35753010.98,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q1,2025-03-31,EBIT,28179350.42,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q2,2025-06-30,Net Interest Income,-22529551.75,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q1,2025-03-31,Net Interest Income,-14202317.58,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q2,2025-06-30,Interest Expense,19369326.42,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q1,2025-03-31,Interest Expense,18068122.7,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q2,2025-06-30,Interest Income,2116570.64,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q1,2025-03-31,Interest Income,2708268.9,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q2,2025-06-30,Normalized Income,23995375.205,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q1,2025-03-31,Normalized Income,11861657.88,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q2,2025-06-30,Net Income From Continuing And Discontinued Operation,17706172.07,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q1,2025-03-31,Net Income From Continuing And Discontinued Operation,13071950.97,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q2,2025-06-30,Total Expenses,1678584303.44,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q1,2025-03-31,Total Expenses,1504847888.03,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q2,2025-06-30,Total Operating Income As Reported,16947926.15,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q1,2025-03-31,Total Operating Income As Reported,10144808.9,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q1,2025-03-31,Diluted Average Shares,186742157.0,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q1,2025-03-31,Basic Average Shares,186742157.0,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q1,2025-03-31,Diluted EPS,0.07,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q1,2025-03-31,Basic EPS,0.07,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q2,2025-06-30,Net Income Common Stockholders,17706172.07,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q1,2025-03-31,Net Income Common Stockholders,13071950.97,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q2,2025-06-30,Otherunder Preferred Stock Dividend,0.0,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q1,2025-03-31,Otherunder Preferred Stock Dividend,0.0,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q2,2025-06-30,Net Income,17706172.07,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q1,2025-03-31,Net Income,13071950.97,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q2,2025-06-30,Net Income Including Noncontrolling Interests,17706172.07,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q1,2025-03-31,Net Income Including Noncontrolling Interests,13071950.97,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q2,2025-06-30,Net Income Continuous Operations,17706172.07,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q1,2025-03-31,Net Income Continuous Operations,13071950.97,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q2,2025-06-30,Tax Provision,-1322487.51,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q1,2025-03-31,Tax Provision,-2960723.25,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q2,2025-06-30,Pretax Income,16383684.56,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q1,2025-03-31,Pretax Income,10111227.72,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q2,2025-06-30,Other Non Operating Income Expenses,-564241.59,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q1,2025-03-31,Other Non Operating Income Expenses,-33581.18,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q2,2025-06-30,Special Income Charges,-3261152.07,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q1,2025-03-31,Special Income Charges,-8964024.16,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q2,2025-06-30,Other Special Charges,108238.43,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q1,2025-03-31,Other Special Charges,30851.97,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q2,2025-06-30,Write Off,1282896.06,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q1,2025-03-31,Write Off,2954923.83,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q2,2025-06-30,Impairment Of Capital Assets,1870017.58,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q1,2025-03-31,Impairment Of Capital Assets,5978248.36,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q2,2025-06-30,Net Non Operating Interest Income Expense,-22529551.75,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q1,2025-03-31,Net Non Operating Interest Income Expense,-14202317.58,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q2,2025-06-30,Total Other Finance Cost,5276795.97,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q1,2025-03-31,Total Other Finance Cost,-1157536.22,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q2,2025-06-30,Interest Expense Non Operating,19369326.42,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q1,2025-03-31,Interest Expense Non Operating,18068122.7,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q2,2025-06-30,Interest Income Non Operating,2116570.64,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q1,2025-03-31,Interest Income Non Operating,2708268.9,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q2,2025-06-30,Operating Income,47334095.12,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q1,2025-03-31,Operating Income,21919189.86,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q2,2025-06-30,Operating Expense,83020998.31,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q1,2025-03-31,Operating Expense,86450113.19,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q2,2025-06-30,Other Operating Expenses,5173460.82,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q1,2025-03-31,Other Operating Expenses,4129018.58,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q2,2025-06-30,Research And Development,53749951.62,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q1,2025-03-31,Research And Development,46181254.46,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q2,2025-06-30,Selling General And Administration,-9878248.65,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q1,2025-03-31,Selling General And Administration,46691448.78,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q2,2025-06-30,Selling And Marketing Expense,-3103585.15,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q1,2025-03-31,Selling And Marketing Expense,17906723.36,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q2,2025-06-30,General And Administrative Expense,-6774663.5,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q1,2025-03-31,General And Administrative Expense,28784725.42,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q2,2025-06-30,Gross Profit,130355093.43,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q1,2025-03-31,Gross Profit,108369303.05,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q2,2025-06-30,Cost Of Revenue,1595563305.13,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q1,2025-03-31,Cost Of Revenue,1418397774.84,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q2,2025-06-30,Total Revenue,1725918398.56,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q1,2025-03-31,Total Revenue,1526767077.89,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q2,2025-06-30,Operating Revenue,1725918398.56,CNY
603681.SS,Shanghai Yongguan,competitor,label_materials,China,2025-Q1,2025-03-31,Operating Revenue,1526767077.89,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q2,2025-06-30,Tax Effect Of Unusual Items,172370.236903,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q1,2025-03-31,Tax Effect Of Unusual Items,635188.375,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q2,2025-06-30,Tax Rate For Calcs,0.046204,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q1,2025-03-31,Tax Rate For Calcs,0.25,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q2,2025-06-30,Normalized EBITDA,-11639858.66,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q1,2025-03-31,Normalized EBITDA,-29629125.71,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q2,2025-06-30,Total Unusual Items,3730632.08,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q1,2025-03-31,Total Unusual Items,2540753.5,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q2,2025-06-30,Total Unusual Items Excluding Goodwill,3730632.08,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q1,2025-03-31,Total Unusual Items Excluding Goodwill,2540753.5,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q2,2025-06-30,Net Income From Continuing Operation Net Minority Interest,-15983796.75,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q1,2025-03-31,Net Income From Continuing Operation Net Minority Interest,-24081717.75,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q2,2025-06-30,Reconciled Cost Of Revenue,514162805.42,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q1,2025-03-31,Reconciled Cost Of Revenue,465809242.69,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q2,2025-06-30,EBITDA,-7909226.58,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q1,2025-03-31,EBITDA,-27088372.21,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q2,2025-06-30,EBIT,-7909226.58,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q1,2025-03-31,EBIT,-27088372.21,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q2,2025-06-30,Net Interest Income,-1748069.12,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q1,2025-03-31,Net Interest Income,500623.85,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q2,2025-06-30,Normalized Income,-19542058.593097,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q1,2025-03-31,Normalized Income,-25987282.875,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q2,2025-06-30,Net Income From Continuing And Discontinued Operation,-15983796.75,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q1,2025-03-31,Net Income From Continuing And Discontinued Operation,-24081717.75,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q2,2025-06-30,Total Expenses,561028543.98,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q1,2025-03-31,Total Expenses,515026948.59,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q2,2025-06-30,Total Operating Income As Reported,-17648692.78,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q1,2025-03-31,Total Operating Income As Reported,-22088244.85,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q1,2025-03-31,Diluted Average Shares,802723925.0,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q1,2025-03-31,Basic Average Shares,802723925.0,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q1,2025-03-31,Diluted EPS,-0.03,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q1,2025-03-31,Basic EPS,-0.03,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q2,2025-06-30,Net Income Common Stockholders,-15983796.75,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q1,2025-03-31,Net Income Common Stockholders,-24081717.75,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q2,2025-06-30,Otherunder Preferred Stock Dividend,0.0,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q1,2025-03-31,Otherunder Preferred Stock Dividend,0.0,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q2,2025-06-30,Net Income,-15983796.75,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q1,2025-03-31,Net Income,-24081717.75,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q2,2025-06-30,Net Income Including Noncontrolling Interests,-15983796.75,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q1,2025-03-31,Net Income Including Noncontrolling Interests,-24081717.75,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q2,2025-06-30,Net Income Continuous Operations,-15983796.75,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q1,2025-03-31,Net Income Continuous Operations,-24081717.75,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q2,2025-06-30,Tax Provision,-774291.2,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q1,2025-03-31,Tax Provision,2459296.85,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q2,2025-06-30,Pretax Income,-16758087.95,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q1,2025-03-31,Pretax Income,-21622420.9,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q2,2025-06-30,Other Non Operating Income Expenses,890604.83,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q1,2025-03-31,Other Non Operating Income Expenses,465823.95,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q2,2025-06-30,Special Income Charges,2959899.82,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q1,2025-03-31,Special Income Charges,1978731.2,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q2,2025-06-30,Other Special Charges,-19558.52,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q1,2025-03-31,Other Special Charges,-1163932.45,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q2,2025-06-30,Write Off,-3040333.19,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q1,2025-03-31,Write Off,-1078927.72,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q2,2025-06-30,Impairment Of Capital Assets,99991.89,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q1,2025-03-31,Impairment Of Capital Assets,264128.97,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q2,2025-06-30,Net Non Operating Interest Income Expense,-1748069.12,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q1,2025-03-31,Net Non Operating Interest Income Expense,500623.85,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q2,2025-06-30,Total Other Finance Cost,736742.62,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q1,2025-03-31,Total Other Finance Cost,-500623.85,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q2,2025-06-30,Operating Income,-23902685.6,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q1,2025-03-31,Operating Income,-27088372.21,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q2,2025-06-30,Operating Expense,46865738.56,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q1,2025-03-31,Operating Expense,49217705.9,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q2,2025-06-30,Other Operating Expenses,3608287.43,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q1,2025-03-31,Other Operating Expenses,3497224.85,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q2,2025-06-30,Research And Development,22273448.83,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q1,2025-03-31,Research And Development,19918708.8,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q2,2025-06-30,Selling General And Administration,-17140366.26,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q1,2025-03-31,Selling General And Administration,29529075.69,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q2,2025-06-30,Selling And Marketing Expense,-3622258.05,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q1,2025-03-31,Selling And Marketing Expense,8071970.94,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q2,2025-06-30,General And Administrative Expense,-13518108.21,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q1,2025-03-31,General And Administrative Expense,21457104.75,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q2,2025-06-30,Gross Profit,22963052.96,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q1,2025-03-31,Gross Profit,22129333.69,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q2,2025-06-30,Cost Of Revenue,514162805.42,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q1,2025-03-31,Cost Of Revenue,465809242.69,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q2,2025-06-30,Total Revenue,537125858.38,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q1,2025-03-31,Total Revenue,487938576.38,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q2,2025-06-30,Operating Revenue,537125858.38,CNY
000859.SZ,Anhui Guofeng,competitor,films,China,2025-Q1,2025-03-31,Operating Revenue,487938576.38,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q2,2025-06-30,Tax Effect Of Unusual Items,-4072770.17,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q1,2025-03-31,Tax Effect Of Unusual Items,-150017.887985,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q2,2025-06-30,Tax Rate For Calcs,0.25,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q1,2025-03-31,Tax Rate For Calcs,0.392934,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q2,2025-06-30,Normalized EBITDA,27699749.76,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q1,2025-03-31,Normalized EBITDA,3390416.55,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q2,2025-06-30,Total Unusual Items,-16291080.68,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q1,2025-03-31,Total Unusual Items,-381789.37,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q2,2025-06-30,Total Unusual Items Excluding Goodwill,-16291080.68,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q1,2025-03-31,Total Unusual Items Excluding Goodwill,-381789.37,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q2,2025-06-30,Net Income From Continuing Operation Net Minority Interest,3281275.04,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q1,2025-03-31,Net Income From Continuing Operation Net Minority Interest,4658799.2,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q2,2025-06-30,Reconciled Cost Of Revenue,270853213.0,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q1,2025-03-31,Reconciled Cost Of Revenue,277718248.05,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q2,2025-06-30,EBITDA,11408669.08,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q1,2025-03-31,EBITDA,3008627.18,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q2,2025-06-30,EBIT,11408669.08,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q1,2025-03-31,EBIT,3008627.18,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q2,2025-06-30,Net Interest Income,5569137.92,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q1,2025-03-31,Net Interest Income,3786496.42,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q2,2025-06-30,Interest Income,4332867.68,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q1,2025-03-31,Interest Income,5818738.3,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q2,2025-06-30,Normalized Income,15499585.55,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q1,2025-03-31,Normalized Income,4890570.682015,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q2,2025-06-30,Net Income From Continuing And Discontinued Operation,3281275.04,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q1,2025-03-31,Net Income From Continuing And Discontinued Operation,4658799.2,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q2,2025-06-30,Total Expenses,305947862.75,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q1,2025-03-31,Total Expenses,308341057.58,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q2,2025-06-30,Total Operating Income As Reported,6612444.54,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q1,2025-03-31,Total Operating Income As Reported,6413334.23,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q1,2025-03-31,Diluted Average Shares,1863519680.0,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q1,2025-03-31,Basic Average Shares,1863519680.0,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q1,2025-03-31,Diluted EPS,0.0025,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q1,2025-03-31,Basic EPS,0.0025,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q2,2025-06-30,Net Income Common Stockholders,3281275.04,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q1,2025-03-31,Net Income Common Stockholders,4658799.2,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q2,2025-06-30,Otherunder Preferred Stock Dividend,0.0,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q1,2025-03-31,Otherunder Preferred Stock Dividend,0.0,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q2,2025-06-30,Net Income,3281275.04,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q1,2025-03-31,Net Income,4658799.2,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q2,2025-06-30,Net Income Including Noncontrolling Interests,3281275.04,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q1,2025-03-31,Net Income Including Noncontrolling Interests,4658799.2,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q2,2025-06-30,Net Income Continuous Operations,3281275.04,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q1,2025-03-31,Net Income Continuous Operations,4658799.2,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q2,2025-06-30,Tax Provision,3235323.99,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q1,2025-03-31,Tax Provision,3015484.09,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q2,2025-06-30,Pretax Income,6516599.03,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q1,2025-03-31,Pretax Income,7674283.29,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q2,2025-06-30,Other Non Operating Income Expenses,-95845.51,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q1,2025-03-31,Other Non Operating Income Expenses,1260949.06,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q2,2025-06-30,Special Income Charges,-16291080.68,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q1,2025-03-31,Special Income Charges,-381789.37,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q2,2025-06-30,Write Off,179664.43,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q1,2025-03-31,Write Off,381789.37,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q2,2025-06-30,Net Non Operating Interest Income Expense,5569137.92,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q1,2025-03-31,Net Non Operating Interest Income Expense,3786496.42,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q2,2025-06-30,Total Other Finance Cost,-1462684.18,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q1,2025-03-31,Total Other Finance Cost,2032241.88,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q2,2025-06-30,Interest Income Non Operating,4332867.68,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q1,2025-03-31,Interest Income Non Operating,5818738.3,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q2,2025-06-30,Operating Income,19361407.55,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q1,2025-03-31,Operating Income,3008627.18,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q2,2025-06-30,Operating Expense,35094649.75,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q1,2025-03-31,Operating Expense,30622809.53,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q2,2025-06-30,Other Operating Expenses,5192694.44,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q1,2025-03-31,Other Operating Expenses,3097326.74,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q2,2025-06-30,Research And Development,13107767.97,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q1,2025-03-31,Research And Development,13477631.51,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q2,2025-06-30,Selling General And Administration,-8671507.44,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q1,2025-03-31,Selling General And Administration,19732189.09,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q2,2025-06-30,Selling And Marketing Expense,48300.7,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q1,2025-03-31,Selling And Marketing Expense,2378082.11,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q2,2025-06-30,General And Administrative Expense,-8719808.14,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q1,2025-03-31,General And Administrative Expense,17354106.98,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q2,2025-06-30,Gross Profit,54456057.3,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q1,2025-03-31,Gross Profit,33631436.71,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q2,2025-06-30,Cost Of Revenue,270853213.0,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q1,2025-03-31,Cost Of Revenue,277718248.05,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q2,2025-06-30,Total Revenue,325309270.3,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q1,2025-03-31,Total Revenue,311349684.76,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q2,2025-06-30,Operating Revenue,325309270.3,CNY
002263.SZ,Zhejiang Dadongnan,competitor,films,China,2025-Q1,2025-03-31,Operating Revenue,311349684.76,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q2,2025-06-30,Tax Effect Of Unusual Items,-2010668.20252,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q1,2025-03-31,Tax Effect Of Unusual Items,-1463753.468903,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q2,2025-06-30,Tax Rate For Calcs,0.164428,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q1,2025-03-31,Tax Rate For Calcs,0.11501,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q2,2025-06-30,Normalized EBITDA,-57528798.09,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q1,2025-03-31,Normalized EBITDA,-39985648.2,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q2,2025-06-30,Total Unusual Items,-12228284.91,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q1,2025-03-31,Total Unusual Items,-12727202.78,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q2,2025-06-30,Total Unusual Items Excluding Goodwill,-12228284.91,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q1,2025-03-31,Total Unusual Items Excluding Goodwill,-12727202.78,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q2,2025-06-30,Net Income From Continuing Operation Net Minority Interest,-67491092.26,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q1,2025-03-31,Net Income From Continuing Operation Net Minority Interest,-56535086.84,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q2,2025-06-30,Reconciled Cost Of Revenue,279886853.81,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q1,2025-03-31,Reconciled Cost Of Revenue,251122173.87,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q2,2025-06-30,EBITDA,-69757083.0,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q1,2025-03-31,EBITDA,-52712850.98,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q2,2025-06-30,EBIT,-69757083.0,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q1,2025-03-31,EBIT,-52712850.98,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q2,2025-06-30,Net Interest Income,-8963924.38,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q1,2025-03-31,Net Interest Income,-8480699.06,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q2,2025-06-30,Interest Expense,11068375.5,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q1,2025-03-31,Interest Expense,11214480.58,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q2,2025-06-30,Interest Income,2285660.02,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q1,2025-03-31,Interest Income,2652867.54,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q2,2025-06-30,Normalized Income,-57273475.55252,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q1,2025-03-31,Normalized Income,-45271637.528903,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q2,2025-06-30,Net Income From Continuing And Discontinued Operation,-67491092.26,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q1,2025-03-31,Net Income From Continuing And Discontinued Operation,-56535086.84,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q2,2025-06-30,Total Expenses,306147894.36,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q1,2025-03-31,Total Expenses,275495642.64,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q2,2025-06-30,Total Operating Income As Reported,-80825857.38,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q1,2025-03-31,Total Operating Income As Reported,-63871293.84,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q1,2025-03-31,Diluted Average Shares,375398983.0,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q1,2025-03-31,Basic Average Shares,375398983.0,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q1,2025-03-31,Diluted EPS,-0.1506,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q1,2025-03-31,Basic EPS,-0.1506,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q2,2025-06-30,Net Income Common Stockholders,-67491092.26,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q1,2025-03-31,Net Income Common Stockholders,-56535086.84,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q2,2025-06-30,Otherunder Preferred Stock Dividend,0.0,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q1,2025-03-31,Otherunder Preferred Stock Dividend,0.0,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q2,2025-06-30,Net Income,-67491092.26,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q1,2025-03-31,Net Income,-56535086.84,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q2,2025-06-30,Minority Interests,44425.7,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q1,2025-03-31,Minority Interests,39972.98,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q2,2025-06-30,Net Income Including Noncontrolling Interests,-67535517.96,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q1,2025-03-31,Net Income Including Noncontrolling Interests,-56575059.82,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q2,2025-06-30,Net Income Continuous Operations,-67535517.96,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q1,2025-03-31,Net Income Continuous Operations,-56575059.82,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q2,2025-06-30,Tax Provision,-13289940.54,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q1,2025-03-31,Tax Provision,-7352271.74,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q2,2025-06-30,Pretax Income,-80825458.5,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q1,2025-03-31,Pretax Income,-63927331.56,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q2,2025-06-30,Other Non Operating Income Expenses,398.88,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q1,2025-03-31,Other Non Operating Income Expenses,-56037.72,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q2,2025-06-30,Special Income Charges,-12351169.29,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q1,2025-03-31,Special Income Charges,-12804087.24,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q2,2025-06-30,Write Off,495158.75,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q1,2025-03-31,Write Off,-136470.14,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q2,2025-06-30,Impairment Of Capital Assets,11855681.51,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q1,2025-03-31,Impairment Of Capital Assets,12940557.38,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q2,2025-06-30,Net Non Operating Interest Income Expense,-8963924.38,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q1,2025-03-31,Net Non Operating Interest Income Expense,-8480699.06,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q2,2025-06-30,Total Other Finance Cost,181208.9,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q1,2025-03-31,Total Other Finance Cost,-80913.98,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q2,2025-06-30,Interest Expense Non Operating,11068375.5,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q1,2025-03-31,Interest Expense Non Operating,11214480.58,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q2,2025-06-30,Interest Income Non Operating,2285660.02,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q1,2025-03-31,Interest Income Non Operating,2652867.54,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q2,2025-06-30,Operating Income,-61521278.58,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q1,2025-03-31,Operating Income,-44678776.95,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q2,2025-06-30,Operating Expense,26261040.55,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q1,2025-03-31,Operating Expense,24373468.77,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q2,2025-06-30,Other Operating Expenses,2996428.33,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q1,2025-03-31,Other Operating Expenses,1966561.82,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q2,2025-06-30,Research And Development,10958474.36,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q1,2025-03-31,Research And Development,12196851.86,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q2,2025-06-30,Selling General And Administration,2300227.94,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q1,2025-03-31,Selling General And Administration,12185481.84,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q2,2025-06-30,Selling And Marketing Expense,1370366.23,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q1,2025-03-31,Selling And Marketing Expense,773275.5,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q2,2025-06-30,General And Administrative Expense,929861.71,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q1,2025-03-31,General And Administrative Expense,11412206.34,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q2,2025-06-30,Gross Profit,-35260238.03,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q1,2025-03-31,Gross Profit,-20305308.18,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q2,2025-06-30,Cost Of Revenue,279886853.81,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q1,2025-03-31,Cost Of Revenue,251122173.87,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q2,2025-06-30,Total Revenue,244626615.78,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q1,2025-03-31,Total Revenue,230816865.69,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q2,2025-06-30,Operating Revenue,244626615.78,CNY
300305.SZ,Jiangsu Yuxing Film,competitor,films,China,2025-Q1,2025-03-31,Operating Revenue,230816865.69,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q2,2025-06-30,Tax Effect Of Unusual Items,399405.013036,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q1,2025-03-31,Tax Effect Of Unusual Items,-127051.026519,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q2,2025-06-30,Tax Rate For Calcs,0.137532,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q1,2025-03-31,Tax Rate For Calcs,0.182324,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q2,2025-06-30,Normalized EBITDA,386168700.32,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q1,2025-03-31,Normalized EBITDA,240055967.3,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q2,2025-06-30,Total Unusual Items,2904082.34,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q1,2025-03-31,Total Unusual Items,-696840.78,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q2,2025-06-30,Total Unusual Items Excluding Goodwill,2904082.34,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q1,2025-03-31,Total Unusual Items Excluding Goodwill,-696840.78,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q2,2025-06-30,Net Income From Continuing Operation Net Minority Interest,303519207.43,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q1,2025-03-31,Net Income From Continuing Operation Net Minority Interest,169266605.02,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q2,2025-06-30,Reconciled Cost Of Revenue,2168916529.81,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q1,2025-03-31,Reconciled Cost Of Revenue,1851838012.05,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q2,2025-06-30,EBITDA,389072782.66,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q1,2025-03-31,EBITDA,239359126.52,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q2,2025-06-30,EBIT,389072782.66,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q1,2025-03-31,EBIT,239359126.52,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q2,2025-06-30,Net Interest Income,-16275482.79,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q1,2025-03-31,Net Interest Income,-19394033.6,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q2,2025-06-30,Interest Expense,23066318.1,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q1,2025-03-31,Interest Expense,22861665.14,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q2,2025-06-30,Interest Income,5819195.51,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q1,2025-03-31,Interest Income,5843092.7,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q2,2025-06-30,Normalized Income,301014530.103036,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q1,2025-03-31,Normalized Income,169836394.773481,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q2,2025-06-30,Net Income From Continuing And Discontinued Operation,303519207.43,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q1,2025-03-31,Net Income From Continuing And Discontinued Operation,169266605.02,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q2,2025-06-30,Total Expenses,2502965921.09,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q1,2025-03-31,Total Expenses,2131017685.93,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q2,2025-06-30,Total Operating Income As Reported,365544717.21,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q1,2025-03-31,Total Operating Income As Reported,214581511.75,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q1,2025-03-31,Diluted Average Shares,1511308973.0,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q1,2025-03-31,Basic Average Shares,1511308973.0,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q1,2025-03-31,Diluted EPS,0.112,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q1,2025-03-31,Basic EPS,0.112,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q2,2025-06-30,Net Income Common Stockholders,303519207.43,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q1,2025-03-31,Net Income Common Stockholders,169266605.02,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q2,2025-06-30,Otherunder Preferred Stock Dividend,0.0,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q1,2025-03-31,Otherunder Preferred Stock Dividend,0.0,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q2,2025-06-30,Net Income,303519207.43,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q1,2025-03-31,Net Income,169266605.02,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q2,2025-06-30,Minority Interests,-12149560.18,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q1,2025-03-31,Minority Interests,-7758102.33,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q2,2025-06-30,Net Income Including Noncontrolling Interests,315668767.61,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q1,2025-03-31,Net Income Including Noncontrolling Interests,177024707.35,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q2,2025-06-30,Net Income Continuous Operations,315668767.61,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q1,2025-03-31,Net Income Continuous Operations,177024707.35,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q2,2025-06-30,Tax Provision,50337696.95,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q1,2025-03-31,Tax Provision,39472754.03,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q2,2025-06-30,Pretax Income,366006464.56,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q1,2025-03-31,Pretax Income,216497461.38,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q2,2025-06-30,Other Non Operating Income Expenses,461747.35,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q1,2025-03-31,Other Non Operating Income Expenses,1915949.63,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q2,2025-06-30,Special Income Charges,1279124.64,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q1,2025-03-31,Special Income Charges,-290163.08,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q2,2025-06-30,Other Special Charges,-2014899.24,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q1,2025-03-31,Other Special Charges,-17614.98,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q2,2025-06-30,Write Off,482200.78,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q1,2025-03-31,Write Off,411158.14,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q2,2025-06-30,Impairment Of Capital Assets,253573.82,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q1,2025-03-31,Impairment Of Capital Assets,-103380.08,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q2,2025-06-30,Net Non Operating Interest Income Expense,-16275482.79,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q1,2025-03-31,Net Non Operating Interest Income Expense,-19394033.6,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q2,2025-06-30,Total Other Finance Cost,-971639.8,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q1,2025-03-31,Total Other Finance Cost,2375461.16,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q2,2025-06-30,Interest Expense Non Operating,23066318.1,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q1,2025-03-31,Interest Expense Non Operating,22861665.14,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q2,2025-06-30,Interest Income Non Operating,5819195.51,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q1,2025-03-31,Interest Income Non Operating,5843092.7,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q2,2025-06-30,Operating Income,382207851.28,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q1,2025-03-31,Operating Income,231887360.56,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q2,2025-06-30,Operating Expense,334049391.28,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q1,2025-03-31,Operating Expense,279179673.88,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q2,2025-06-30,Other Operating Expenses,43207236.05,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q1,2025-03-31,Other Operating Expenses,19417325.62,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q2,2025-06-30,Research And Development,89782322.45,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q1,2025-03-31,Research And Development,77138984.32,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q2,2025-06-30,Selling General And Administration,-49579774.67,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q1,2025-03-31,Selling General And Administration,199534331.6,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q2,2025-06-30,Selling And Marketing Expense,15732192.99,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q1,2025-03-31,Selling And Marketing Expense,31757447.28,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q2,2025-06-30,General And Administrative Expense,-65311967.66,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q1,2025-03-31,General And Administrative Expense,167776884.32,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q2,2025-06-30,Gross Profit,716257242.56,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q1,2025-03-31,Gross Profit,511067034.44,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q2,2025-06-30,Cost Of Revenue,2168916529.81,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q1,2025-03-31,Cost Of Revenue,1851838012.05,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q2,2025-06-30,Total Revenue,2885173772.37,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q1,2025-03-31,Total Revenue,2362905046.49,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q2,2025-06-30,Operating Revenue,2885173772.37,CNY
600210.SS,Shanghai Zijiang,competitor,label_materials,China,2025-Q1,2025-03-31,Operating Revenue,2362905046.49,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q2,2025-06-30,Tax Effect Of Unusual Items,-687659.3025,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q1,2025-03-31,Tax Effect Of Unusual Items,-105307.61,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q2,2025-06-30,Tax Rate For Calcs,0.25,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q1,2025-03-31,Tax Rate For Calcs,0.25,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q2,2025-06-30,Normalized EBITDA,-18544374.29,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q1,2025-03-31,Normalized EBITDA,-26032006.9,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q2,2025-06-30,Total Unusual Items,-2750637.21,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q1,2025-03-31,Total Unusual Items,-421230.44,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q2,2025-06-30,Total Unusual Items Excluding Goodwill,-2750637.21,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q1,2025-03-31,Total Unusual Items Excluding Goodwill,-421230.44,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q2,2025-06-30,Net Income From Continuing Operation Net Minority Interest,-24343232.0,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q1,2025-03-31,Net Income From Continuing Operation Net Minority Interest,-28596200.17,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q2,2025-06-30,Reconciled Cost Of Revenue,306086122.41,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q1,2025-03-31,Reconciled Cost Of Revenue,251095779.69,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q2,2025-06-30,EBITDA,-21295011.5,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q1,2025-03-31,EBITDA,-26453237.34,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q2,2025-06-30,EBIT,-21295011.5,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q1,2025-03-31,EBIT,-26453237.34,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q2,2025-06-30,Net Interest Income,461847.66,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q1,2025-03-31,Net Interest Income,2325135.93,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q2,2025-06-30,Interest Expense,175037.15,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q1,2025-03-31,Interest Expense,151525.36,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q2,2025-06-30,Interest Income,1649780.67,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q1,2025-03-31,Interest Income,1734679.77,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q2,2025-06-30,Normalized Income,-22280254.0925,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q1,2025-03-31,Normalized Income,-28280277.34,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q2,2025-06-30,Net Income From Continuing And Discontinued Operation,-24343232.0,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q1,2025-03-31,Net Income From Continuing And Discontinued Operation,-28596200.17,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q2,2025-06-30,Total Expenses,376058601.93,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q1,2025-03-31,Total Expenses,318485205.52,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q2,2025-06-30,Total Operating Income As Reported,-21232618.38,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q1,2025-03-31,Total Operating Income As Reported,-26648379.17,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q1,2025-03-31,Diluted Average Shares,553117992.0,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q1,2025-03-31,Basic Average Shares,553117992.0,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q1,2025-03-31,Diluted EPS,-0.0517,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q1,2025-03-31,Basic EPS,-0.0517,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q2,2025-06-30,Net Income Common Stockholders,-24343232.0,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q1,2025-03-31,Net Income Common Stockholders,-28596200.17,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q2,2025-06-30,Otherunder Preferred Stock Dividend,0.0,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q1,2025-03-31,Otherunder Preferred Stock Dividend,0.0,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q2,2025-06-30,Net Income,-24343232.0,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q1,2025-03-31,Net Income,-28596200.17,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q2,2025-06-30,Minority Interests,-1923684.58,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q1,2025-03-31,Minority Interests,-1080458.58,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q2,2025-06-30,Net Income Including Noncontrolling Interests,-22419547.42,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q1,2025-03-31,Net Income Including Noncontrolling Interests,-27515741.59,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q2,2025-06-30,Net Income Continuous Operations,-22419547.42,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q1,2025-03-31,Net Income Continuous Operations,-27515741.59,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q2,2025-06-30,Tax Provision,949498.77,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q1,2025-03-31,Tax Provision,910978.89,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q2,2025-06-30,Pretax Income,-21470048.65,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q1,2025-03-31,Pretax Income,-26604762.7,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q2,2025-06-30,Other Non Operating Income Expenses,-237430.27,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q1,2025-03-31,Other Non Operating Income Expenses,43616.47,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q2,2025-06-30,Special Income Charges,-4514320.35,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q1,2025-03-31,Special Income Charges,-2350702.91,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q2,2025-06-30,Other Special Charges,-3654.83,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q1,2025-03-31,Other Special Charges,-70131.46,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q2,2025-06-30,Write Off,1776686.61,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q1,2025-03-31,Write Off,2420834.37,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q2,2025-06-30,Net Non Operating Interest Income Expense,461847.66,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q1,2025-03-31,Net Non Operating Interest Income Expense,2325135.93,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q2,2025-06-30,Total Other Finance Cost,1012895.86,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q1,2025-03-31,Total Other Finance Cost,-741981.52,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q2,2025-06-30,Interest Expense Non Operating,175037.15,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q1,2025-03-31,Interest Expense Non Operating,151525.36,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q2,2025-06-30,Interest Income Non Operating,1649780.67,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q1,2025-03-31,Interest Income Non Operating,1734679.77,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q2,2025-06-30,Operating Income,-22451424.52,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q1,2025-03-31,Operating Income,-28506101.68,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q2,2025-06-30,Operating Expense,69972479.52,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q1,2025-03-31,Operating Expense,67389425.83,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q2,2025-06-30,Other Operating Expenses,3903125.01,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q1,2025-03-31,Other Operating Expenses,2872993.0,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q2,2025-06-30,Research And Development,25336430.55,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q1,2025-03-31,Research And Development,24952724.54,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q2,2025-06-30,Selling General And Administration,-19988640.19,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q1,2025-03-31,Selling General And Administration,42201442.21,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q2,2025-06-30,Selling And Marketing Expense,-5307721.3,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q1,2025-03-31,Selling And Marketing Expense,12246769.25,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q2,2025-06-30,General And Administrative Expense,-14680918.89,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q1,2025-03-31,General And Administrative Expense,29954672.96,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q2,2025-06-30,Gross Profit,47521055.0,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q1,2025-03-31,Gross Profit,38883324.15,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q2,2025-06-30,Cost Of Revenue,306086122.41,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q1,2025-03-31,Cost Of Revenue,251095779.69,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q2,2025-06-30,Total Revenue,353607177.41,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q1,2025-03-31,Total Revenue,289979103.84,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q2,2025-06-30,Operating Revenue,353607177.41,CNY
600135.SS,Lekai Film,competitor,release_films,China,2025-Q1,2025-03-31,Operating Revenue,289979103.84,CNY
